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ABSTRACT
The biological role of the trace metal chromium has
been a much studied topic since it was identified as a major
component of the glucose tolerance factor.

This factor,

isolated from yeast, has been. shown by numerous investigators
to have a significant effect on the improvement of impaired
glucose tolerance in certain animal and human subjects.

It

has also been shown to have a potentiating effect on insulin
with regard to glucose oxidation by epididymal adipose tissue.
Although the exact identity of the glucose tolerance factor
is unknown at present, it is known with certainty that one
of its components namely trivalent chromium, possesses similar activities.

Such observations have led many investigators

to label trivalent chromium as a cofactor of carbohydrate
metabolism and a factor necessary for insulin action.

In this

dissertation the techniques of circular dichroism spectroscopy
and frontal gel chromatography were utilized to provide evidence for an interaction between insulin and trivalent chromium
in an attempt to further clarify the role of this trace metal.
A solution of porcine zinc-free insulin (1.71 X l0- 5M)

.
was prepared in 0.067M phosphate buffer, pH 7.42.

Cr

+3

and Zn

+2

were added to final concentrations of 1.71 X 10- 4 and 0.85 X
l0- 5M, respectively.

Circular dichroism spectra were recorded

over the range of 250 to 310nm.

For porcine zinc-free insulin,

a broad negative extremum was observed at 274nm with an

·vi

ellipticity of -143 deg cm 2 per decimole.

For porcine zinc

insulin the negative extremum was observed at 276nm with an
ellipticity of -165 deg cm 2 per decimole.

Addition of tri-

valent chromium to the porcine zinc insulin resulted in a
significant diminution of the negative band to -144 deg cm 2
per decimole; the same ellipticity observed for porcine.zincfree insulin.

These results are consistent with a dissociative

effect for cr+3.
Under similar conditions, the circular dichroism spectra
of porcine zinc-free insulin at concentrations of O.lmg/ml,
0.2mg/ml and 0.5mg/ml were recorded in lOcm, 5cm and 2cm cells,
respectively, in an attempt to focus attention on the insulin
aggregation process.

For the O.lmg/ml solution in the lOcm

cell, the negative extremum was observed at 274nm with an ellipticity of -179 deg cm 2 per decimole.

For the remainding

solutions, ellipticities of -191 and -197 deg cm 2 per decimole
were obtained.

This clearly indicates a concentration dependent

aggregation with progression to the more concentrated solutions.
The addition of zn+ 2 to zinc-free insulin resulted in a significant increase in the negative extremum in all three cases.
Situations with both cr+3 and zn+2 present resulted in ellipticities nearer to that of zinc-free insulin again highly
suggestive of a dissociative effect for cr+3.
Finally, the technique of frontal_ gel chromatography
was utilized as an aid in the clarification of the previously
discussed circular dichroism changes.

Insulin concentrations

over the range of 0.005 to 4mg/ml were studied and molecular

vii

weights from 4,503 to 26,077, respectively, were determined.
The technique was then utilized to study the effect of Cr+ 3
and Zn+ 2 on the aggregation of porcine zinc-free insulin in
0.067M phosphate buffer, pH 7.42.

Solutions identical to

those used in the circular dichroism studies were chromatographed.

Molecular weights of 8,565, 10,079, and 12,502

were obtained for zinc-free insulin at concentrations of
O.lmg/ml, 0.2mg/ml and 0.5mg/ml, respectively.

Pre-incubation

of the insulin solutions with zn+ 2 resulted in molecular
weights of 8,387, 11,022 and 16,866.

Pre-incubation with

. molecular weights of 8,521,
both Zn +2 and Cr +3 resulted in
10,187 and 13,105 for the same concentration sequence, further
supporting a dissociative effect for Cr+ 3 .
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CHAPTER 1
INTRODUCTION
Elements which are necessary for biological function
are known as essential, that is, without them, life does not
exist.

This definition was broadened by Schroeder (1), to

include those elements necessary for special purposes which
1

provide

pe~fect

health but without which life can still exist

at an unhealthy level.

Both of these categories remain un-

filled at the present time.

However, with the help of

sophisticated techniques, scientists are gradually unraveling
the mysteries of the nature and mechanism of action of more
recently characterized essential elements.

By the most rigid

definition, no trace element essential for life in other mammals has been proven to be essential for human beings.

In

other words, according to Schroeder, no one has deprived a
group of people of an element to the point that deficiency has
resulted in death and as a result the minimal human requirements of many essential trace elements are not known.
The Essential Trace Elements
At present, two groups of elements (essential bulk
elements and essential trace elements) have been defined (1).
Under the heading of "essential bulk elements" are included
calcium, sodium, silicon, potassium, magnesium, sulfur, phos-·
phorus and chlorine.

Included as "essential trace elements"

1
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are

iron, manganese, fluorine, chromium, zinc, copper, cobalt,

molybdenum, iodine, selenium, vanadium, nickel, and arsenic.
In another study, tin and silicon have been designated as
essential trace elements (2).

Human requirements for most of

the bulk elements are known since, according to Schroeder,
disorders have resulted from depletion and have been cured by
restoration.
Let us now briefly review the principal functions of
the essential trace elements.
The role of iron in the body is almost exclusively
confined to the processes of cellular respiration.

Iron is

a component of hemoglobin, myoglobin and cytochrome, as well
as the enzymes catalase and peroxidase.

In all of these

compounds, the iron is a component of porphyrin.

Collagen

is synthesized by a series of sequential steps involving
assembly of a praline and lysine rich polypeptide precursor
called "protocollagen"

(3).

Hydroxylation of appropriate

praline and lysine residues in protocollagen, which occurs
before the collagen extrudes into the extracellular matrix,
requires iron as Fe (II).

No other metal ion will replace iron.

Although animal experiments have indicated that manganese is an essential element, its functions are poorly
understood.

In vitro, manganese activates several enzymes,

among them blood and bone phosphatases, yeast, intestine and
liver phosphatases, arginase, carboxylase and cholinesterase.
A role for manganese as a coenzyme for certain intracellular
respiratory enzyme systems has also been suggested.

Deficiency

F
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in animals and birds affects bone, reproduction, and brain
growth, resulting in abnormalities of bony growth, stillbirths,
early death and sterility of the mother and convulsions.
It has been shown that fluorine is essential for growth
and general development (2).

Fluorine concentration in blood

plasma is homeostatically controlled with bone and teeth
serving as the main storage organs and containing normally
between 100 to 7,000 ppm.

The fetus contains fluorine and the

placenta plays an active role in fluoride transfer.

Rather

constant concentrations are maintained in soft tissues such
as liver, heart and brain.

The element occurs in practically

all foods and feeds; food being the main source for animals
and man aside from drinking water.
some enzyme systems.

Fluoride is a poison for

Specifically, it inhibits the conversion

of glyceric acid to pyruvic acid by enolase in anerobic
glycolysis.

The importance of organically bound fluorine must

be mentioned since it has been determined that the fluorinecontaining compound in human serum is a weak lipid soluble
organic acid.

Despite an increasing interest in this

el~ment,

certain basic questions such as the chemical nature of fluorine
in food, discrepancies in the utilization of fluorine compounds,
its biochemistry in soft tissues, and its mode of action remain
to be clarified.
Chromium has been classified as a necessary cofactor
in carbohydrate metabolism.

Studies have further suggested

that trivalent chromium may act together with insulin in promoting utilization of glucose.

Chromium (III) is the element
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of major interest in this dissertation and will be presented
in greater detail later.
Zinc is a structural and functional component of the
enzyme carboxypeptidase A and participates directly in the
catalytic action of the enzyme (4).

Carboxypeptidase A

catalyzes hydrolysis of that peptide bond which is adjacent
to

th~

terminal free carboxyl group.

Zinc is also associated

with several other enzymes, including carbonic anhydrase
which is involved in acid-base balance and alcohol dehydrogenase whiph begins the oxidation of alcohol.

In all these

enzymes, zinc is present in amounts stoichiometric to the
number of catalytic sites.

It has also been demonstrated

that a zinc deficient diet impaired the cell mediated immune
system whereas it did not adversely effect the humoral system.
Copper is an excellent catalyst for oxidation-reduction
systems, showing great versatility for an impressive variety
of reactions, including an association with cytochrome oxidase
of the electron transport scheme.

Copper is also associated

with catalase, tyrosinase, monoamine oxidase, ascorbic acid
oxidase an<l uricase.

In a recent study (5), copper chelates

of certain drugs have been shown to improve anti-inflammatory
activity dramatically.

In the case of aspirin the copper

aspirinate was found to be 20 times more active than aspirin
in animal tests simulating arthritis.

Compounds that normally

don't show any anti-inflammatory activity, namely anthranilic
acid and nicotinic acid, became active in animal tests when
chelated with copper.

In this study copper complexes were
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also shown to have antiulcer activity.

Since copper

deficiency has been shown to lead to aneurisms and softening of
bones in experimental animals, a role for copper in promoting
the tensile strength of the f iberous proteins collagen and
elastin has been suspected (3).
Cobalt's principal function is as a necessary constituent of vitamin B12

1

which is manufactured by bacteria

and required by mammals for the production of red blood cells.
Molybdenum is a constituent of the enzyme xanthine
oxidase which is involved in the metabolism of purines to uric
acid.

Liver aldehyde oxidase, a f lavoprotein which catalyzes

the oxidation of aldehydes, also contains molybdenum.

This

element is also a constituent of the nitrogenase enzyme
complex involved in the process of nitrogen fixation by bacteria
and blue-green algae.
Iodine has only one well-established role in the body,
namely, to complete the formation of thyroxin, the thyroid
hormone, which contains four atoms of iodine per molecule.
Very little is known about the specific role or roles
of selenium and, to date, there are only three enzyme-catalyzed
reactions that have been shown to require the participation of
a selenium containing protein (6).

These are the reactions

catalyzed by (i) formate dehydrogenase of bacteria,

(ii)

glycine reductase of clostridia and (iii) glutathione reductase
of erythrocytes.
Nutritional studies from four laboratories have shown
that vanadium is an essential trace element for the chick and

r
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rat (7).

Those physiological functions that became impaired

when either the rat, or the chick, or both, consumed a diet
low in vanadium were reduced body and feather growth, impaired
reproduction and survival of the young, altered blood cell
levels and iron metabolism, impairment of hard tissue metabolism and altered blood lipid levels.
techn~ques

In this study, current

of refinement and purification of diet constituents

were implicated as the cause of the low levels of this element
as well as others in man's diet.

More specifically, high

levels of ranadium have been reported to lower serum lipids,
the effect resulting from the ability of this element to
inhibit the synthesis of cholesterol.
Nickel deficiency in chicks results in suboptimal liver
function as evidenced by ultrastructural degeneration, increased lipid and a decreased phospholipid fraction,

Rats

deprived of nickel also show a reduced oxidative ability of
liver homogenates and abnormalities in the liver polysome
profile.

These findings

(8) are consistent with nickel being

an essential nutrient for chicks and rats.
Arsenic may be an essential nutrient, at least in rats
(9).

Pregnant rats raised on a diet containing just 30 ppb

arsenic developed rough hair, slow growth rates, and enlarged
and darkened spleens that contained 50% more iron than those
of control animals receiving 5 ppm of arsenic,

Blood cells

of off spring of the arsenic deprived rats broke down more
easily in saline solution than those of control rats.
Tin is necessary for growth in rats at a level of
1-2 ppm in the diet (2).

It occurs normally in foods, feeds
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and tissues.
effective.

Tin salts as well as organotin compounds are
Its biological chemistry is unexplored.

Silicon is necessary for growth in rats, meta-silicate
producing optimal effects at 50mg/100g in the diet (2).
deformations develop in silicon deficiency.

Bone

Silicic acid in

bound form is a building block of connective tissue, serving
as a cross-linking agent.

High levels of bound silicon wer~

detected in acid mucopolysaccharides and in connective tissue
proteins, notably collagen.

The silicon atom, having the

same steroechemistry as carbon is structurally rigid and thus
contributes to the architecture of connective tissue and
membranes.
Concerning the association of ions in biological
systems, cytochrome c oxidase may be regarded as the ultimate
in the integration of the functions of iron and copper.

Here

in a single molecule are combined the talents of the heme
group and copper ions to bind oxygen, reduce it with electrons
from other cytochromes in the electron transport chain and
finally convert the reduced oxygen to water.

Other cupro-

ferro (heme) proteins include a chemically similar enzyme,
tryptophan-2,3-dioxygenase, that catalyzes the insertion of
molecular oxygen into the pyrrole ring of tryptophan, yielding
N-formylkynurine.

It has been found to have two atoms of

Cu(I) and two molecules of heme.

Recent work on the biosynthesis

of connective tissue components has revealed a direct role for
iron and copper enzymes and a probable role for manganous and
zinc ions as well.

Finally, a recently discovered enzyme,
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cysteamine oxygenase, has been reported to contain one atom
each of copper, iron and zinc in a molecule weighing 100,000
daltons (10).
The discovery of the essentiality of these trace
elements has opened up new possibilities in the areas of
biochemistry and medicine.

It is the purpose of this dis-

sertation to concentrate on one important essential trace
element, namely chromium, in an attempt to further elucidate
its mode of action in the development of impaired glucose
tolerance.:Chemistry of Chromium
The most important ore of chromium is chromite, Fecr 2 o 4 •
The element was not known to the ancients, but was discovered
in 1798 in lead chromate, PbCro 4 , which occurs in nature as
the mineral crocoite.
Chromium is a member of group VIA of the periodic table.
It has oxidation states ranging from Cr- 2 to Cr+ 6 , but it most
common 1 y occurs as Cr o, Cr +2 ,

c r +3 ,

an d

c r +6 ,

Divalent

chromium, however, is relatively unstable, being rapidly
oxidized to the trivalent form; thus only two forms, trivalent
and hexavalent, are found in nature.

The oxidation potential

of hexavalent to trivalent chromium is strong, and therefore
it is highly unlikely that oxidation of the trivalent form
could occur

!.!!..

vivo (11).

The hexavalent form of chromium,

almost always linked to oxygen, is a strong oxidizing .agent.
By far the most stable and important oxidation state of
chromium is chromium (III).

It is the most stable of the
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trivalent transition metal cations in water.

The trivalent

ion has a 3d3 configuration, which leaves 6 orbitals, 4sl,
3d2, and. 4p 3 , to accept electron pairs from ligands.

The three

electrons of the Cr+ 3 ion are unpaired and are in low energy
orbitals.
Trivalent chromium forms octahedral complexes of coordination number 6, and a large number of complexes are known
including water, ammonia, urea, ethylenediamine, halide,
sulfate and organic acids.

Ligand displacement reactions of

cr+ 3 complexes are about 10 times faster than those of Co+ 3 ,
with half-times in the range of several hours.

It is largely

because of this kinetic inertness that the compounds persist
for relatively long periods in solution, even under conditions
in which they are thermodynamically very unstable.
ion does not exist in solution.

Chromic

It forms complexes with water

and other anions in acid solution.

In alkaline solution, it

olates by forming polynuclear compounds that precipitate with
time.

Olation is enhanced by alkali and by heating to

120°C (12).
The hexaquo ion,

[Cr(H 2 o) 6 J+3, which is regular octa-

hedral, occurs in aqueous solution and in numerous salts such
as the violet hydrate,

[Cr(H 2 o) 6 JC13, and in an extensive

series of alums MCr(so 4 ) 2 .12H 2 o in which Mis any common
univalent, monatomic cation except for L:i+r which is too small
to be accommodated without loss of stability of the structure.
The aquo ion is acidic (pK=4), and the resulting hydroxo ion
condenses, in a process referred to as elation, to give a

10
dimeric hydroxo bridged species:
+3 _-H+
___..
+2~
[Cr (H 0) oH] ~ [ (H 0) cl?""'OH- Cr (H O)
[Cr (H 0) 1
2 5 'ow·'
2 5
2 6
2

s

]

+4

on addition of further base, soluble polymeric species of high
molecular weight and eventually dark green gels are formed.
Direct evidence on hydration (aquation) is not easy to
acquire.

However, according to Benson (13), oxygen-18-

experiments have clearly established the existence of the
species [Cr(H20)6]+ 3 .

On mixing a solution of chromium and

H 18 o, a ~~ow isotopic exchange takes place:
2
[Cr(H 2 o)nl+ 3 + nH 2 18 o ;::=rcr(H 2 18 o)nl+ 3 +

nH 2o

which can be followed by sampling the oxygen-18 content of the
solvent at various times by vacuum distillation.

The isotopic

exchange has a half life of about 40 hours at 25°C.

For a

given solution of chromium, the number of "unbound" water
molecules can be calculated from the isotopic dilution which
. '
. .
' d wit
. h t h e 18 0 -containing
resu 1 ts a f ter a s h ort mixing
perio

solvent.

The number of "bound" water molecules is the dif-

ference between this value and the total number present.

The

ratio of chromium ions to molecules of bound water was found
to be 1 to 6 as a result of experiments similar to the above.
The number of water molecules comprising the primary coordination
shell of a metal ion has rarely been so exactly defined as
for the case of Cr(III).
The replacement of water in an aquo complex by an
anionic group (the reversal of aquation) is called anation,
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For example, consider a chromium complex in which A is a
ligand:
(CrA H o)+3
5 2

+

Y----4 (CrA Y)+ 2
5

+

H 0
2

The following scheme occurs:

(CrA 5 )

+3

+ y

(CrA5

+3

) (Y )

+2
+3
rate= d(CrA 5 Y )/dt = k 3 (CrA 5 ) (Y)
In ... a study concerned with the behavior of chromium
,··

compounds in the physiological pH range (14), the absorption
spectrum of chromic acetate in phosphate buffer exhibited
two maxima near 420 and 570 nm.

Both maxima underwent gradual

bathochromic shifts to 430 and 600 nm respectively as the
elation process began.

Decreased absorbance (hypochromism)

was also observed at both maxima.

According to the article,

a previous study resulted in a marked hyperchromism as the number of carboxyl groups coordinated to the central chromium atom
increased.

It was concluded that the bathochromic shifts with

hypochrornism were evidence of the entrance of hydroxy groups
into the coordination sphere of chromium.
Chromium Occurrence in Biological Material
One of the earlier experiments indicating that chromium
ions might have biological activity was that of Curran (15)
who showed that the synthesis of cholesterol and fatty acids
from acetate by rat liver was enhanced in their presence.
Since then many attempts have been made to establish tissue
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levels of this element and to identify it with certain biochemical reactions.

Plasma chromium concentrations have been

reported by many investigators (16,17).
fall between 10 and 50 ppb.

Most of the values

Low plasma chromium levels may

be suggestive of low dietary chromium intake, but they do not
necessarily mean chromium deficiency.
in

eq~ilibrium

Plasma chromium is not

with the body stores and consequently may re-

flect only the most recent dietary intake.

Feldman (18)

reported an average plasma chromium concentration of 29 ppb
with a range from 11 to 64 ppb.

It has also been suggested

(19) that plasma concentrations of chromium may only represent
1/100 of the chromium concentrations in most organs.

Reports

on urinary chromium cover an even wider range, from nondetectable amounts to a maximum of 350µg/liter

(20).

In two care-

fully controlled studies, averages of 5 and 4µg/liter were
found (21,22), with ranges from 3.5 to 6.Sµg/liter and 1.8 to
llµg/liter respectively.
The question of the valence state of chromium found in
biological material has not been completely answered.

Divalent

chromium probably does not exist in biological material, since
it is easily oxidized by air.

It is possible to distinguish

between the trivalent and hexavalent forms of chromium with
methods that require oxidation to the highest oxidation state
for solvent extraction or for formation of a colored complex
(23).

Omission of the oxidation step would result in the de-

termination of hexavalent chromium only.

Another assay with

the oxidation step included would yield the total chromium
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content of the sample.

The difference between the two would

give a measure of the trivalent form.

One group of investi-

gators, using atomic absorption spectroscopy and solvent
extraction with and without prior oxidation, were unable to
detect any hexavalent chromium in human serum (18).

Also,

after intravenous injection of chromate into rats no hexavalent chromium was detectable.

Hexavalent chromium added to

tissue in vitro was reduced within a few minutes, indicating
that this valence state is very unstable when in contact with
organic matter (24).

As a result it has been concluded that

chromium is probably present in biological matter in the trivalent state.
In the absence of stabilizing ligands, the elation
process of trivalent chromium discussed previously, would lead
to the formation of large hydroxo bridged species of colloidal
nature which would eventually precipitate out of solution.
Reaction of cr+3 with ligands that successfully compete with
OH- for coordination protects against precipitation at neutral
pH by minimizing or preventing elation and resulting in soluble
chromium-ligand complexes (25).

It is this coordination with

ligands present in the intestines that keeps chromium soluble
and makes it available for absorption.
Chromium-Protein Interactions
As far as chromium-protein interactions are concerned,
probably the best understood reaction of chromium with a protein
is the chrome tanning of hide.
collagen into leather through

The tanning process transforms
cross~linking

of the protof ibrils
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of collagen by chromium. · It has been suggested that chromium
reacts with the free carboxyl groups of the acidic amino
acids of the protein forming stable interchain and intrachain
complexes.

As confirmatory evidence, methylation of the free

carboxyl groups prevents the tanning process (26).

The tan-

ning reaction is initiated by raising the pH of the solution,
resul~ing

in the formation of elated complexes.

These act by

accepting carboxyl
groups of the collagen strands into their
..,
coordination sphere, at the expense of previously bound water
molecules.:
By means of ultracentrifugation techniques, three metals
namely Al+3, Fe+3, and cr+3, were shown to cross-link the protein conarachin II (27).
......

Al+ 3 and Fe+ 3 reacted rapidly, but

the metal-protein complexes were unstable and easily dissociated
by dialysis against phosphate buffer suggesting an ionic bond.
The reaction of chromium proceeded much slower with the resulting complex resistant to dialysis against phosphate buffer.
These findings indicate the formation of coordinate covalent
links through which chromium binds to protein.
The ability of trivalent chromium to stabilize the
conformation of a protein was studied by Pchelin and co-workers
(28).

They studied the thermal dependent conversion of gelatin

from a spiral form to a random conformation utilizing optical
rotation techniques.

They concluded that salts of trivalent

chromium fix the random coil as well as the spiral conformation
so that the transition does not occur.
At pH 7.35, ovalbumin and human plasma proteins were
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found to strongly bind Cr+

3

as the acetate complex, but not

er +3 , as potassium chromate.
~

(29).

More detailed measurements

vitro and in vivo subsequently demonstrated that of all

serum proteins, siderophilin bound almost all the chromium
administered in physiological doses (30).

Stimulation of oxy-

gen consumption in a succinic-cytochrome c dehydrogenase system
by Cr·+3 has been reported (31).

Chromium had the greatest ef-

feet of all the metals tested, producing approximately twice
the stimulation of the next effective element, aluminum, on a
~

mole-to-mole basis.

The enzyme phosphoglucomutase, which has

a very important function in the early steps of glucose metabolism, also has a requirement for chromium (32).

There is

evidence that the digestive enzyme trypsin contains one atom
of chromium per enzyme molecule.

Chromium can be removed by

dialysis, indicating that it is not firmly bound.

The residual

activity of trypsin after dialysis is only 5% of the original,
and it is restored to normal by addition of chromium (33).
Chromium was also reported to stimulate the activity of another
protein-splitting enzyme, rennin, as measured by an increased
rate of milk coagulation (34).
Chromium Requirement for Microorganisms
The studies on the effect of chromium in bacteria reported in the literature are few and do not allow a conclusion
as to the function of the element in these organisms.

Aerobacter

aerogenes responded to a reduction of the metal content of the
medium with a deranged pattern of fermentation products (35) ..
Addition of chromium or manganese restored the pattern to normal.

16
chromium, like other metals, can inhibit various functions
when higher concentrations are applied.

Corynebacterium

5
2
diphtheriae responded to 10- M Cr+ with reduced toxin proauction and with depressed growth (36).

Chromium, iron and

aluminum in the trivalent state caused irreversible inactivation
of E. coli (37).
The relation between chromium and brewers' yeast is
being investigated again, after it had been shown that brewers'

y~st,

but not Torula yeast, is an excellent source of glucose

tolerance ~actor (GTF).

This factor is a chromium-containing

organic complex required for the maintenance of a normal glucose tolerance in rats (38).

It has also been shown (39) that

the addition of glucose to the medium of brewers' yeast greatly
enhances the uptake of chromium by this organism.
governing this stimulation is unknown.

The mechanism

Also, a 16-hr preincu-

bation of the yeast with chromium, but not the direct addition
of the element of the reaction flasks, resulted in a 40-50%
stimulation of

co 2

production over that of controls.

The re-

sults strongly suggest that the chromic ion does not act as the
simple complex that is added to the medium (hexaquo chloride),
but that it is built into an organic complex or chelate after
it penetrated into the yeast.

In another experiment, chromium

containing fractions were extracted from yeast grown in a
chromium-enriched medium.

Addition of these fractions to yeast

in the Warburg apparatus produced an immediate stimulation of

co 2

production, whereas chromic chloride was without effect in

this system (39,40).

This provided further support for the

existence of an activated chromium complex.
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Glucose Tolerance
Male Sprague-Dawley rats fed a 30% Torula yeast ration
for a few weeks after weaning developed a progressive impairment of intravenous glucose tolerance (41).

Glucose tolerance

remained normal in rats fed the basal Torula diet to which
was added a small percent of brewers' yeast (38).

These ob-

servations suggested a deficiency in the Torula yeast ration
of a yet unidentified nutritional factor.

This unknown

principle was designated glucose tolerance factor
point out

~ts

only then known function (42).

(GTF) to

Purified fractions

were obtained that not only prevented the development of impaired glucose tolerance but also cured the impairment overnight
with a single oral dose of lOOµg/lOOg of body weight.

Careful

ashing of an active preparation failed to destroy most of the
initial activity.

These observations indicated the presence

of an inorganic material responsible for the biological effects.
Subsequent testing of 47 different elements in GTF-deficient
rats detected GTF activity only in trivalent chromium complexes
(43).

Similar effects have been observed when chromium com-

plexes were incorporated in the diet (44) or when they were
intravenously injected (45), however the latter route required
a lower dose,
The influence of chromium on glucose tolerance is
closely tied to the action of insulin (46).

When rats raised

on a low chromium diet were subcutaneously injected with 100 mu
of insulin/lOOg of body weight after 18 hr of fasting, their
hypoglycemic response was significantly less than that of

. 18
chromium-supplemented controls.

Similarly, incorporation of

glucose carbon into tissue glycogen 1 hr after injection of
1 mu of insulin/lOOg of body weight was much greater in
chromium-supplemented rats than in their chromium-deficient
controls.

Chromium-supplemented rats also maintained a higher

glycogen concentration in their tissues after 18 hr of fasting
than

~id

low chromium controls.

The results suggest that the

impaired glucose tolerance in chromium deficiency may be due
to a decreased response of the deficient animal to its endogenous insµlin.
A more severe impairment of glucose tolerance than is
observed in rats in an ordinary environment develops when
the animals are maintained in a laboratory from which traces
of metals are excluded as much as possible.

The average glucose

removal rate for 6 rats raised under these conditions was
1.12

~

0.2 (47), as compared with 2.6

in an ordinary environment (38).

~

0.1 % /min' for a group

Chromium supplementation

improved the impaired rate to an average of 3.5%/min, a value
normal for rats of the age group utilized.
Mode and Site of Chromium Action (Effect of Synthetic Chromium
Complexes)
Epididymal adipose tissue removed from rats raised
on a low chromium diet exhibited a decreased glucose uptake
in the presence of insulin as compared to the chromium supplemented rats (Table 1).

Also, the addition of optimal doses of

chromium to the medium resulted in a potentiation of the insulin
effect, as reflected in a steeper slope of the dose-response
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TABLE I. ~Effect of dietary chromium supplementation on
intravenous glucose tolerance and on glucose uptake by
epididymal fat tissue [From Mertz, et.al. (44)].

Glucose uptake
Supplement

N"o. of
rats

\\'eight

Glucose removal
rate
Without

-- --µg Cr/100 g diet"

None
1000
a

b

.·~'·

.•

••

,. I

g

g

244

10

236

3

excess glucose/

minb

3.7 ± 0.5
5.7 ± 0.5

l\Vith lmilliunit insulin
per Jlask

µg/ 100 mg//,,b

20 ± 3
22 ± 4

Added as hexaurca chromium(III) trichloride.
l\Iean and standard error .

I

33 ± 5
55 ± 5
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curve to insulin in the presence of chromium (Figure 1) ,
Chromium also increased the effect of insulin on the
utilization of glucose for fat synthesis (44) as well as for
oxidation to C02 (45),

In these systems the magnitude of the

effect of optimal chromium concentrations was similar to that
observed when glucose uptake was measured.

The fact that

glucose uptake and the utilization of glucose for two different pathways are affected by chromium and that the element
is ineffective in the absence of insulin suggests that the
site of action of chromium is near the site of action of insulin.
Mitochondria have been found suitable for polarographic
measurements (48).

Mitochondrial preparations exhibit a

polarographic wave under appropriate conditions, that appears
to originate from sulfhydryl groups located in the mitrochondrial
membrane.

This wave was shifted to a more positive potential

when insulin was added, indicating a reaction of membrane
sulfhydryl groups with insulin.

Chromium was also shown to

react with membrane sulfhydryl groups and to form a complex
with three insulin molecules,

Finally, when chromium was added

to a mixture of mitochondria and insulin, the shift of the
resulting polarographic wave to a more positive potential was
threefold greater than the sum of the shifts caused by chromium
or insulin individually (49).

These results have been inter-

preted to mean that chromium facilitates the formation of
disulfide links between the intrachain disulfide of insulin
and the membrane sulfhydryls by participating in a ternary
complex.

It has been suggested that in such a complex the
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FIGURE l • .' Potentiation of low levels of insulin by
chromium in vitro. Epididymal adipose tissue of lowchromium rats incubated for 2 hr in Krebs-Ringer phosphate medium. Solid circles, without; open circles,
with O.lµg cr+3/flask. [From Mertz, et.al. (44)).
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chromium probably coordinates to the four sulfur atoms invalved in the formation of the disulfide bridges.

It remains

to be proven, however, that the chromium-sulfur bonds are of
major importance when one considers the possible interaction
of this metal with other residues.
Metabolism of Chromium
Chromium is excreted in urine and feces.

Urinary ex-

cretion is the major route, accounting for at least 80% of
injected chromium, but elimination via the intestine also plays
a role although the mechanism remains unclear.

The plasma

chromium level in the fasting state is not a meaningful indicator of the tissue chromium stores and may be related to the
nutritional chromium state only in extreme cases.

A much more

sensitive indicator is the reaction of plasma chromium to a
glucose challenge (50).

It was found that young, healthy

persons responded to an oral glucose load of lOOg with a distinct rise of their plasma chromium levels within 30-120 minutes.
Increases from 30 ppb in the fasting state to 150 ppb after
glucose have been observed.

In contrast to these findings,

rises were not always seen in diabetic patients.

In four dia-

betics with impaired glucose tolerance, plasma chromium did
not respond to glucose at all.

After two of these were given

daily chromium supplements for extended periods of time, which
led to an improvement of glucose tolerance, both exhibited
pronounced increases in their chromium levels during repeated
glucose tolerance tests.

Similar results were seen in

diabetics to whom chromium was given but failed to improve
glucose utilization.
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The lack of plasma chromium response and its appearance in certain diabetics after chromium supplementation
suggest that the plasma increments of chromium after a glucose
load are derived from a specific pool that may be deficient
in some persons and that can be replenished after a period of
chromium supplementation.

The form in which chromium appears

in the plasma is unknown,

It might be the biologically active

complex, glucose tolerance factor, secreted into the plasma
when excessive amounts of glucose have to be metabolized.
In

~

recent study concerning the role of chromium in

the diabetogenic effect of pregnancy (51), the mean fasting
Cr concentration for pregnant women near term was found to be
considerably lower than that of nonpregnant subjects.

The

administration of an intravenous or oral glucose load did not
result in any significant change in the low plasma chromium
concentration of pregnant subjects, but it consistently provoked
a rapid fall of plasma Cr in nonpregnant subjects.

This fall

in plasma Cr in normal women was not accompanied by a decrease
in plasma concentrations of other heavy metals.

Fasting levels

of blood glucose were within the normal range for all subjects.
The mean rate of glucose assimilation after a single glucose
load was nearly identical for the pregnant and nonpregnant
subjects, however, decreased tolerance to glucose was demonstrated with repetitive glucose loading for the former group.
Also, mean fasting plasma insulin levels were statistically
similar, however, the pregnant group exhibited an expected
marked increase in insulin release after a glucose load that
was not exhibited by the normal group.

The investigators

'
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suggested that the failure of pregnant women to respond with
a plasma chromium fall may be related to the already depressed
state of the plasma chromium concentration.

The fall in plasma

chromium in this study was in contrast to the observations of
a previous study (50).

The authors suggest that the exaggerated

insulin secretion in pregnant subjects may be compensatory for
the

i~pairment

of peripheral glucose utilization.

They further

suggest that Cr may be necessary for insulin to express its
maximal hormonal action and that the poor chromium mobility
in

pregnan~y

may be related to the altered carbohydrate meta-

bolism and insulin ''resistance" observed in late pregnancy by
various investigators (52,53).

The developing fetus reportedly

accumulates chromium such that fetal tissues at term contain
appreciably higher levels than maternal tissues (54).

Mertz

(55)

suggests that pregnancy may accentuate the marginal chromium
nutrition in the mother and result in a lowering of the body
stores of chromium.
In another study it was shown that the stress of acute
infectious illness induces a decrease in serum chromium concentrations following a glucose load (56).

Such factors as

decreased food intake were eliminated but increased excretion
and metal redistribution remained to be investigated.

The

authors concluded that such alterations in Cr metabolism may
be related to the diabetogenic characteristics of pregnancy
and that decreases in plasma Cr may serve as a sensitive
indicator of peripheral carbohydrate metabolism.

It was also

pointed out that stress-induced chromium deficiencies may antagonize insulin action which may in 9art explain the prediabetic

25
or glucose intolerant states observed during infection and
pregnancy.
ToxicitV of Chromium
According to a recent report (25) published by the
committee on Biologic Effects of Atmospheric Pollutants, a
division of the National Academy of Sciences, chromium as a
metal was labeled as biologically inert and unable to produce
toxic or other harmful effects in man.

Also, compounds of

chromium in the trivalent state were stated as having no established' toxicity.

According to the report, the chief health

problems associated with chromium are related to hexavalent
chromium compounds, which are irritant and corrosive and may
be absorbed by ingestion, through the skin and by inhalation.
Acute systemic poisoning was stated as a rare occurrence and
usually accidental.

Chromium in the hexavalent form was clearly

implicated as a cause of ,ulceration of the skin and of ulceration and perforation of the nasal septum.

The report pointed

out that the only important long-term effect of hexavalent
chromium was an increased incidence of lung cancer in workers
exposed to high levels of airborne chromate and that the incidence of cancer at other sites in the body is not increased;
nor does the risk appear in the user industries.

Skin effects

of hexavalent chromium were classified as "Primary Irritant
Dermatoses" and "Allergic Eczematous Contact Dermatitis".
Glucose Tolerance Factor (Actions)
The effect of trivalent chromium complexes on the im-.
provement of impaired glucose tolerance has been discussed

~

:
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above (50).

The glucose tolerance factor

(GTF), extracted

from brewers' yeast also has the ability to improve impaired
glucose tolerance.

The extraction procedures differ among

investigators, from a simple alcohol extraction followed by
fractionation by gel filtration (57) to a 50% ethanol extraction,
adjustment to pH 3.5, treatment with activated charcoal, elution
with .NH 4 0H-ethanol-ether followed by Dowex-50 cation exchange
and Sephadex column chromatography (58).

As discussed pre-

viously, GTF has chromium as its active ingredient.
the

chemi~al

At present

nature of this factor has not been determined with

certainty, however, some of the biological properties have been
characterized.

In the rat epididymal adipose assay, GTF frac-

tions produced a significant increase in co 2 production from
14
glucose-1- c in the presence of insulin as compared to controls
of insulin alone (57).

In another study (59) a single intra-

peritoneal injection of GTF significantly lowered the non-fasting
plasma glucose levels in genetically diabetic mice from 830 to
537 mg/lOOml (29%), 4 hrs post-injection.

Furthermore, in

support of the suggestion that insulin and GTF act synergistically, a combination treatment of GTF and insulin was found
to be more effective than either treatment alone.

GTF lowered

the non-fasting plasma glucose level by 180 mg/100 ml (16%)
12 hrs post-injection, insulin lowered the glucose level by
128 mg/100 ml (11%), while the combination of GTF and insulin
lowered the level by 406 mg/100 ml (37%).
Recently a group of investigators observed that diabetic
patients excrete less GTF-chromium in their urine than do
non-diabetics (60).

This low incidence of GTF-chromium in
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diabetic urine was presumed to arise through a blockage or
impairment in the in vivo conversion of chromium to its biologically active form.

In this study several insulin re-

quiring diabetics were given 10 grams of brewers' yeast (the
richest source of GTF) daily.

According to the investigators,

the subjects experienced an average decrease of 25 units in
their daily insulin requirement, resulting in a decrease of
one-fourth to one-third of the insulin need.
As far as chromium-insulin interactions are concerned,
it has be.en discussed above that trivalent chromium forms
complexes with insulin and mitochondria and that both complexes may involve chromium-sulfur linkages (48).

It has

also recently been shown that partially purified GTF binds
to insulin, the resulting product having a significantly
greater effect on glucose uptake by epididymal adipose tissue
that that of native insulin (61).

According to the authors,

acetylation of the a and £ amino groups of insulin inhibited
the binding of GTF to insulin thus implicating these moieties
in GTF binding.

The acetylation of insulin also inhibited

the potentiating effect of GTF with respect to glucose uptake

by epididymal adipose tissue.
Identification of The·Glucose Tolerance Factor
According to one group of investigators (19), two categories of chromium exist in nature.

The first consists of

simple compounds such as chrom alum and chromic chloride
which have been shown to possess insulin potentiating activity
in vitro.

The second category consists of compounds related
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to GTF which have outstanding insulin potentiating activities in vitro.

Since the discovery of the glucose tolerance

factor or as it is sometimes called "compounds exhibiting
GTF activity", many attempts have been made to elucidate its
structure.

Recently nicotinic acid was identified by mass

spectroscopy as the compound associated with chromium in the
complex (58).

According to the author, analysis of highly

purified GTF preparations from yeast also indicated the presence of glycine, glutamic acid and a sulfur containing amino
acid.

With this in mind an attempt was made to synthesize

synthetic compounds which hopefully would exhibit GTF activity.
Synthetic complexes were prepared which potentiated the action
of insulin on glucose oxidation by chromium deficient rat
epididymal adipose tissue and improved the impaired glucose
tolerance of chromium deficient rats when injected intravenously (62).

Another study was performed to eliminate

nicotinic acid as the causative agent (63).

It was found

that the product of incubating nicotinic acid with insulin
at a molar ratio of 1 was no more effective on glucose oxidation than insulin alone whereas that of nicotinic acidchromium complexes and insulin was significantly more potent.
The results of another study (64) concerned with the
comparison of certain physical and chemical properties of
synthetic nicotinic acid-chromium complexes and purified
concentrates from brewers' yeast yielded striking similarities.

In both cases absorption spectra were almost identical

with a maximum at 262 nm.

Biological activity was found in
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similar eluates of Dowex-50 cation columns eluted with NH 4 0H
and Sephadex G-15 columns eluted with acid.

Also, similar

Rf values were found through paper chromatography utilizing
biological activity as a means of identification.

According

to the author, the findings suggest, but do not prove, that
GTF activity of yeast is related to nicotinic acid-chromium
complexes.
At present the exact structure of the synthetic nicotinic acid-chromium complexes is not known with certainty.
Recently, in analogy to the well known nicotinic acid complexes
of other transition

metals, it has been suggested (65) that

the complex could be described as the tetra-aquo-dinicotinato
form (Figure 2) .

A complex such as this can still undergo

olation and eventually precipitate out of solution with time.
Stabilization of the complex can be achieved however by replacing the coordinated water molecules with ligands not
undergoing elation.

Since glycine, glutamic acid and a sulfur

containing amino acid were also found to be associated with
the glucose tolerance factor, an attempt was made to react
these amino acids with the preformed chromium-nicotinic acid
complex in the following manner (58).

Chromic acetate and

nicotinic acid were dissolved at a molar ratio of 1:2 in 80%
ethanol and boiled under reflux for 2 hours until the color
of the preparation had turned to blue.

Subsequently

L-glutamic, L-glycine and L-cysteine were added at molar
ratios to chromium of 1:1 and the solution boiled under reflux for an additional 6 hours.

At the end of the reaction
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FIGURE
Tetra-Aquo-Di-Nicotinato Chromium Complex
[From Mertz (65)].
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the ethanol was distilled off in vacuo and the clear purple
solution was filtered from an insoluble precipitate.

The

resulting compound (soluble fraction) showed great stability
against alkali and heat and also exhibited biological activity equal to or greater than that of the tetra-aquo-dinicotinato chromium complex.
sugg~sted

An appropriate structure was

(Figure 3).

A possible mode of interaction between GTF, insulin and
the receptor site has been proposed utilizing the synthetic
models

di~cussed

above (58).

The two nicotinic acid ligands

supposedly are attracted to basic groups on the insulin molecule and tissue receptor, thus bringing the insulin close
to its site of action (Figure 4).

According to the authors,

the amino acids coordinated to the four coplanar sites are
important for stability during transport of the complex and
would have to dissociate and be replaced by water molecules
before the ternary complex can be formed.

The four coordinated

water molecules could then exchange with the four sulfur
atoms involved in the disulfide exchange reaction.

Again,

I would like to point out that the exact chemical structure
of the naturally occuring glucose tolerance factor has not
been identified arid that these structures and modes of interaction are only hypothetical.
Levels of Chromium in Human Tissues
It has been shown that the chromium content of human
tissue declines with advancing age (66).
Mertz

According to

(67), a decrease of tissue levels of several elements

.....

FIGURE 3.: Possible structure of dinicotinato-amino acid
Cr-complex [From Mertz, et.al. (58)).
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FIGURE 4 .. Hypothetical ternary complex of chromium at
site of action [From Mertz, et.al. (58)].
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has been observed during the early days of life, however
chromium is outstanding in that its concentrations continue
to decline until old age.

He proposes that the overall

decline can be discussed from two aspects.

It may be a re-

flection of a normal process, eliminating from the organism
I

excessive amounts that are no longer required as age increases.
The .alternative explanation is nutritional.

It assumes that

a suboptimal dietary chromium intake is the cause for the declining tissue levels in the U.S. population.

According to

the authqr, it is probably safe to accept an average chromium
concentration of Sµg/liter of urine in the U.S. population,
corresponding to an average daily urinary excretion of 7-8µg.
Accepting the highest observed figure for absorption of chromic
chloride, 3% of an oral dose, the daily dietary intake would
have to be at least 270µg of the element in order to compensate
for the losses.

This is considerably less than the estimated

50-BOµg of chromium in the average U.S. diet.

At present,

the average dietary chromium requirement of man is a much debated issue, however, if the above figures are valid, it is
evident that a suboptimal chromium intake could easily lead
to a depletion of body chromium stores.
According to Schroeder (1), the causes of the losses
from body stores in adolescence and later are probably explained as follows: When pure sugar (glucose) is fed in a
large amount to a fasting person, three changes take place:
a) blood sugar is elevated; b) insulin in blood increases;
c) chromium in blood increases, being mobilized from tissue
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In a diabetic, variable amounts of sugar are ex-

stores.

creted in the
may appear.

u~ine

whereas in normal people little or none

The chromium in the blood, elevated in response

to the sugar and perhaps accompanying the insulin, reaches
the kidneys where some is excreted, perhaps 20% of that in
the blood according to Schroeder.

At this point the author

impl.icates the refining of foods and points out that if the
sugar is unrefined and contains chromium as all unrefined
sugars do, presumably enough is absorbed to compensate for
the urinary loss and as a result no net loss develops.
'

Fur-

ther information is provided concerning the chromium content
of refined and unrefined sugar.

150 grams of glucose was

reported to have 3-4µg of chromium whereas a similar equivalent of raw sugar contained approximately 36µg of the metal.
These facts together with the obligatory urinary loss of
12-25µg of chromium per day as reported by Schroeder could
lead to a severe depletion of chromium.

The report also

stated that the major source of carbohydrate calories in the
American diet other than sugar is refined white flour.

Re-

portedly whole wheat contains 175µg of chromium per 100 grams
whereas refined white flour contains 23µg.

Also white bread

has 14 while whole wheat has 49µg of chromium.
As stated previously, chromium deficiency may be a
contributing factor to the impaired glucose tolerance associated with late pregnancy (51).

It has also been demon-

strated that the mean chromium level in the hair of parous
women was less than one-third of the average concentration
in nulliparous women (68).

In another study it was re-

ported that hair chromium levels were significantly lower
for diabetic children as compared to nondiabetics (69).
Also, a recent study concerned with the determination of
hepatic chromium content in post-mortem tissue from diabetic
and control subjects demonstrated a significantly lower mean
hepatic chromium content for the diabetic group thus supporting

~he

relationship between impaired glucose tolerance and

chromium deficiency (70) .
Effect of Chromium Supplementation

'
It has been reported that oral supplementation with 150
to lOOOµg of chromium (III) per day for 15 to 120 days was
associated with an improved glucose tolerance in 3 out of 6
diabetics (71).

In the same study short term administration

of the element was ineffective.
of normals was not influenced.
this study was

~he

Also, the glucose tolerance
One interesting aspect of

utilization of the following tests in an

attempt to detect untoward reactions to chromium (III).

The

following determinations were performed during control tests
and post test periods: erythrocyte sedimentation rate, hematocrit, total and differential leukocyte counts, erythrocyte
morphology on

sme~r,

blood urea nitrogen, creatinine clearance,

urine concentrating ability, renal excretion of phenosulfonphthalein, plasma clearance of bromsulfalein and serum
levels of alkaline phosphatase and glutamate-oxaloacetic
transaminase.

With the above criteria, no detectable toxicity

was found.
i

l

According to the authors, the improvement of glucose
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tolerance observed could be due to a mechanism by which
chromium facilitates the insulin-tissue interaction resulting
in a more effective insulin action.

The authors also point

out that impaired glucose tolerance is not the only symptom
of a low chromium state in animals.

A more severe deficiency

results in depressed growth and life span as compared with
chromium supplemented controls.

Also the incidence of athero-

mata in the aorta as well as the concentration of aortic lipids
increase significantly.

An excellent treatment concerning

chromium,'deficiency and atherosclerosis has recently been
presented (1).

Finally, the authors we.re quick to point out

the fact that their data, as well as that of others (25),
was consistent with the hypothesis that not all cases of
diabetes are complicated by chromium deficiency.
In another study (72), chromium (III) supplements of
lSOµg daily were given to 10 apparently healthy residents
of an old-age home.

Each elderly subject exhibited an ab-

normal oral glucose tolerance test.

Chromium administration

was associated with disappearance of all abnormal features
of the mean glucose tolerance test in 4 of the 10 elderly individuals so treated, and with no change in the test of the
remaining 6 subjects.

It was suggested that some of the

non-responders may have been severely deficient of chromium
and may have shown improvement in the glucose tolerance test
if chromium supplementation had been continued over a longer
period of time.
It has been suggested that chromium (III) deficiency
may be the cause of the impaired glucose tolerance seen in

J8
certain malnourished infants.

As a result the effect of

chromium (III) administration was investigated (73).

Twelve

malnourished infants with impaired glucose tolerances were
treated with 250µg of Cr(III) as CrC1 3 .6tt 2 o.

All twelve im-

proved rapidly whereas only 2 out of the 5 cases not given
cr(III) improved.

In another study, the effect of chromium

(III) on the fasting blood sugar levels and glucose removal
rates in cases of protein-calorie malnutrition of the marasmic
type was investigated (74).
the 14

ca~es

According to the authors, 9 of

of infant Marasmus included in the investigation

showed a significant improvement of glucose removal after
administration of chromium.
of the cases.

No change was observed in five

Also, the administration of chromium caused

no significant changes in the fasting blood sugar values.
Insulin Biosynthesis and Release
Despite the fact that accounts of diabetes mellitus
appear in man's earliest medical literature, the etiology
of the condition remains unknown.

According to a recent

article (75), diabetes is a rapidly increasing health problem.
The number of diabetics in the United States has grown from
1.2 million in 1950 to an estimated 5 million now, an increase of more than 300 percent while the population has
grown only about 50 percent.

Treatment with insulin has

markedly increased the life expectancy of diabetics.

But

in spite of treatment with insulin, strict diets, and oral
antidiabetic agents, diabetes is still the fifth leading
cause of death by disease in this country and the second

39
leading cause of blindness.
There is increasing evidence to suggest that diabetes
mellitus may represent a heterogenous group of disorders
characterized by glucose intolerance.

Epidemiologists have

produced much evidence that there is a link between viral
infection and the onset of diabetes

(75,76).

Defects in the

number or integrity of insulin receptors or in their coupling
to messengers which effect the biological activity of insulin
in tissues sensitive to this hormone have also been implicated (777.

An unusual diabetic syndrome with severe insulin

resistance due to antibodies that impair insulin-receptor
binding to monocytes has been reported (78).

Endocrinolo-

gists have shown that a second hormone, glucagon, is involved
in the pathology of diabetes, suggesting that much better
control of diabetic symptoms can be accomplished by regulation
of the concentration of both insulin and glucagon (79).
In view of the fact that most of the current literature
suggests that the defect exists at the level of the pancreatic
islet, I feel that it is most appropriate to briefly discuss
some of the current concepts of insulin biosynthesis and release together with current thoughts about insulin-receptor
interactions and the phenomenon of insulin self association
which I feel may be important sites for the action of
chromium (III).
A recent review (GO), concerned with the intracellular
aspects of protein synthesis recognizes the process as
occurring in the following six steps.

(1) synthesis,
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(2) segregation,
tration,

(3) intracellular transport,

(4) concen-

(5) intracellular storage, and (6) discharge.

The

article was written with respect to the pancreatic exocrine
cell, however, the same concepts apply to the endocrine cell.
In the latter, the contents are released directly into the
blood stream.

Also, endocrine cells apparently discharge

their secretory product along the entire plasmalemma instead
of discharging within restricted plasmalemmal regions as exocrine cells do.

According to the author, proteins for export

are synth~sized on polysomes attached to the membrane of the
rough endoplasmic reticulum.

The new peptide chains elongate

directly into the cisternal space of the endoplasmic reticulum
through pores beneath the point of ribosomal attachment and
are thus separated from the cytoplasm of the cell as they are
synthesized.

It is well recognized that proinsulin is syn-

thesized in this manner (81).

Processes such as conformational

change and disulfide bound formation were suggested as possible
reasons why the segregation process is irreversible and that
once inside the cisternal space, the polypeptide can no longer
get out.

Disulfide bond formation within the proinsulin

molecule may occur spontaneously as the molecule enters the
cisternal space of the endoplasmic reticulum, thus preventing
its exit.

•·

From the cisternal spaces of the rough endoplasmic

reticulum, the secretory proteins are transported to the
Golgi complex.

The geometry of the connections between the

endoplasmic reticulum and the Golgi complex is a confusing
matter.

Some investigators have reported that the two com-
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partments are permanently connected by continuous tubules
(82) while others have reported that the connection is intermittent and continuity is established by shuttling vesicles
which are probably buds of the reticular network (83).

These

vesicles are thought to travel into the Golgi region of the
cell where they empty their contents into larger vesicles
call~d

condensing vacuoles or immature granules.

Also, very

little is known about the energy requirements of this transport process.
The

~ecretory

proteins reach the condensing vacuoles in

a dilute solution that is progressively concentrated at these
sites into a level comparable to that found in mature secretion granules.
achieved (84).

A large concentration factor is supposedly
The energy requirement of this concentrating

process is the subject of much debate.

It has been suggested

that large, stable aggregate formation under the influence
of a sulfated polyanion {85), or through protein-protein
interactions could be partly responsible.

Such a hypothesis

could explain concentration and intracellular transport
against a chemical gradient.

This is highly possible in

the case of proinsulin since it exhibits a self-associative
behavior similar to insulin (86).

Proinsulin differs from

insulin in that it has a connecting polypeptide portion (Cpeptide) which links the carboxy terminus of the insulin B
chain to the amino terminus of the insulin A chain.

It has

been suggested that the conformation of the insulin moiety
in proinsulin is nearly identical to that of insulin
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itself (87).

The connecting peptide does not appear to obs-

cure those monomer surf aces of insulin which are involved in
the association of insulin to dimers and to hexamers (88).
The current structure of the proinsulin hexamer has the Cpeptide portion oriented externally which, according to many
investigators (89), may facilitate conversion of proinsulin
to insulin.

This intracellular proteolytic conversion of

proinsulin to insulin in the beta cell is a distinctive feature
of insulin and distinguishes it from the classical zymogen
activation (90).

The Golgi complex appears to be the site

of this partial proteolysis (91), however, other observations
indicate that it probably continues within the secretory
granules as they collect and mature within the cytosol (90,
92,93).

Two types of proteolytic activity have been proposed

to exist for the conversion of proinsulin to insulin (94).
One is a trypsin-like protease and the other similar to carboxypeptidase B, which is necessary to remove the C-terminal
basic residues remaining after trypsin action.

Only limited

success has been achieved in actually isolating these activities from beta cell granule preparations (95,96).

Evidence

has been provided (97) that the proteolytic activities may
he localized in the membrane containing fraction of the
granule.

Finally, at

th~

level of the Golgi complex the

secretory product is transformed from a high permeability
membrane (endoplasmic reticulum) to a membrane whose lipid
composition approaches that of the plasma membrane, in preparation for discharge (98,99).

At this point the term
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secretion granule or beta granule is pref erred to condensing
vacuole since the original body, now present in the cytosol,
has been modified anatomically and has reached the end of the
concentration step.

The protein of interest (insulin in this

case) is stored within the beta cell in these secretion granules until discharge.

Many changes take place in these

graqules as they remain in the cytosol, one being the final
conversion of proinsulin to insulin as was discussed previously.
Within the secretory granule, insulin exists as an aggregate

~ssociated

with zinc leading eventually to a crystal-

line zinc inclusion.

Current research seems to indicate that

the functional role of this aggregation process is to insure
efficient storage of insulin in the granules.
whereby zinc accumulates is not known.

The mechanism

However, it has been

demonstrated that proinsulin binds more than 5 g-atom zn+ 2 ;mol
of protein and polymerizes to form soluble aggregates under
conditions where insulin binds only 1 g-atom/mol and is almost
completely precipitated from solution (100).

It has also been

suggested that the binding of zinc to proinsulin may influence
the conversion of proinsulin to insulin (101) •

The C-peptide

resulting from the proteolysis of proinsulin is also present
in the granule and is released along with zinc when discharge
is accomplished.

The chemical process whereby the zinc-insulin

hexamer or the highly associated insulin species present in
the granule is converted to a soluble, dissociated species
which is released to the blood stream is poorly understood.
One possible explanation could be the existence of a factor
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capable of causing dissociation of aggregated insulin species.
Finally, I would like to briefly discuss insulin discharge from the beta cell.

According to Palade (80), discharge

is accomplished by a process originally called "membrane
fusion" and later termed "exocytosis''.

He further states that

in preparation for discharge, the membrane of the secretion
granule fuses with the plasmalemma and that subsequent re- '
organization leads to fission of the fused membranes within
the area of fusion (Figure 5).

The final result, according

to Palade; is continuity between the granule compartment and
the extracellular medium along with continuity of the granule
membrane and the plasmalemma of the beta cell.

The author

also points out that under normal steady-state conditions,
excess membrane must be removed from the receiving compartment
and added to the donor compartment, otherwise the plasma membrane would continuously increase.

Just exactly how this

redistribution process is achieved remains a mystery, however,
recent evidence (102) seems to indicate that the beta cell
may be capable of digesting its own membrane.
A major problem which has not yet been clearly resolved for any secretory cell type concerns the factors involved
in the translocation of granules to the cell membrane during
exocytosis.

It has been postulated that microtubules and

microfilaments play a role in effecting secretory discharge,
as well as in directing or moving secretory granules to their
sites of discharge (103).

There seems to be agreement how-

ever, that the manner in which these elements are involved

~·
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in granule movement is speculative at present.

Another theory,

focusing attention on actinomyosin-like contractile proteins
as possible elements in the secretory process has been proposed (80,103).

An active role for the granule and its mem-

brane in the release mechanism has also been put forward (104).
According to the authors, the secretion granules undergo a
morp~ological

change termed ''binesis".

Binesis which means

"to couple", is a process whereby the granular membrane forms
a lingula that protrudes from one secretory granule and inserts intp an adjoining secretory granule.

According to the

authors there was a threefold increase in the incidence of
granules demonstrating binesis at a stimulatory glucose concentration (300 mg/ml) as compared to the granules of islets
incuhated at a basal glucose concentration (90 mg/ml) indicating active participation of the insulin secretory granule
and its membrane in the insulin release mechanism.

It was

further suggested that this process may represent a morphological concomitant of glucose-mediated activation of the
insulin secretory granules before exocytosis of the granule
contents.
Superimposed upon each or all of these processes are
various modulating mechanisms, which influence the total release sequence at the beta cell level.

The basic requirement

of calcium ion and energy for exocytosis has been well established (105).

Lacy and co-workers (106) proposed that

calcium may be the trigger that would initiate contraction or
a change in the physical conformation of the microtubules or
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microf ilaments attached to the membrane around the beta
granule.

This would 'result in a rapid displacement of the

granules to the cell surface and liberation of these granules
in tandem at specific loci on the plasma membrane.

This view

is further supported by an observation that microtuhules can
be reassembled in the presence of a calcium chelating agent
(107~.

An excellent treatment concerning the control of in-

sulin secretion has recently been presented (108).
distinguished two classes of stimulating agents.
group,

wh~ch

The authors
The first

included those agents themselves capable of eli-

citing insulin release, were termed "initiators''.

The second

group, termed potentiators, had no effect by themselves on
insulin secretion but increased the response to initiators.
Examples of initiators included glucose, mannose and leucine.
Potentiators included other amino acids, agents which increased
cyclic Af1P concentrations and certain sugars other than glu-

case and mannose.

Of ultimate importance to this scheme was

the fact that the absence of calcium ion blocked the secretory
response to all agents.
Since glucose is the major effector of insulin release,
two models for the glucoreceptor at the beta cell level have
been proposed (108) .

In the first model termed "regulator

site" model, glucose acts as an allosteric modifier of a cell
surface receptor.

Combination of glucose with this receptor

leads to an increase in membrane permeability with regard to
calcium ion with eventual initiation of exocytosis.

In the

second model termed "substrate-site" model, glucose is meta-
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bolized by the beta cell which results in the presence of a
metabolite that has the capability of initiating calcium influx and exocytosis.
Insulin-Receptor Interactions
Many aspects of insulin-receptor interactions have been
characterized in the past few years.
been reviewed in detail {109,110).

Much of the work has
In a recent report Blecher

and co-workers {111) found that two hormones involved in diabetes namely insulin and glucagon, bind in specific ways to
surface receptors on human peripheral mononuclear leukocytes.
Their most important observation concerns the difference in
binding they found for both hormones between normal persons
and those with overt late-onset diabetes or no diabetes symptoms but a family history of diabetes.

They found that for

all normal controls studied, there was good receptor binding
of both glucagon and insulin.

On the other hand, for overt

late-onset diabetics, glucagon and insulin binding was about
one-third that of controls.

Similar low binding levels of

both hormones were found in a third group with no symptoms
but with a family history of diabetes.
In contrast, the insulin insensitivity of adipocytes
from obese individuals was not found to be consistent with a
decrease in insulin binding, a decrease in the number of receptors per cell or an increase in the degradation of insulin
(77).

As a result of this study it was proposed that meta-

bolic alterations might render large fat cells less sensitive
to some of the actions of insulin· which would in turn appear

as insulin resistance.
In another study (112), incubation of cultured human
lymphocytes or isolated rat fat cells at 37°C with insulin
resulted in a time-dependent fall in the ability of the
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thoroughly washed cells to bind
I-labeled insulin. The
effect was dependent on the concentration of insulin used in
the preincubation period.

The kinetic properties of the af-

fects, according to the authors, were more consistent with a
catalytic, destructive process (proteolytic) than with a pro-

.

cess of receptor occupation.

Various insulin analogs were

studied to determine whether the destructive effect of insulin
could be correlated with the biological activity of the hormone and with its proteolytic activity.

These analogs of

insulin, having greatly decreased or no biological activity

I

as measured by ability to stimulate glucose oxidation and
having no binding to insulin as measured by their inability
to compete for the binding of iodoinsulin, are nevertheless
effective in their ability to reduce insulin binding upon
preincubation with fat cells.

Also, all of the analogs de-

monstrated proteolytic activity, but particular mention was
made of the insulin B-chain.

Although the proteolytic effect

was observed upon preincubation with physiological levels of
insulin for periods greater than 16 hrs, the same effects were
observed in shorter periods (1 to 3 hrs) with extraordinarily
high concentrations of insulin (above Sµg/cc) .

According to

the authors, it was difficult to exclude the possibility that
such destructive effects may under certain circumstances be

r
'
'
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manifest in vivo and the possibility exists that these effects
may contribute to certain metabolic or pathologic derangements,
specifically in hyperinsulinemic states such as obesity and
adult-onset diabetes.

The assumption that a higher aggregated

species of insulin could possess proteolytic activity may explain the results that preincubation with concentrations of
insulin greater than Sµg/cc caused decreased binding of labeled
insulin to the cells with shorter preincubation periods.

It

would be interesting if one could synthesize a covalent dimer
or higher:order aggregate of insulin and study possible proteolytic effects.

At this time, it may be important to also

mention the possible beneficial effects of a metabolite or
other factor that could prevent aggregation or cause dissociation.
The Three-Dimensional Structure of Insulin
Finally, I would like to discuss the structure of the
insulin molecule.

I want to point out beforehand that the

current three-dimensional structure that we now have of the
insulin molecule was obtained by the X-ray analysis of insulin crystals.

According to Hodgkin (113), the beta granules

show dense aggregates in the electron microscope which appear
crystalline in nature and seem to resemble rhombohedral
crystals of insulin.

Within these crystals, particles are

visible, the arrangement of which strongly resembles the
packing of the hexamers in the insulin crystal structure as
derived from X-ray analysis.

As a result it has been sug-

gested that insulin probably exists as a hexamer in the beta
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granule (114) and that further association of the hexamers
occurs to achieve efficient

sto~age

of the insulin (115,116);

the final product resembling rhombohedral insulin crystals.
Also, there seems to be agreement among investigators that
the conformation of insulin in solution agrees with the results of X-ray crystallography (115-117).
Insulin is a polypeptide consisting of 51 amino acids
and having a molecular weight of 5778.

The insulin molecule

is composed of two polypeptide chains, designated "A" and
"B", whicri are connected by two interchain disulfide bridges
of cystine (Figure 6).

The "A" chain of insulin contains an

intrachain disulfide bridge within which a species difference
in amino acid composition occurs, primarily at positions
9, and 10.

B,

Pork and human insulin have a similar amino acid

composition at these positions and differ only in the carboxy
terminal end of the "B" chain.

Pork insulin, like that of

beef, has alanine at this position; human insulin has
threonine.
Let us now take a closer look at the atomic arrangement of the insulin monomer.

I will begin with a discussion

of the conformation of the "B" chain followed by that of the
"A" chain.

According to Blundell and co-workers (117), the

first seven residues in the "B" chain have an extended configuration (Figure 7) which is then followed by a sharp turn
at the glycine at B8.

The residues B9 to Bl9 form part of a

well defined right handed helix.

The helix separates the

cystine disulfide bridges at B7 and Bl9 and it appears to be

""'

.......
,

~

Val

3

9

Val

As!

3

rx

9y

lie

B CHAIN
2

Gly

2

A CHAIN

s:: c

~

Hi

0

Thr

Pro
lys
Ala

Ala

27

Glu

V;j

14

28

13

Z4

Phe

25

Phe
Tyr

Leu

Tyr
Leu

26

17
16
15

Cys
Val

Glu21

Gly

Arg22
23

Cys

20

Gly20

19

Tyr

19

18

Asn

Gu
Leu
Gi'l

TJf
Leu

12

18
17
16
15·

ro

:::l

......

()

Ii

0

'd

~

......

C/l

ro

s::

0..

ro
C/l
......

Ii

0..

......

()

p,

'-' 0

-~

00 ......

s

1--' pi
1--'

~

......

X"' ro

l.,Q ()

0..

o ro

::r: s::

s ...0ro

0 (/)

Ii

•

.°'

l:I1

"tj.

,......,

~

......

1--' ~

\4

29

Leu

His

Ser

Gly

Cys
Leu

His
Gin.

"tj

H
C/l G)

~

......

13

30

11
10

9

8
7

Ser

Cys
lie

SaTh-

6

Cys

Cys
Gi'l

12

n
10
9

8

5

7
6
5

4

Glu

4

···:-,,

Asn

21

.:

.·.

.:

I\)

\./\

53

..

...
'•

..

7.:

FIGURE
The "B" chain of porcine insulin [From
Blundell, et.al. (116)].
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an important structural feature in the insulin molecule.

The

residues following the helix B20 to B23 constitute a "U" turn
in the polypeptide chain so that the remaining residues B24
to B30 can form an extended chain lying antiparallel and
against the helix B9 to Bl9.

Concerning the "A" chain

(Figure 8), Blundell further states that residues A2 to A8
make a short piece of distorted a-helix and the right-handed
helical sense is retained for residues A9 to All.

This ar-

rangement easily accommodates the A6-All cystine disulfide
bridge.

The residue Al2 has an extended form so that the

following amino acids Al3 to Al9 can form a distorted righthanded helix with its axis nearly antiparallel to that of the
helix A2 to AB.

The remaining peptides have an extended

conformation.
Within the hollow formed by the arms of the "B" chain,
the "A" chain lies as a compact unit; the most obvious stabilizing forces resulting from the disulfide bonds.

According

to Hodgkin (118), the covalent bonding of the two chains
through the disulfide residues is reinforced by van der Waal's
interactions between residues belonging to strategically placed
nonpolar groups, B-11 leucine, B-14 alanine, B-15 leucihe,
B-18 valine, A-13 leucine, A-16 leucine, and A-2 isoleucine,
and these cluster around the A6-All disulfide bond.

As a

result, these nonpolar residues and the A6-All disulfide bond
are buried within the molecule.

The conformation of the in-

sulin monomer without the disulfide bonds is shown in Figure 9.
In this configuration most of the polar groups extend over
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FIGURE 8. The "A" chain of porcine insulin [From
Blundell, et.al. {116)] .
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FIGURE
The polypeptide backbone of the whole insulin
molecule [From Blundell, et.al. (116)].
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the surface of the molecule together with a few nonpolar residues which take part in further close contacts between the
molecules in the dimer and the hexamer.

As far as the inter-

chain disulfide bonds are concerned, the B7-A7 is on the
outside of the molecule and consequently accessible to solvent
while the Bl9-A20 is partially buried but still accessible to
solv~nt.

This is an important consideration since earlier in

this discussion it was postulated that chromium (III) may exert
its effect through a disulfide interaction (49,58).
be

rememb~red,

It must

however, that by no means is the disulfide bond

the only site of interaction between insulin and chromium.
Other groups, namely amino, carboxyl and hydroxy, have also
been implicated in chromium-protein interactions (119) arid
therefore cannot be eliminated.
In several recent studies concerning the receptor binding
region of insulin certain surf ace regions of the insulin monomer have been implicated (116,120).

Possible candidates in-

cluded Al Gly, AS Gln, Al9 Tyr, A21 Asn, B24 Phe, B25 Phe,
B26 Tyr, Bl2 Val and Bl6 Tyr.

The effects on X-ray diffraction,

circular dichroism, receptor binding and biological potency
of modifying the Al Gly with groups of increasing size was
recently studied (121).

The results were consistent with a

model in which hydrophobic residues such as B24 Phe, B25 Phe,
B26 Tyr, Bl2 Val and Bl6 Tyr are involved in receptor binding
in a manner similar to their involvement in dimerization.
Other studies have implicated the a-amino group of the Al
glycine as very important for biological activity (115,116).
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The main corttacts in the dimer are between nonpolar
sidechains particularly in the B21 to B30 region (Figure 10).
According to Hodgkin (118), the interaction is strong and invalves both hydrogen bonds forming part of a beta-pleated
sheet type of structure between the peptide groups of B24 and
B26 and close van der Waal\s contacts between a number of nonpolar residues (Figure 11).

Dimer formation covers a number

of hydrophobic groups on the surface of the individual molecules
while others are concealed when contacts are made between the

.

dimers within the hexamer.
In the crystalline structure and therefore probably also
in the pancreas, aggregation occurs around 2 zinc atoms to
form a hexamer (Figure 12).

According to Blundell (117), each

zinc is bound to an imidazole nitrogen of one of the BlO histidines of each of the dimers, therefore, each zinc has bound
to it three imidazole rings.

The coordination of the zinc is

completed by solvent molecules.

Hodgkin reported (118), that

the only hydrophobic groups remaining exposed on the surface
of the hexamer are the AlO isoleucine and the B25 phenylalanine and that these are both involved in direct intermolecular
contacts in the crystal structure (Figure 13).

The author

also reported that there are small channels passing between
the hexamers in the crystal structure through which small
molecules and ions can penetrate and interact with the surface
residues of the insulin molecules.

Such channels could pro-

vide a means by which chromium (III) could gain access to
critical insulin residues.
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FIGURE io: View of the insulin dimer [From Blundell,
et.al. (116)] .
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FIGURE 11; The pleated sheet structure developed
between monomers [From Blundell, et. al. ( 116)] .
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FIGURE 12. The development of' the dimers from monomers
and their organization into hexamer [From Blundell, et.
al. (116)) .
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FIGURE 13~ The packing between the hexamers in the
crystal [From Blundell, et.al. (116)) .
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Insulin Conformation in Solution
It has been reported that the zinc-insulin complex formed
in solution consists of 6 insulin molecules associated with
a minimum of 2 zinc ions (115).

According to the authors, one

of the most prominent changes that occurs when zinc is added
to a solution of insulin is a marked increase in the negative
circ.ular dichroic band at 275nm (Figure 14).

A recent study

(122), assigns changes in the near ultraviolet circular dichroic
. spectrum (275nm) to the aromatic residues (tryosine and phenylalanine)• contrary to a previous report (123) attributing the
'

band to a strained disulfide bridge.
assignment is presented.

Evidence in favor of the

According to the authors, attenuation

of the band at 275 is correlated with conditions that bring
about disaggregation while a strengthening of the band is associated with conditions which enhance aggregation.

A number

of metal ions other than zinc were also studied with regard to
their effect on the near ultraviolet circular dichroic spectrum
of insulin.

F e 2+ I

c U 2+

I

Pb 2 +, Mn 2 +, Co 2 +, Cd 2 + and Ni 2 + in-

creased the magnitude of the minimum at 275nm while Fe3+ and
Mg 2 + produced no significant change.

Another study (124) indi-

cated a major contribution from tyrosine moieties to the near
ultraviolet circular dichroism spectrum.

It must be remembered

that the self association of insulin is a process that depends
upon a number of factors, among them protein concentration,
pH and ionic strength and that in the absence of zinc, insulin
solutions are probably a mixture of dimers, tetramers and hexamers all in equilibrium with the insulin monomer.

The presence
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FIGURE 14. Near ultraviolet CD spectrum of insulin without zinc (A) and with zinc (B).
Insulin concentration of
1 mg/ml at pH 7.4. Zinc concentration in solution for
lower curve of 1 gm-atom zinc per 2 moles of insulin.
e reprisents mean residue ellipticity in units of deg cm 2
dmole- and A represents wavelength. [From Frank, et.al.
(115)].
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of zinc displaces the equilibrium in the direction of the
hexamer.
At present there is much debate on the molecular size
of the ultimate physiological unit of insulin.

Unknown factors

such as the concentration of insulin at the receptor regions
of insulin responsive tissues add to the problem.

A great

deal of evidence seems to support the view that the monomer
is the active form.

This is supported by the fact that certain

insulins, such as sulfated insulins and nitrated insulins,
which only exist as monomers, are biologically active (118,125).
Calculations based on the equilibrium constant for dimer formation show that the mole ratio of monomer to dimer would be
about 800,000 to 1 at physiological concentrations (about
O.lng/ml of serum)

(126).

Finally, the retention of biological

activity by insulin-agarose derivatives, which according to
Cuatrecasas (127) contains bound insulin molecules that are
exclusively monomers, provides strong evidence that the biologically active species of insulin is the monomer.
In summary, the relation between chromium deficiency
and impaired glucose tolerance has been clearly established.
Evidence for a potentiating affect on insulin action has also
been presented.

It remains to be shown, however, whether

trivalent chromium, the active component of the glucose tolerance factor, can directly induce a conformational change in
insulin or interact with the molecule in such a manner as to
affect the association-dissociation process.

The implications

for this interaction are that it may significantly alter the
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insulin-receptor interaction or the mechanism of insulin release from the beta cell both of which have been implicated
in impaired glucose tolerance.

There are several excellent

techniques available for studying protein conformation and
aggregation.

Among them are circular dichroism spectroscopy

and frontal gel chromatography.

It is the purpose of this

dissertation to utilize these techniques to provide evidence
for a chromium-insulin interaction in hopes of clarifying the
role of this important trace metal in carbohydrate metabolism.

CHAPTER II
MATERIALS AND METHODS
Materials
Studies concerning protein-metal interactions require
the use of a relatively pure metal-free protein preparation
as well as strict metal-free conditions with regard to the
preparation of solutions and cleaning of glassware.

All

glassware utilized in this study was washed in an EDTA
(ethylenediamine tetraacetic acid)-soap solution, rinsed with
deionized-distilled water, soaked in dilute HCl solution,
rinsed thoroughly with deionized-distilled water and dried
at 175°C before use.

Glassware utilized in the frontal gel

analysis experiments was treated with Siliclad, a water soluble
concentrate produced by Clay Adams, Parsippany, NJ, followed
by rinsing and drying at room temperature for 24 hrs.
Two different insulin preparations were used in this
study.

One was a porcine zinc-free preparation produced by

Eli Lilly and Co., Indianapolis, IN; the other was a bovine
zinc insulin produced by Sigma Chemical Co., St. Louis, MO.
The Lilly insulin (lot PJ7412) was reported as containing

f

!

less than 0.04% zinc.

This is equivalent to 0.035 g-atom of

f.

l

zinc per mole of insulin.
having 0.5% zinc.

The Sigma insulin was stated as

This would be equivalent to 0.44 g-atom

of zinc per mole of insulin.
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The trivalent chromium complex utilized was chrom alum
crK(S0 4 ) 2 ·12H 2 o.
phosphate.

The buffer selected was 0.067M Sorensen's

It was prepared by making separate 0.067M solu-

tions of di-sodium hydrogen orthophosphate (Na 2 HP0 4 , 9.47g/l)
and potassium dihydrogen orthophosphate (KH 2 Po 4 , 9.08g/l).
All three of these reagents were of the ANALAR grade and were
obtained from BDH Chemicals Ltd., Poole, England.

The final

buffer solution was prepared by mixing 164ml of the KH 2 Po 4
solution and 836ml of the Na 2 HP0 4 solution.
tently remained between 7.45 and 7.47.

The pH consis-

Other physiological

buffers, namely TES [N-tris (hydroxymethyl) methyl-2-ethanesulfonic acid], BICINE [N,N-bis(2-hydroxyethyl) glycine],
HEPES [N-2-hydroxy-ethylpiperazine-N-2-ethane-sulf onic acid]
and MES (2-(N-morpholino) ethanesulfonic acid] were obtained
from Pierce Chemical Co., Rockford, IL, and reported as having
less than Sppm Fe or heavy metals such as Pb.

TRIS (hydroxy-

methyl) aminomethane was obtained from Calbiochem, La Jolla,
CA, and contained less than lppm heavy metals.

Ultra pure

urea was obtained from Schwarz/Mann, Orangeburg, NJ.

It was

reported as having a heavy metal content of less than O.Olppm.
Deuterium oxide (D 2 0) was obtained from International Chemical
and Nuclear Corporation, Irvine, CA, while deuterium chloride
was obtained from Isotopes Incorporated, Westwood, NJ.

All

other chemicals used were of reagent grade and obtained from
standard commercial sources.
Proteins used for column calibration were ovalbumin and
equine myoglobin (Nutritional Biochemicals Corp., Cleveland, OH),

chymotrypsinogen A (Worthington Biochemical Corp., Freehold,
NJ), ribonuclease A (Sigma), carbonic anhydrase (Boehringer
Mannheim Corp., New York, NY), ACTH (Armour Pharmaceuticals,
Kankakee, IL), and a nitrated insulin that was synthesized.
Blue dextran for void volume determination and Sephadex G-50
superfine resin were obtained from Pharmacia Fine Chemicals,
Piscataway, NJ. Chelex 100, a chelating resin selective for
heavy metals, was obtained from Bio Rad Laboratories, Richmond,
CA.

Dialysis was performed in Spectrapor tubing produced by

Spectrum Medical Industries, Los Angeles, CA, and reported to
have a molecular weight cutoff of 3500.
Preparation of Zinc-Free Insulin
In order to insure the absence of metal contamination,
the insulin preparations were subjected to one of the two
following procedures.

The first procedure is well established

and has previously been used to produce zinc-free insulin
(128).

The method consists of converting the insulin to the

hydrochloride salt by dissolution in 0.25N HCl (15mg/ml).

In

this form, the zinc ions which are normally bound to the B-10
histidines are released because of the positive charge on the
imidazole nitrogens at the acidic pH.

Eighteen volumes of

acetone were then added and after 16 hours at 5°C, the resulting precipitate was collected and washed several times
with acetone and finally with anhydrous ether utilizing a
Millipore suction filtration apparatus and Whatman #42 filter
paper.

The product was then dried in a vacuum at room tem-

perature for 1 hour and stored at -25°C until use.

Since
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no weight change occurred on further drying, 1 hour was seiected as a suitable drying period.

In a recent article (122),

it was reported that the zinc content of an insulin preparation subjected to this procedure was approximately 0.003 g-atom
of zinc per mole of insulin as determined by atomic absorption
spectroscopy.
star~ing

This represented a 190 fold decrease since the

material contained 0.57 g-atom of zinc per mole of

insulin.
The second method consisted of dissolving 20mg of the
insulin

~h

4ml of O.OSM tris-7M urea buffer, pH 8.

To this

was added O.lml of Chelex 100 chelating resin which had been
pre-equilibrated with the same 0.05M tris-7M urea buffer until
the pH remained at 8.

After gentle overnight mixing at room

temperature on a Roto Torque rotator (Cole Parmer, Chicago,
IL), the resin was removed by centrifugation.

The pH was moni-

tored before and after the addition of the insulin and after
the overnight mixing procedure.

In another study, the entire

process was repeated omitting the urea from the buffer and
in the equilibration of the chelating resin.

Both prepara-

tions from this second method were utilized for the synthesis
of nitrotyrosyl insulin.
Isolation of "Single Peak" Insulin
As mentioned previously, an insulin preparation free of
other protein contaminants is necessary for these experiments.
It has been shown that commercial preparations of crystalline
insulin contain as much as 8% non-insulin components (129).
As much as 6 of the 8% may be proinsulin with the remainder
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being insulin aggregates and non-insulin material.

Since

these components may interfere with the planned experiments,
a procedure was selected for their removal.

The purification

method selected consisted of column chromatography at 4°C
with Sephadex G-50 {superfine) resin and lM acetic acid
{57.5ml glacial acetic acid/liter) as the eluant.
sins~

Other re-

namely Sephadex G-75, G-50 medium and G-50 fine were

also tested.

It has been suggested that insulin exists in

the monomeric form in the presence of this eluant (130).
A 1;5 X 90cm Pharmacia column was selected for this
procedure.

It was thoroughly cleaned and rinsed with deion-

ized-distilled water before use.

Both the column and the resin

were known beforehand to be stable toward any adverse effects
of lM acetic acid.

The correct amount of resin was then

weighed, placed in a vacuum flask with enough lM acetic acid
to cover it and subjected to a vacuum at 4°C for a 24 hour
period.

This process insured proper swelling of the resin and

removal of gasses so that the column could be poured easily.
After pouring, the column was equilibrated with a continuous
flow of degassed lM acetic acid for a 24 hour period prior to
protein application.

The bed height was approximately 85 cm:

The protein monitoring and collecting equipment (LKB Instruments, Brorruna, Sweden) consisted of an LKB 8300 UVICORD II
Absorptiometer, LKB 7000 UltroRac fraction collector and an
LKB 12000 VarioPerpex peristaltic pump with 3rrun inner diameter
silicon tubing.

Percent transmittance was monitored at 280nm

and 3ml fractions were collected.

Other parameters included
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a flow rate of 4.2 and 6ml/hr, a recorder speed of lOmm/hr
and a sensitivity of 1:1 on the UV monitor.

In all cases ex-

cellent results were obtained using the above equipment and
column preparation techniques.

The protein purification pro-

cedure consisted of dissolving 35mg of the previously prepared
zinc-free insulins in lml of lM acetic acid followed by
application to the column.

Before application the level of

the eluant was allowed to drop to the level of the resin
without going below it.

The sample was then applied by means

of a Pasteur pipette and allowed to enter the resin in a similar
manner as above.

Eluant was then carefully layered on top of

the resin, initially with a Pasteur pipette so as not to dis-,
turb the resin and finally with the pump until it emerged from
the auxiliary outlet at the top of the column.

At this point

the outlet was closed and the pump controlled the flow rate.
Upon completion of the run, the fractions containing the insulin were pooled, placed in filter seal flasks
Gardiner, NY) and lyophilized.

(Virtis Co.,

Acetic acid serves as an ex-

cellent eluant as it is removed during this process.

In

several instances the lyophilized protein was redissolved in
a minimal amount of acetic acid and relyophilized in a smaller
flask to insure less'loss during transfer.

The insulin was

then placed in screw cap vials, sealed with Parafilm (American
Can Co., Greenwich, CT) and stored at -25°C in jars containing
a drying agent.

At this point the preparation was referred

to as "single peak zinc-free insulin".

Finally, a sample of

the bovine insulin before and after purification was subjected
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to sephadex G-50 (superfine) column chromatography in O.OSM
tris-7M urea, pH 7.4 and polyacrylamide disc gel electrophoresis according to the method of Williams (131), with staining
according to the method of Chrambach (132).
Nitration of Insulin
An attempt was made to prepare a derivative of insulin
that does not self-associate.

This derivative could then be

utilized for calibration of the column used in the frontal
gel

analy~is

study, since a non-associating marker protein

with a molecular weight in the range of insulin was desired.
It has been suggested that nitrated insulin does not selfassociate (118,122).
as a candidate.

As a result, this derivative was selected

Two methods were considered for the nitration

of insulin (133,134), both of which utilized tetranitromethane
(TNM) for the nitration of tyrosine residues.
selected was a hybrid of both.

The method

The starting material was the

zinc-free insulin prepared in the presence and absence of urea
as discussed above.

As a result, two different nitration pro-

cedures were performed; one in the presence of urea and one
in the absence of urea.
effect of urea

wo~ld

It was assumed that the dissociating

allow a greater extent of nitration.

The procedure consisted of adding 20 microliters of TNM
(Aldrich Chemical Co., Milwaukee, WIS) to Sml screw cap vials
containing the respective zinc-free insulin preparations.
This amount of TNM was calculated to be a 10 fold excess with
respect to the tyrosyl residues of insulin.

Each preparation

was then incubated at room temperature on a Roto Torque rotator
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for a 2 hour period.

After incubation the reaction was term-

inated by the addition of 1 drop of concentrated HCl.

In

both cases the pH was determined before the addition of TNM
and after the 2 hour incubation with TNM.

A similar study

was performed without insulin to eliminate changes in pH resulting from interactions between TNM and the buffer constituents.
Before using this technique as a preparative method,
it was decided to perform a study to determine whether 2 hours
was a sufficient period for nitration.
performed using non-urea conditions.

A pilot study was
The procedure was similar

to that above except that 50 microliter aliquots were removed
from the reaction vial at intervals of O, 10, 40, 80, 155,
200 and 1127 minutes and placed directly into a Beckman quartz
cell (Beckman Instruments, Fullerton, CA) containing 2.2ml
of O.OlN HCl.

This was considered to be sufficient acidity

to terminate the reaction.

Absorbance was recorded at 276

and 353nm with a Heath EU707-ll spectrophotometer (GCA/
McPherson Instruments, Acton, MA) and 0.05M tris, pH 8, as
the reference.

Under acidic conditions, tyrosine residues

absorb at 276nm while nitre-tyrosine residues absorb at both
276 and 353nm.

Another experiment was performed to compare

the extent of nitration in the presence and absence of urea.
Conditions were similar to those above except that aliquots
were removed at O, 10, 40, 80 and 120 minutes and UV scans
were performed over the range of 240 to 400nm with either
0.05M tris, pH 8 or 0.05M tris-7M urea, pH 8 as the reference.
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In a separate experiment, the buffers were treated with TNM
in a similar manner as the previous experiment which included
insulin.

This was done in order to determine the amount of

absorbance due to interactions between TNM and the buff er
constituents.
Since it is known that insulin polymerizes during nitrat~on

with TNM (134), a series of experiments were designed

to examine the molecular weight distribution after various
periods of nitration.

Nitrations were performed in the pre-

sence and:absence of urea as before.

The reactions were

completed at selected time intervals by the addition of 1 drop
of concentrated HCl to the appropriate reaction vials.

The

intervals were 120 and 1127 minutes for nitration in 0.05M
tris, pH 8 and 15, 30, 60, and 120 minutes for nitration in
0.05M tris-7M urea, pH 8.

The contents were then dialyzed in

Spectrapor tubing at 4°C against deionized-distilled water
(2 changes-4 liters each) and lyophilized in small Virtis
vials.

Upon completion, lml of 0.05M tris-7M urea, pH 7.4

was added directly to the lyophilization flask and after dissolution, the contents were chromatographed at 4°C on a 1.5 X
90cm Pharmacia column with Sephadex G-50 (superfine) resin
and 0.05M tris-7M urea, pH 7.4 as the eluant.
resin were prepared as previously described.

The column and
Protein moni-

toring and collecting equipment as well as conditions, were
identical to those used during insulin purification except
that the flow rate was maintained at 4.2ml/hr.
Finally, the initially described procedure was utilized

16
for the nitration of insulin.

After nitration, the product

was dialyzed against deionized-distilled water, lyophilized
and chromatographed in O.OSM tris-7M urea, pH 7.4 under the
conditions of this section.

Prior to chromatography, however,

the column was calibrated with lml of the following markers
at the stated concentrations: blue dextran (MW 2,000,000-lmg/
ml), .chymotrypsinogen A (MW 25,000-4mg/ml), myoglobin (MW
17,800-6mg/ml), ribonuclease A (MW 13,600-9mg/ml), and single
peak porcine zinc-free insulin (MW 5778-9mg/ml).
tein

conc~ntrations

These pro-

resulted in excellent zones with the UV

monitor set at a 1:2 response.

The nitrated insulin fractions

migrating in the vicinity of the native insulin marker were
collected and pooled.

Dialysis at 4°C against deionized dis-

tilled water was followed by lyophilization.

The final pro-

duct, designated "nitrated insulin", was stored at -25°C until
use.
Solubilization of Trivalent Chromium
This study was performed to determine the maximum amount
of chromium (III) that could be solubilized under the condition
of physiological pH.

As a result, a suitable buffer was se-

lected in which tq perform the spectral analysis of chromium
(III)-insulin interactions.

Some of the difficulties of solu-

bilizing this trace metal under physiological conditions have
already been investigated (14).

The trivalent chromium com-

plex used in this study was chrom alum (CrK(so 4 J 2 ·12H 2 oJ,
formula weight 499.41.

A 10-lM stock solution of this metal

was prepared by dissolving 0.499g in lOml of dilute HCl.
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chromium (III) is stable under this condition (pH less than 4)
and olation is minimized (67).

This process and its conse-

quences were thoroughly explained in Chapter I.

The chromium

stock solutions were kept at room temperature for at least 3
days, during which a slight color change from violet to bluegreen occurred and remained indefinitely.

Aliquots of 50,

100 and 200 microliters were removed from the stock solution
and added to 15ml screw cap vials containing lOml of the following buffers at pH 7.4: 0.067M Sorensen's phosphate, 0.13M
phosphate, 0.05M tris, O.lM barbital, 0.05M TES, 0.05M MES,
0.05M HEPES and 0.05M BICINE.

The addition of the above ali-

quots of chromium (III) resulted in chromium concentrations
of 5 X 10- 4 , 1 X 10- 3 and 2 X l0- 3M, respectively.

In each

case the pH was taken before and after the addition of chromium.
The solutions were then agitated on a Labquake shaker (Labindustries, Berkeley, CA) for a period of 18 to 24 hours at
room temperature.

This was done to insure adequate time for

the coordination of chromium and to determine whether a precipitate would form with time even though it was not observed
initially.

Finally, the solutions were checked for precipi-

tation by placing them in the light path of an inverted Bausch
and Lomb microscope lamp.

They were then labelled as either

suitable or unsuitable.
In another experiment, various nitrogen containing
compounds were added to 0.067M Sorensen's phosphate, pH 7.4
and to 0.13M phosphate buffer, pH 7.4 in an attempt to solubilize more chromium (III).

It was assumed that these

The fol~

compounds would act as weak cheiators of the metal.

lowing compounds, with their molecular weights stated, were
added in O.lM concentrations: niacinamide (122.1), nicotinic
acid (123.1), pyridine (79.1), urea (60.06), imidazole (68.08),
formamide (45.04), ethylenediamine (60.1) and glycine (75.07).
Where appropriate, the pH of the buffer was adjusted to 7.4
with·the addition of lN HCl or l.6N NaOH.

Four hundred micro-

liters of the 10-lM chromium (III) stock solution was then
added to lOml of O.lM solutions of the above compounds in the
respective phosphate buffers.
concentration of 4 X 10

-3

This resulted in a chromium

M which was determined to be the most

desirable concentration for the proposed studies.

The solu-

tions were then agitated on a Labquake shaker for a period of
18 to 24 hours.

The pH in this case was determined before

the addition of the chromium aliquots and upon completion of
the incubation period.

The solutions were checked for pre-

cipitation as before.
Chromium-Niacinamide Interactions
This study was designed primarily to provide evidence
for an interaction between niacinamide and chromium (III),
under conditions 0£ physiological pH and without harsh treatment such as boiling, which has previously been utilized to
produce a chromium (III)-nicotinic acid complex (58).

Nia-

cinamide was chosen since it is structurally similar to
nicotinic acid which has been identified as a component of
the glucose tolerance factor.

Also, dissolution of niacinam{de
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produces a negligible pH change·when compared to nicotinic
acid.
An experiment was designed in which a spectrophotometer
was utilized to record precipitation.

It must be remembered

that in the previous studies precipitation was determined by
visual methods and that it is somewhat difficult to visually
deter~ine

different degrees of precipitation.

The use of this

instrument would undoubtedly yield more reliable data.

It was

decided to monitor the test solutions at 400nm with a Heath
EU707-ll

~pectrophotometer.

This wavelength has been used by

microbiologists to monitor the turbidity due to bacterial
growth (135).

In the procedure, lOml of 0.067M phosphate

buffer, pH 7.4 was placed in each of five 15ml screw cap vials.
Likewise, lOml of a solution of O.lM niacinamide (Sigma) in
0.067M phosphate buffer, pH 7.4 was placed in each of five
vials.

Chromium (III), in aliquots of 0, 100, 200, 300, and

400 microliters was added to each set of five vials resulting
in chromium (III) concentrations of 0, 1 X 10- 3 , 2 X 10- 3 ,
3 X 10- 3 , and 4 X l0- 3 M, respectively.

The vials were then

agitated on a Labquake shaker at room temperature for a period
of 18 hours.

Aliquots were then withdrawn and the absorbance

measured at 400nm in a lcm Beckman cell with 0.067M phosphate
buffer, pH 7.4 as the reference.

The recorder was adjusted

to give a 1 to 0.1 absorbance response.

After transfer, the

spectrophotometric cell was inverted three times before the
absorbance value was recorded.

The pH was recorded before

the addition of chromium, after the addition of chromium and
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upon completion of the incubation period.
Following this, a study was performed concerning the
effect of chromium (III) on the UV absorption spectrum of
niacinamide at physiological pH.

Stock trivalent chromium

solutions in the form of CrK(S04)2·12H 2 o (l0- 1 M) were prepared in dilute HCl.

Aliquots of 10 and 100 microliters were

removed and added to 12 X 150mm screw cap culture tubes containing 50ml of 2 X 10- 5M niacinamide in 0.13M phosphate
buffer, pH 7.4.

.

The pH was monitored before and after the

addition of the acidic chromium aliquots.
trations of chromium were 2 X 10-

4

The final concen-

and 2 x 10- 5 M, resulting

in chromium-to-niacinamide ratios of 10:1 and 1:1, respectively.
The solutions were then agitated gently on a Labquake shaker
for a period of 19.5 hours at room temperature.

Upon comple-

tion of the incubation period, the solutions were visually
checked for precipitation and the pH was taken.

Aliquots were

removed and placed in a lOcm Beckman cell and the UV spectra
were recorded on a Cary 15 recording spectrophotometer (Varian
Instruments, Concord, CA) over the range of 230 to 350nm.
Blanks containing phosphate buffer, phosphate buffer-niacinamide
and phosphate buffer with the appropriate chromium (III) concentrations were also prepared and subjected to the same
procedure.
Since 0.13M phosphate buffer was utilized in the previous
experiment, it was decided to study the ability of a solution
5
of 2 X 10- M niacinamide in 0.13M phosphate buffer, pH 7.43,
to solubilize chromium (III).

Fifty milliliters of this

solution was placed in a 15 X 'l50mm screw cap culture tube.
Likewise, 50ml of 0.13M phosphate buffer without niacinamide
was placed in a culture tube.

A 500 microliter aliquot of a

stock 10-lM solution of chromium (III) in dilute HCl was added
to each of the culture tubes resulting in a final chromium
concentration of 1 X 10

-3

M.

Both tubes were then agitated

gently on a Labquake shaker for a period of 96 hours at room
temperature.

They were observed for precipitation and the pH

taken periodically throughout the incubation period.

This

~

pilot procedure was followed by a long term spectrophotometric
study on the solubilization of chromium (III) by 0.13M phos5
phate buffer-2 X l0- M niacinamide solutions, pH 7.43, at
various chromium-to-niacinamide ratios.

The purpose of this

study was to determine how long the chromium (III) would remain
in solution.

The chromium-to-niacinamide ratios selected were

1:1, 10:1, 25:1, 40:1, 50:1, and 100:1, resulting in chromium
-5
-4
-4
-4
concentrations of 2 X 10 , 2 X 10
, 5 X 10
, 8 X 10
1 X 10

-3

, and 2 X 10

-3

M, respectively.

Fifty milliliters of

the phosphate buf fer-niacinamide solution was placed in each
of 6 screw cap culture tubes.

A seventh tube contained only

0.13M phosphate buffer, pH 7.43.

Aliquots of 10, 100, 250,
1
400, 500, and 1000 microliters of a stock (l0- M) solution of
chromium (III) in dilute HCl were added to the 6 tubes, respectively.

The tubes were then incubated at room temperature.

Aliquots were withdrawn at 1, 7.5, 19, 25, 31, 43, 57, 67.5,
80.5, 95.5, 118, 138, 150, 162 and 185 hours and placed in a
lOcm Beckman cell.

A lOcm cell was chosen to accentuate the

82
effect of precipitation.

A Cary 15 recording spectrophoto-

meter was utilized to measure the absorbance at 400nm.
pH was recorded after 1 and 185 hours of incubation.

The
Finally,

as a check for bacterial presence, O.lml was removed from each
tube and added to 9.9ml of sterile saline.
was removed and plated on blood agar.

After mixing, O.lml

The plates were incu-

bated at 37°C for 48 hours after which colonies were counted
and identified.

Identification was made according to conven-

tional biochemical tests.
Hydrogen-Deuterium Exchange of Insulin
Hydrogen-deuterium exchange of proteins, as measured by
infrared spectroscopy, is an extremely useful tool for the
study of protein structure.

Infrared spectra are directly in-

volved with the vibrations of atoms or groups of atoms in a
molecule as distinguished from rotations of the whole molecule
or from electronic motions characteristic of ultraviolet and
visible absorption spectra.

Absorption band positions are

given in wave numbers which are expressed as cm-1.

According

to Parker (136), three bands involving the peptide bond (-CONH-) are most frequently considered in the conformational
studies of proteins.

The first band, located at 3450cm-l,

is due mainly to N-H stretching.

The second, a strong ab-

sorption band at approximately 1680cm-l, is due mainly to the
C=O stretching vibration.

The third band is ascribed to a

mixed vibration involving N-H in-plane bending and the C-N
stretching modes.

It occurs at approximately lSOOcm-1 and is

termed a weak absorption band.

The .latter two bands are re-
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ferred to as amide I and amide· II, respectively.

According

to Parker, the above frequencies refer to amide groups that
are not hydrogen bonded.

When hydrogen bonded, the N-H

stretching vibration shifts to approximately 3300cm-1 .

The

amide I and II bands also shift when hydrogen bonds are formed.
It has been said that the shift of the N-H stretching vibration
to 3300cm

-1

is independent of conformation while the shifts

of the amide I and II bands to 1650cm

-1

tively, are dependent upon conformation.

and 1550cm

-1

, respec-

For an interpretation,

let us consider the a-helical and 6-pleted sheet conformation
of polypeptides.

The 6-pleated sheet is stabilized by hydro-

gen bonds between NH and CO groups in different polypeptide
strands, whereas in the a-helix, the hydrogen bonds are between NH and CO groups in the same polypeptide chain.

The N-H

stretching vibration of both the a-helical and 6-pleated sheet
forms occurs at approximately the same frequency, whereas the
amide I and II frequencies differ between the two forms.

As

a result, workers have frequently used the ti-H stretching vibration shifts as a sign of hydrogen bonding in the absence
of conformational effects.

Simple peptides exchange their

labile hydrogen atoms (those bound to oxygen, nitrogen and
sulfur) with solvent water in a few minutes.
the exchange may take 24 hours.

For proteins,

According to Parker (137), the

amide II band is very sensitive to hydrogen-deuterium exchange.
According to Nielsen (138), the process takes place as follows:
-CO-NH-

+

-CO-ND-

+

HDO
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AS deuteration proceeds, the amide II band at 1550cm

-1

is

progressively replaced by the deuterated amide II band at
1450cm

-1

, while the intensity of the amide I band remains

constant.

The extent and rate of deuteration can be deter-

mined by measuring either the disappearance of the amide II
band or the appearance of the deuterated amide II band.

Inter-

ference from HOD absorption makes the latter band less suitable
for exchange studies.
In this case, the exchange experiment was performed according to previously established methods

(139,140).

The

procedure consisted of placing O.Olg of a lyophilized bovine
zinc-insulin preparation (Sigma) into a small vial containing
lml of

n2 o.

The time of this addition was taken as T=O.

In

order to achieve dissolution, the pD was adjusted to 2.5 by
the addition of 10 microliters of a 25% DC1-D 2 o solution.
cording to Glasoe (141), the pD of a solution in

Ac-

o 2 o can be

determined by the use of the equation
pD

=

pH meter reading

+

0.40

where the "pH meter reading" is obtained with an apparatus
standardized to read pH in H2 o solutions.

The solution was

then transferred QY means of a syringe to a CaF 2 cell (Barnes
Engineering, Stamford, CT) with a calibrated pathlength of
0.065rnm.

o2 o

The reference cell, pathlength 0.065rnm, contained

adjusted to pD 2.5 with a DCl solution.

of the deuterated amide II peak at 1450cm

-1

The appearance
was measured for

a six hour period with a Perkin-Elmer (model 337) grating

in~

frared spectrophotometer (Perkin-Elmer, Norwalk, CT) equipped
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with an ordinate scale expander.

The instrument was equili-

brated with high purity dry nitrogen to minimize effects due
to water.

Temperature was maintained at 37.5°C with a chamber

developed by Barnes Engineering.
In another experiment, bovine zinc insulin was examined
by infrared spectroscopy in the presence of 10- 6 to 10-8M
chromium (III) potassium sulfate.
with DCl.

The pD was adjusted to 2.5

Temperature was maintained at 37.5°C as before.

The same CaF2 cells were utilized.

In this case the reference

cell contained a chromium-n 2 o solution adjusted to pD 2.5 with
DCl.

Exchange was measured at 1450cm

-1

for a 6 hour period.

Another experiment was performed in which the reference solutions, adjusted to pD 2.5 with DCl, were placed in both the
sample and reference cells and the absorbance at 1450cm
recorded with time under the same conditions as above.
would attribute spectral changes solely to insulin.

-1

This

It was

then decided to test the pD of the insulin-o 2 o solutions with
time.

Since the solutions were not buffered, a pD change

could account for variations in the hydrogen-deuterium exchange.
Ten milliliters of a solution of O.Olg/ml insulin in o 2 o was
placed in a jacketed cell and the pD adjusted to 2.5 with DCl.
The temperature was maintained at 37.5°C with an adjustable
heating source.

A micro electrode attached to a Corning re-

search pH meter (Corning Scientific Ins., Corning, NY) was
placed in the cell and the pH versus time was recorded with a
Sargent SLR recorder (Sargent-Welch, Skokie, IL) over a period
of 8 hours.

The solution was stirred slowly and equilibrated
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with nitrogen throughout the experiment.
Calibration of the CaF 2 cells was performed according to
the Fringe method (142) .

In this method the empty cell is

placed in the spectrophotometer in the sample side.
is placed in the reference beam.

No cell

The spectrophotometer is

operated as near as possible to the 100% line on the paper to
produce fringes of greatest amplitude.

Enough of the spectrum

is run so that 20 to 50 fringes are produced.

The cell thick-

ness is calculated by the following equation.

1

=

where
1

=

cell thickness in microns

w1

= starting wavelength (in microns)

w2

= finishing wavelength (in microns)

n = number of fringes between

w1

and

w2

If the measurements are made in wavenumbers, the equation becomes
1

=

n

where
1 = cell thickness (in cm)
f 1 = starting frequency
f

2

=finishing.frequency
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!hermal Analysis of Insulin-Chromium III Solutions
This experiment was designed to study the spectral
behavior of insulin-chromium (III) solutions at elevated ternperatures.

The apparatus utilized was a Beckman T analyzer
m

with a Moseley X-Y recorder which permits automatic recording
of absorbance versus temperature.

The T analyzer was prom

grammed to cover the range of 28 to 98°C in 25 minutes.

The

absorbance at 238 and 276nm was measured concurrently with
the change in temperature by means of a Cary 15 recording
spectrophotometer attached to the T analyzer.
.
m

The procedure

consisted of adding either 10 microliters of a stock solution
of CrK(S0 ) ·12H o in dilute HCl or 10 microliters of a dilute
4 2
2
HCl solution to each of two lOml screw cap vials containing
lOml of a l0- 4 M solution of single peak zinc-free insulin in
0.13M phosphate buffer, pH 7.43.

Insulin concentrations were

determined on a Cary 15 spectrophotometer at 276nm using an
extinction coefficient of 1.04 ODU/cm (mg/ml).

Similarly,

10 microliters of the stock chromium (III) solution or 10
microliters of the dilute HCl solution were added to lOml of
0.13M phosphate buffer, pH 7.43.
4
chromium was l0- M in both cases.

The final concentration of
The tubes were then placed

on a Labquake shaker and incubated for 1 hour at room ternperature.

The above aliquots were added in a sequential manner

such that each tube was incubated for exactly 1 hour.

Upon

completion of the incubation period, a 3.5ml sample was
removed, placed in a lcm Beckman cell and the UV spectrum
recorded between 220 and 320nm with a Cary 15 recording
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spectrophotometer.

The sample was then subjected to the

temperature change as discussed above by engaging the Tm
analyzer.

The pH was recorded before and after the addition

of the acidic aliquots and upon completion of the incubation
procedure after the solutions reached room temperature.

For

comparative purposes, 10 microliters of a stock solution of
znso 4 ·7H20 (0.5 X l0- 1 M) was added to lOml of 0.13M phosphate
buffer, pH 7.43, and subjected to the above procedures.
circular Dichroism Spectroscopy of Insulin chromium II I)

(Effect of

A plane polarized beam of light can be considered as
being composed of right and left circularly polarized components.
The principal part of an instrument used to measure circular
dichroic properties is a modulator crystal which resolves the
plane polarized monochromatic ray into two circularly polarized
components.

The modulation is based on the phenomenon that

certain uniaxial crystals, such as ammonium dihydrogen phosphate, when subjected to an alternating current, change their
dichroic properties.

The modulator is positioned between a

polarizer and a sample which absorbs the left and right components to a different degree dependent upon the wavelerigth
and structural properties of the sample.

This difference is

detected by a sensitive photocell and recorded.

Circular

dichroism, therefore, refers to the difference in absorption
of left and right circularly polarized light and is expressed
in terms of molar absorption (molar extinction coefficient)
and represented by 6E=EL-ER, where 6E = CD intensity, EL=

rnolar absorptivity for left circ·:.ilarly polarized light and
ER

== molar absorptivity for right circularly polarized light.

In practice, the difference in optical density for the two
circularly polarized components is measured directly.

This

difference is then converted to a difference in extinction
coefficient.
opti~ally

When plane polarized light passes through an

active medium, the light becomes elliptically

polarized, owing to the unequal absorption of the left and
right circularly polarized components.

According to

Strickland (143), there are two types of CD instruments.

One

type measures the difference in absorbance of left and right
circularly polarized light whereas the other measures the
amount of ellipticity produced by a solution.

In this case

circular dichroism (CD) spectra were recorded using a DurrumJasco ORD/UV-5 spectropolarimeter modified to a maximum
sensitivity of 2 X 10
CA).

-3

deg/cm (Durrum Instruments, Palo Alto,

The instrument was calibrated with camphor sulfonic acid

to give a deflection of 15.65cm at 290nm with a scale setting
of 0.02 deg/cm.

Measurements were carried out in cells with

optical pathlengths ranging from 2 to lOcm so that for every
measurement optical densities remained below 2.

The degrees

of ellipticity were obtained from the following relationship:
degrees of ellipticity = scale setting X reading
where "scale setting" is degrees for a lcrn deflection on the
Jasco instrument (only 2 X 10- 3 was used in this work) and
"reading" is centimeter deflection from the baseline of the
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CD tracing at wavelength A.

Circular dichroism data are

reported as the mean residue ellipticity represented by
2
.
and having
uni. t s o f d eg cm dm o l e -l .

[8]A

. .
E 11'ip t.icities
were

calculated from CD spectral tracings by the following equation
(144):

=
where 1 is optical pathlength in decimeters, c is protein
concentration in g/100 ml,

eA is the measured ellipticity at

wavelength A, in degrees and

~o

is the mean residue molecular

weight, taken to be 112 in the case of insulin (122).
are two CD regions of interest.

There

One deals primarily with the

region below 250nrn and is ref erred to as the far-UV CD.
in this region usually indicate secondary structure.

Bands

The

other deals with the region from 250 to 320nm and is referred
to as the near-UV CD.

These bands may arise from tryptophanyl,

tyrosyl, phenylalanyl and cystinyl residues (122, 123, 124)
and usually reflect tertiary structure.
Ten milliliters of a solution of Sigma bovine crystalline zinc insulin (l.71 X l0- 5 M) in 0.067M phosphate buffer,
pH 7.42, was placed in each of two screw cap vials labeled 1
and 2.

Likewise, lOml of a solution of the same preparation

in 0.067M phosphate buffer-0.15M NaCl, pH 7.42, was placed in
each of two vials labeled 3 and 4.

One hundred microliters of

a stock (1.71 X l0- 2M) solution of CrK(so 4 ) 2 •12H 2 o in dilute HCl
was added to tubes 1 and 3 resulting in a

chromi~m

(III) con-
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centration of approximately 1.71 x 10- M and a chromium (III)to-insulin ratio of 10:1.

Similarly, 100 microliters of a

dilute HCl solution was added to tubes 2 and 4.

The tubes

were then incubated for l hour at room temperature with occasional mixing.

Upon completion of the incubation period,

the contents were removed
the

~ircular

a~d

placed in a lOcm Jasco cell and

dichroism spectra recorded over the range of 250

to 320nm with a Durrum-Jasco ORD/UV-5

spectropolarimeter~

Baselines were recorded with either 100 microliters of
~

chromium {III) or 100 microliters of dilute HCl in lOml of
0.067M phosphate buffer, pH 7.42.

Solutions to be utilized

for baseline determination were subjected to the same treatment as the insulin solutions.

The acidic aliquots were added

in a sequential manner such that each tube incubated for
exactly 1 hour.

The pH was recorded before the additions and

upon completion of the CD spectra.

Similarly, 100 microliters

of a stock (4.28 X l0- 2 M) solution of CrK(S0 4 ) 2 ·12H o in di2
lute HCl was added to lOml of a solution of 1.71 X l0- 5M Sigma
bovine crystalline zinc insulin in 0.067M phosphate buffer,
pH 7.42.

This resulted in a chromium (III) concentration of
4
4.28 X l0- M and a chromium (III)-to-insulin ratio of 25 to

1.

Upon completion of a 1 hour incubation period, the CD

spectra were recorded as above.

Another study was performed

to observe the effect of a smaller concentration of chromium
(III) and a longer incubation period.

One hundred microliters

of a stock (1 X 10 -3 M) solution of CrK(S0 ) ·12H o in dilute.
4 2
2
HCl was added to lOml of a 1.71

x

10-SM solution of Sigma
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bovine crystalline zinc insulin in 0.067M phosphate buffer,
pH 7.42.
1

x

This resulted in a chromium (III) concentration of

l0- 5 M and a chromium (III)-to-insulin ratio of 0.58 to 1.

similarly, 100 microliters of a dilute HCl solution was added
to lOml of the insulin solution.

Upon completion of incubation

periods of 24 and 48 hours, CD spectra were recorded over the
rang~

of 250 to 320nm as above.

Another study was designed

to observe the time dependency of the effect of chromium (III)
on the near-UV CD spectrum of insulin.

A solution of 1.71 X

10-5M Sig~a bovine crystalline zinc insulin was prepared in
0.067M phosphate buffer, pH 7.42.
recorded as above.

The CD spectrum was then

One hundred microliters of a stock (1.71

X l0- 2M) chromium (III) solution in dilute HCl was then added
at time (T)=O.

After a brief mixing, the CD spectrum was re-

peatedly recorded over the range of 250 to 320nm for a 33
minute period.

The first spectrum was recorded at T=3 minutes.

Other spectra were recorded at T=l3 and T=23 minutes.

A base-

line solution was prepared and subjected to the same treatment along with the insulin solution.

The pH was taken before

the addition of the acidic aliquots and upon completion of
each incubation period.

Finally, 100 microliters of a stock

(1 X l0- 2 M) solution of CrK(S0 ) ·12H o in dilute HCl was
4 2
2
7
added to lOml of a 6.66 X l0- M bovine crystalline zinc insulin solution in 0.067M phosphate buffer, pH 7.42.

This

resulted in a chromium (III) concentration of 1 X l0- 4 M and
a chromium (III)-to-insulin ratio of 6660 to 1.

As before,

100 microliters of a dilute HCl solution without chromium was
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added to lOml of the insulin solution for comparative purposes.
upon completion of a 24 hour incubation period, the OD spectra
were reported.

In this case, however, the range 215 to 250nm

(far-UV CD) was examined.
The remainder of the CD studies were performed with
Lilly single-peak porcine zinc-free insulin.

The term "zinc-

free .insulin" will be utilized below for this preparation.
Ten milliliters of a solution of zinc-free insulin (1.71 X
'10- 5 M) in 0.067M phosphate buffer, pH 7.42, was placed in each
sere~

Additions of znso 4 ·7H 2 o
(0.85 X l0- 3M) in dilute HCl, CrK(S0 4 ) 2 •12H 2 o (1.71 X l0- 2 M)

of 4

cap vials labeled 1 to 4.

in dilute HCl and dilute HCl (pH 3.5) were made according to
the following scheme:
TABLE II.

Effect of zn+2 and cr+3 on the CD spectrum of
zinc-free insulin (addition scheme).

Tube

#

zn+2
(µ 1)

1

cr+3
( µ 1)

Dilute
HCl
(µ 1)

100

100
200

2
3

100

4

100

100
100

This resulted in a chromium (III) concentration of 1.71 X 10- 4 M
and a zinc (II) concentration of 0.85 X l0- 5 M.

It also re-

sulted in chromium (III)-to-insulin, and zinc (II)-to-insulin
ratios of 10 to 1 and 0.5 to 1, respectively.

Solutions

uti~

lized for baselines contained the above combinations of Zn

+2

,
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cr+3 and dilute HCl in 0.067M phosphate buffer, pH 7.42.

The

tubes were then incubated at room temperature (22 to 24°C)
for 1.5 hours.

Upon completion of the incubation period, the

solutions were placed in a Jasco lOcm cell and the CD spectra
recorded on a Durrum-Jasco ORD/UV-5 spectropolarimeter over
the range of 250 to 320nm.
afte~

The pH was recorded before and

the addition of the acidic aliquots and upon completion

of the incubation period.

.

Insulin Aggregation as Evidenced by CD Spectroscopy
A stock lmg/ml (1.71 X 10-4M) solution of zinc-free
insulin was prepared in 0.067M phosphate buffer, pH 7.47.
Aliquots of 5ml were removed and placed in lOml, 25ml and
50ml volumetric flasks dessignated A, B and C, respectively.
Each was then diluted to the total volume with 0.067M phosphate buffer, pH 7.47.

The solutions were then transferred

to screw cap culture tubes in the following manner.

Solution

A (lOrnl) was placed in a lOml screw cap tube, while solution
B (25ml) and solution C (50rnl) were placed in 50rnl screw cap
tubes.
(0.85

The insulin concentrations were approximately 0.5mg/ml

x

lo-4M), 0.2rng/rnl (0.34

lo-5M), respective;y.

x

10-4M) and O.lrng/rnl (1.71

x

A stock (1 X 10-lM) solution of

CrK(so 4 ) 2 ·12H 2 o in dilute HCl was prepared.

Likewise, a stock

(0.25 X 10-lM) solution of znso 4 ·7H 2 o in dilute HCl was prepared.
The procedure consisted of adding 10 microliters of zn+2 or
50 rnicroliters of cr+3 or a combination of both to the above
solutions (A, Band C).

This resulted in a zn+2 concentration
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of o.25 X l0- 4M in solution A, 0.1 X 10-4M in solution B and
o.05 X l0- 4M in solution C.

This represented a zinc (II)-to-

insulin ratio of 0.3 to 1 in all three solutions.

Similarly,

it resulted in a cr+3 concentration of 5 x 10-4M in solution
A, 2 X l0- 4M in solution B and l X lo- 4M in solution

c.

This

represented a chromium (III)-to-insulin ratio 0£ 5.9 to l in
all three solutions.

A 3 hour incubation period on a Lab-

quake shaker at room temperature was selected and divided into
two 1.5 hour periods.

This was necessary since both zn+ 2 and

cr+3 were:studied in certain cases.

One addition was made at

the beginning of the first period and the other at the beginning of the second period.

The following 9 addition pairs

were studied, each on a separate day: 10 microliters zn+2~
50 microliters dilute HCl, 50 microliters dilute HCl-10 microliters zn+2, 50 microliters cr+3_10 microliters dilute HCl,
10 microliters dilute HCl-50 microliters cr+3, 10 microliters
dilute HCl-50 microliters dilute HCl, 10 microliters zn+2_50
microliters cr+3, 50 microliters cr+3_10 microliters zn+2
and 10 microliters EDTA (lo-lM)-50 microliters dilute HCl.
The scheme for one experiment is shown in Table III with the
first addition in pair as an example.
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TABLE III.

Incubation periods for the effect of zn+ 2 on
the CD aggregation study of zinc-free insulin.

Solution

Period 1
0 to 1.5 hrs

Period 2
1. 5 to 3 hrs

A

zn+2

(lOi.il)

HCl (50i.il)

B

zn+2 (lOi.il)

HCl (50i.il)

c

zn+2 (lOi.il)

HCl (SOi.il)

*

*Refers to dilute HCl (pH 3.5)
It must

b~

remembered that baseline solutions containing the

elements or dilute HCl were also prepared and treated in an
identical manner as the protein solutions.

Upon completion

of the incubation period, an aliquot was withdrawn from
solution A and placed in a 2crn Beckman cell (volume=6ml) .
Likewise, aliquots were withdrawn from solutions B and C
and placed in a Beckman 5cm cell (volume=l4.5ml) and a Beckman
lOcrn cell (volume=28ml), respectively.

Tl1e CD spectra of the

solutions and their respective baselines were then recorded
on a Durrum-Jasco ORD/UV-5 spectropolarimeter over the range
of 250 to 320nm.

UV scans between 220 and 320nm were recorded

with a Cary 15 spectrophotometer for each solution upon completion of each CD spectrum.
completion of the UV spectra.

The pH was recorded upon
Additions to the tubes were

made in a sequential manner such that each tube incubated for
exactly 3 hours.

A typical addition scheme for the Zn+ 2 -

dilute HCl pair is shown in Table IV.
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TABLE IV.

-

Stepwise addition of Zn
study.

Time
Add 10µ1 Zn

9:30

Add 10µ1 Zn

10:00

Add 10µ1 Zn

11:00

for CD aggregation

Procedure

9:00 AM

10:30

+2

+2
+2
+2

to baseline solution A
to solution A
to baseline solution B

+2
Add 10µ1 Zn
to solution B
Add 50µ1 dilute HCl to baseline solution A
+2
Add 10µ1 Zn
to baseline solution c
Add 50µ1 dilute HCl to solution A

11:30

Add 10µ1 zn+ 2 to solution C
Add 50µ1 dilute HCl to baseline solution B

12:00 PM

Add 50µ1 dilute HCl to solution B
Record CD spectrum of baseline solution A

12:30

Record CD spectrum of solution A
Add 50µ1 dilute HCl to baseline solution

c

1:00

Add 50µ1 dilute HCl to solution c
Record CD spectrum of baseline solution B

1:30

Record CD spectrum of solution B

2:00

Record CD spectrum of baseline solution

2:30

Record CD spectrum of solution

c

c
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Finally, an attempt was made to study the time dependency
of the CD change at 274nm.

This is the wavelength of maximum

negative CD intensity in the near-UV CD spectrum of insulin.
This study was performed in two parts.

In part I, 10 micro-

liters of a stock (0.25 X l0- 1 M) solution of ZnS04·7H 2 o in
dilute HCl was added to lOml of solution A in tube A.

Upon

completion of a 1.5 hour incubation period, 50 microliters of
1
a stock solution (1 X l0- M) CrK(So ) ·12H o in dilute HCl was
2
4 2
added.

The time of this addition was taken as T=O and the

chart recorder was engaged at this point.

Tube A was then in-

verted several times and it's contents were placed in a 2cm
Beckman cell and the CD intensity at 274nm monitored for a
period of 73 minutes with a Durrum-Jasco ORD/UV-5 spectrapolarimeter.
procedure.

Solution B was then subjected to the same
The contents of solutions A and B are defined in

the previous paragraph.

As before, the CD spectra of the base-

line solutions were recorded prior to spectra of the insulin
solutions.

The pH was recorded before the addition of the

acidic aliquots and upon completion of the study.
Part 2 was designed to study the time dependency of insulin association in the presence of zinc.

Ten microliters

of a stock (0.5 X l0- 3M) solution of znso 4 ·7H 2 o in dilute HCl
was added directly to 5.0ml of solution A in a 2cm Beckman
cell.

The solution was mixed and the CD intensity monitored

at 274nm for a period of 10 minutes.
Frontal Gel Analysis of Insulin
It was demonstrated by Winzor and Scheraga (145) that
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molecular sieve chromatography possesses all the qualitative
features predicted by Gilbert (146) for ultracentrifugational
analysis of reversibly associating protein systems.

Subse-

quently, Ackers and Thompson (147) developed a theoretical
treatment applicable to molecular sieve chromatography.

More

recently, it was demonstrated (148) that the technique is extrem~ly

valuable for studies involving subunit proteins.

There

are two methods by which interacting protein systems can be
studied by means of gel chromatography.

One method, called

zonal chr¢matography, is familiar to most of us since it is
utilized for protein purification and fractionation.

It in-

volves applying small volumes of the sample to the column.
The sample then migrates through the column and is

eventu~lly

detected by a UV monitor which records an elution profile.
In this case the elution volume is taken as the volume to the
peak of the profile.

This method is not very valuable for

studying proteins with interacting subunits, except under
conditions where a slow attainment of equilibrium between
interacting subunits takes place.

Under these conditions an

equilibrium constant may be determined because the entities
may be separable and the areas under the peaks may be proportional to the equilibrium concentrations of the various species
present.

Zonal chromatography of a rapidly associating-

dissociating protein such as insulin in a solvent (eluant)
which

promotes association-dissociation is evidenced by a

spreading-out of the profile and loss of the sharp peak, which
would be present if chromatography had been performed with an
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eluant such as urea which promotes dissociation to the monomer.
The other method for studying interacting protein systems is
called frontal analysis.

The method consists of applying large

volumes of the sample to the column such that a sharp leading
boundary, a plateau of constant protein concentration and a
trailing boundary are formed.
is

t~ken

In this case, the elution volume

to the centroid position of the leading boundary or

in other words, to the inflection point of the leading boundary.
The elution volume and the form of the elution profile can be
utilized to describe the nature of the interacting protein
system and to determine the equilibrium constant regardless
of the rate of attainment of equilibrium.
In this study, the technique of frontal gel chromatography was utilized to evaluate the ability of Cr+ 3 , Zn+ 2 and
a combination of both ions to alter the molecular weight distribution of insulin at physiological pH.

The elution volumes

(Ve) were determined by differentiating the absorbance (A)
versus volume (V) plots of the leading boundary as recorded by
the UV monitor.

The inflection point was determined by a plot

of dA/dV versus V.

A correction for skewness was made ac-

cording to the method of Longsworth (149).

The elution volumes

were then utilized to determine the sieve coefficient (o) by
means of the following expression (150):
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a

=

where
Ve = protein elution volume
V0

=

colu..'1ln void volume

Vt

=

column total volume

The sieve coefficient is related to the molecular weight by
the following expression (148):

a

=

-A log MW + B

A jacketed (1.3 x 25cm) column thermostated at 25°C and
adjusted to acconunodate a bed height of 8.Scm was selected
for this study.

The column, as well as all glassware, was

siliconized before use.

Sephadex G-50 (superfine) resin was

placed in 0.067M phosphate buffer, pH 7.47 and equilibrated
for 24 hours under a vacuum with stirring.

The column was

then poured and equilibrated for 24 hours with degassed 0.067I1
phosphate buffer, pH 7.17 by means of a Cheminert continuous
flow metering pump (Laboratory Data Control, Riviera Beach,
CA).

A flow rate of 6.0ml/hour was selected.

A special ap-

paratus was designed to trap bubbles produced by the pump.
It consisted of an inverted plastic test tabe with both an
inlet and outlet at the bottom.

Any bubbles entering would

rise to the top and therefore, would not enter the column.
Absorbance was monitored in a lcm flow cell with either a
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carY 15 or a Beckman DB-G spectrophotometer.

A special 4-way

sample injection valve (Laboratory Data Control) was utilized
to insure proper application of the sample to the column.
valve was placed between the pump and the column.

Basically,

it consists of a main chamber and two loops (A and B)
15).

The

(Figure

The valve is operated by a slider which can be placed

in oDlY two positions.

In one position, solvent flows from

the pump through loop A and into the column.

Meanwhile, loop

B is open to the atmosphere and can be filled with a protein
sample.

~t

position.

any time, the slider can be placed in the other
This will automatically shift the flow of solvent

through loop B forcing the sample ahead of it into the column.
For this study, three different size loops were used in place
of loop B.

The first loop, used primarily for column cali-

bration, contained approximately 0.28ml.

The other two con-

tained 4.8 and 8.0ml and were utilized for the frontal studies.
The frontal gel studies were divided into 2 parts.

Part

I dealt with a study of the self-association of zinc-free in3
sulin whereas part II was concerned with the effect of Cr+ ,
Zn+ 2 and a combination of both ions on the association of zincfree insulin.

For part I, 40mg of zinc-free insulin was placed

in a volumetric flask and diluted to lOml with 0.067M phosphate
buffer, pH 7.47.

Likewise, 25mg was placed in a volumetric

flask and diluted to 25ml with phosphate buffer.

This resulted

in solutions of approximately 4mg/ml (A) and lmg/ml (B),
respectively.

Final insulin concentrations were determined

on a Heath spectrophotometer at 276nm using an extinction co-
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efficient of 1.04 ODU/cm (mg/ml). ·Dilutions of these stock
solutions in 5, 10, 50 and lOOml volumetric flasks were then
made with 0.067M phosphate buffer, pH 7.47. according to the
following scheme.

Kimax (type A) volumetric pipettes (Scien-

tific Products, McGaw Park, IL) were used for all transfers.
TABLE

v.

Dilution of stock solutions for frontal gel analysis.
Solution
A
(ml)

Solution
B
(ml)

Buff er
(ml)

Approx.
Cone.
(mg/ml)

5.0

0

4

2.5

2.5

2

5.0

0

1

4.5

0.5

0.9

3.5

1. 5

0.7

2.5

2.5

0.5

1. 5

3.5

0.3

0.5

4.5

0.1

0.5

9.5

0.05

0.5

49.5

0.01

0.5

99.5

0.005

UV scans were performed on each solution over the range of 212
to 320nm with a Heath spectrophotometer, after which, wavelengths were selected at which to monitor the fronts.
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The column was then calibrated with.the following markers at
the concentrations stated below.

For this calibration pro-

cedure the 0.28ml loop (B) was utilized.
TABLE VI.

Self-association of zinc-free insulin (markers
for column calibration).

Marker
Blue Dex tr an

.
-<

Concentration
(mg/ml)

~1W

2,000,000

1. 5

Ovalbumin

45,000

6.0

Chymotrypsinogen

25,000

2.85

Myoglobin

17,700

3.0

Ribonuclease

12,600

4.0

4,500

5.0

194

0.45

ACTH
K2Cr04

Chymotrypsinogen was prepared by dissolving 28.5mg in lml
dilute HCl.

Aliquots of O.lml were withdrawn and added to

0.9ml of 0.067M phosphate buffer, pH 7.47, resulting in a
final concentration of 2.85mg/ml.

This was necessary because

of the presence of small amounts of chymotrypsin in the sample
which resulted in proteolysis if the solutions were left
standing at neutral pH for long periods of time.
is inactive in dilute HCl.

Chymotrypsin

The markers were inserted into

loop B with a syringe and allowed to enter the column at 0.5
hour intervals.

Absorbance was monitored at 280nm with a

Beckman DB-G spectrophotometer and profiles were recorded with
a Beckman 10" chart recorder set at a speed of 0.2 in/min.
Upon completion of the calibration period, sieve coefficients
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were calculated from the elution volumes.
replaced by a 4.3ml loop.

Loop B was then

This loop was filled with the

insulin solutions stated above and a front was recorded for
each insulin concentration ranging from 4rng/ml to 0.005mg/ml
at its respective wavelength.

Elution volumes were then

determined and the respective sieve coefficients calculated.
The column was then re-calibrated with the markers as before.
In part II, a frontal gel study was performed on the
nitrated insulins prepared previously.
of the

.
nitrated

buffer, pH 7.47.

A O.Slmg/ml solution

insulin was prepared in 0.067M phosphate
It was then diluted 1:10 to obtain a

0.05lmg/rnl solution.

UV scans were performed on both solu-

tions with a Cary 15 spectrophotometer over the range of 220
to 700nm to select the proper wavelengths for monitoring the
fronts.

A sample loop capable of holding 8.0ml was utilized

in place of loop B for this frontal study.

Absorbance was

monitored by a Cary 15 spectrophotometer at the chosen wavelengths for the 0.51 and 0.05lrng/ml solutions, respectively.
All other conditions were identical to

t~e

previous frontal

gel studies except for a column bedheight of 9.0cm.

Elution

volumes were determined and sieve coefficients calculated as
before.

The column was then calibrated with the following

markers at the concentrations stated in Table VII.

For this

calibration procedure the 0.28ml loop (B) was utilized.
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TABLE VII.

+3

.

+2

Effect of Cr
and Zn
on the aggregation of
zinc-free insulin (markers used for column
calibration).
Marker
Blue Dextran

MW

Concentration
(mg/ml)

2,000,000

1.5

Carbonic Anhydrase

31,000

5.0

Chymotrypsinogen

25,000

2.85

Myoglobin

17,700

3.0

Ribonuclease

12,600

4.0

5,891

0.5

194

0.45

Nitrated Insulin
K2 Cro 4

The markers were inserted into the loop with a syringe ahd
allowed to enter the column at 0.5 hour intervals.

Absorbance

was monitored at 280nm with a Cary 15 spectrophotometer and
profiles were recorded at a chart speed of 0.2 in/min.

Elution

volumes were determined and sieve coefficients calculated as
before.

The sample loop was then replaced by an 8.0ml loop

in preparation for the remaining frontal studies.
To complete this study it is necessary to call your
attention to solutions A, B and C of the previous section
concerning insulin aggregation as evidenced by CD spectroscopy.
In order to correlate the CD changes with changes in the molecular weight distribution of insulin, it was decided to utilize
these same solutions for frontal gel studies.

The composition

of each solution is fully described in that section.

Prior

to the addition of the acidic aliquots, however, UV scans were
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performed with a Cary 15 spectrophotometer over the range of
220 to 320nm in order to select the wavelength at which to
monitor the fronts.

Final insulin concentrations were de-

termined at 276nm using an extinction coefficient of 1.04 ODU/
cm (mg/ml).

The procedure was identical except that only 4

addition pairs were studied.

They were 10 rnicroliters dilute

2
HCl-50 rnicroliters dilute HCl, 10 rnicroliters Zn+ -5o rnicroliters dilute HCl, 10 microliters dilute HCl-50 microliters
cr+ 3 and 10 rnicroliters zn+ 2 -5o microliters cr+ 3 .
pletion

o~

Upon com-

the 3 hour incubation period, the 8.0ml loop was

filled with each solution and the fronts were recorded.

The

elution volumes were determined and the sieve coefficient
calculated as before.

The column was then re-calibrated with

the previously stated markers.

CHAPTER III
RESULTS
preparation of Zinc-Free Insulin
Chelex 100 chelating resin was equilibrated with
tris-7M urea buffer, pH 8.

0.05~1

The pH initially rose to 11 and

dropped to 7.9 after 10 changes of buffer.

.

In the preparation

of zinc-fr.ee insulin utilizing this resin, 20mg of the commercial insulin preparation was dissolved in 4ml of 0.05!1
tris-7M urea buffer, pH 8.

Upon dissolution, the pH dropped

to 7.7 and remained there throughout the procedure.

This

drop in pH upon dissolution of insulin was expected since the
pK for insulin is approximately 5.6.

After dissolution, O.lml

of the pre-equilibrated resin was added.

No change in pH was

observed.
Isolation of "Single Peak" Insulin
The composition of "single peak" insulin has been
defined (151).

It is composed of arginine insulin, esterified

insulin, monodesamido insulin and single component insulin.
In this dissertation, commercial insulin was purified by means
of gel chromatography in lM acetic acid.

The approach con-

sisted of utilizing several different Sephadex resins, namely
G-75, G-50 (medium) and G-50 (fine) at a flow rate of 13ml/hr.
It can be seen (Figure 16) that Sephadex G-75 and G-50 (medium)
were inadequate for this purpose.
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On the other hand, chroma-
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FIGURE l&.
Utilization of various Sephadex r~sins for
gel chror,\atography of bovine zinc-free i'.'l.sulin.
;\: 280nm;
Eluant: IM acetic acid; Sample: lml containing 35mg insulin;'.
Flow rate: 13ml per hour; Chart speed: 20mm per hour;
'
Bed: 85cm; ( - ) : G-75; (---) ~ G-50 (medium); ( · • • ·): G-50
(fine) .
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tography with G-50 (fine) resin resulted in some degree of
separation.

The resin selected for the purification of

bovine zinc-free insulin was Sephadex G-50 (superfine) at a
flow rate of 6ml/hr (Figure 17).

After chromatography, the

contents of tubes 36 to 49 were collected and designated
"single peak bovine zinc-free insulin".

Tubes 25 to 33 were

designated "crude proinsulin" and tubes 34 and 35 were disgarded.

The same resin was utilized for the purification of

porcine zinc-free insulin (Figure 18).
a flow rate of 4.2ml/hr was selected.

In this case, however,
Tubes 36 to 48 were

pooled and designated "single peak porcine zinc-free insulin".
Tubes 26 to 33 were designated "crude proinsulin" and tubes
34 and 35 were disgarded.

In a similar study (130), a com-

mercial insulin preparation was chromatographed with G-50
resin and lM acetic acid as the eluant.
profile was obtained.

A similar elution

According to the authors the first

small peak, designated crude proinsulin fraction, was composed
of proinsulin, nonconvertable insulin dimer and proinsulin
intermediates.

Since this peak was effectively removed in

the purification process, it can be said that the above components were not present in the zinc-free insulins utilized
for the experiments of this dissertation.

It has also been

stated (130) that insulin was dissociated into monomers in
the presence of lM acetic acid.

According to Figures 17 and

18, there seemed to be some degree of association as judged
by the skewness of the insulin peaks.
Concerning the recovery, let us take Figure 17 as an
example.

In the previous

~hapter

it was mentioned that 35mg
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FIGURE 17: Chromatography of bovine zinc-free insulin
with Sephadex G-50 (superfine) resin. A: 280nrn; Eluant:
lM acetic acid; Sample: lml containing 35mg insulin;
Flow rate: 6rnl per hour; Chart speed: lOrnm per hour;
Fractions: 3rnl; Bed: 85cm; a: crude proinsulin;
b: insulin.
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FIGURE 18: Chromatography of porcine zinc-free insulin
with Sephadex G-50 (superfine) resin.
A: 230 run; Eluant:
lM acetic acid; Sample: lml containing 35rng insulin; Flow
rate: 4.2rnl per hour; Chart speed: lOmrn per hour; Fractions:
3ml; Bed: 85crn; a: crude proinsulin; b: insulin.
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of the unpurified bovine zinc-free insulin was subjected
to purification by column chromatography.

Upon comp'J{etion

of the chromatographic procedure and after lyophilization of
the respective insulin and proinsulin fractions, it was found
that the designated insulin fraction

weigh~d

approximately

30mg whereas the proinsulin fraction weighed approximately
3.2mg.

This represented a recovery of 33.2 of the original

35mg or approximately 95% by weight recovery of insulin and
proinsulin.
It:has been previously shown (152) that "single peak"
insulin was heterogenous.

According to the authors, the

first band moving toward the anode was monodesamido insulin.
The major band was insulin which may also contain a nonconvertable insulin dimer accounting for about 2% of the total
insulin.

It was very difficult to distinguish between the

monodesamido insulin and the single component insulin, therefore it can be said that the first large band was probably a
combination of monodesamido insulin and single component
insulin.

The next band comprised the proinsulin intermediates.

This was followed by a very prominent band corresponding to
about 4% of the insulin.

It contained arginine insulin, i.e.

insulin with an arginine at position B-31 and insulin ethyl
ester produced by the acid ethanol extraction procedure.
following band, fifth from the anode, was proinsulin.
other bands remained unidentified.

The

All

Polyacrylamide disc gel

electrophoresis of a sample of bovine zinc-free insulin before and after purification was performed (Figure 19).
observations discussed above can be applied.

The

It can be seen
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that after purification, portions corresponding to proinsulin and proinsulin intermediates were removed.
Finally, a sample of porcine zinc-free insulin before
and after purification was subjected to column chromatography
in the presence of urea (Figure 20).
trailing boundaries were obtained.

Hypersharp leading and
Under these conditions,

insulin was completely dissociated into the monomeric form
and as a result a symmetrical peak was obtained.

According

to this study, the crude proinsulin peak represented approximately 5.6% of the total amount of protein eluted from the
column.

This was determined by measuring the areas under the

respective UV elution profiles.

Utilizing the weight figures

discussed previously, the crude proinsulin peak represented.
approximately 9.6% of the total.

These figures were in agree-

ment with a previous report suggesting that 7% of the material
may be proinsulin-like and insulin aggregates (129).
Nitration of Insulin
Insulin was nitrated according to the following
reaction (153).

+

Tyrosine side
chain of
insulin

C(N02))

TNM
(Tetranitromethane)

+
It is quite clear from the above mechanism that the reaction
proceeded with a decrease in pH.

As far as the extent of
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nitration is concerned, it has been suggested by one group
of investigators (134) that the treatment of bovine insulin
with TNM at pH 8 resulted in the nitration of 2.5 of the 4
residues of tyrosine in the insulin molecule.

In another

study (125), it was reported that treatment of zinc-free
insulin in 0.05M tris, pH 8, with TNM yielded an insulin preparation with all four of the tyrosines nitrated.

According

to Gattner (154), the four tyrosines of insulin showed different reactivity toward TNM: TyrA14>
TyrB26.

TyrA19>

TyrB16>

With proceeding nitration the reactivities of TyrA14,

TyrA19 and TyrB16 were equalized whereas TyrB26 kept a significantly lower reactivity.
A UV study of the time dependence of insulin nitration
in 0.05M tris, pH 8 was performed (Figure 21).

A more detailed

explanation of the method was given in Chapter II.

Absor-

bance was measured at 276 and 353nrn at selected points over
an interval of 1127 minutes.

It is important to mention again

that nitrotyrosine residues absorb at both 276 and 353nm at
an acidic pH whereas tyrosine residues absorb only at 276nrn
under acidic conditions.
was approximately 7.8.

The pH prior to the addition of TNM
Upon completion of the incubation

period, the pH dropped to 7.65.

A drop in pH was expected

since 2 protons were released for each tyrosine residue
nitrated.

It was felt that the pH change did not significantly

affect the extent of reaction since it has been reported that
the reaction was terminated by adjusting the pH to 3 (134).
It is evident from Figure 21 that there was only a slow increase
in absorbance at both wavelengths beyond 200 minutes.

The
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nitrated insulin which resulted at the end of 1127 minutes
of reaction with TNM behaved peculiarly in that precipitation
occurred upon acidification with HCl.

Also, this preparation

failed to dissolve in lM acetic acid.

The crystals were

soluble however, in either

0.05~

tris or 0.067.M phosphate

buffer, pH 7.4.

This behavior may indicate a high degree of

polYJ!l.erization.

As a result of this experiment, and keeping

in mind that excessive nitration was accompanied by polyrner i za tion of insulin (134), 2 hours was designated to be a
suff icien£ period for nitration.
A similar UV study was performed to compare the extent
of nitration in the presence and absence of urea.

It was

assumed that the dissociative effect of urea would result in
a greater degree of nitration.

Conditions were identical to

those of the preceeding experiment, except that UV scans were
performed over the range of 240 to 400nm at selected time
intervals.

A series of UV scans for nitration in the presence

of urea are shown (Figure 22).

The absorbance change due to

nitrotyrosine (353nm) between 0 and 120 minutes is evident.
From these scans, plots of absorbance at 276nm and absorbance
at 353nm versus time were made (Figure 23).

These plots in-

cluded corrections for absorbance changes due to interactions
between TNM and the buffer constituents (Tables VIII, IX).
It can be seen that nitration in the presence of urea resulted
in a significant increase in the absorbance at 353nm.

This

seemed to indicate greater nitration of tyrosine residues
since only nitrotyrosine absorbs at 353nm.

Up to 90 minutes
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TABLE VIII.

A UV study of the time dependence of insulin nitration in the absence
of urea.

•

Time
(Hin)

Total
Absorbance
( 353nm)

Blank *
Absorbance
(353nm)

Protein
Absorbance
(353nm)

Total
Absorbance
(276nm)

A

Blank
Absorbance
(276nm)

Protein
Absorbance
(276nm)

0

.006

.003

.003

.042

.004

.038

10

.112

.022

.090

.078

.071

.007
i-'
[\)

40

.471

.019

.452

.185

.062

.123

80

.642

.019

.623

.227

.075

.152

120

.752

.019

.733

.254

.029

.225

*Includes absorbance due to buffer constituents.

~

TABLE IX.

Time
(Min)

A UV study of the time dependence of insulin nitration in the presence
of urea.

Total
P.bsorbance
(353nm)

Blank *
P...bsorbance
(353nrn)

Protein
Absorbance
(353nm)

-

Total
Absorbance
(276run)

.

Blank
Absorbance
(276nm)

Protein
Absorbance
( 2 7 6nm)

0

.012

0

.012

.047

.003

.044

10

.252

.020

.232

.175

.038

.137

'--

t-'
N

40

.574

.022

.552

.218

.039

.179

80

.738

.029

.709

.254

.059

.195

120

.819

.041

.778

.271

.129

.142

*Includes absorbance due to buffer constituents.
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the absorbance at 276nm for the urea situation exceeded that
for the non-urea situation.

After 90 minutes, however, the

absorbance at 276nm for the urea situation dropped off
whereas that for the non-urea condition increased.

Since

tyrosine residues absorb at 276nm, this indicates that
tyrosine residues were more completely nitrated under urea
conditions resulting in a decrease in absorbance at 276nm.
This suggestion is only speculative since nitrotyrosine also
absorbs at 276nm and may have obscured the picture.
To•demonstrate the changes in molecular weight distribution that occurred during nitration of insulin, the
reaction was stopped at various time intervals by the addition
of 1 drop of concentrated HCl to the reaction vessel.

This

resulted in a pH drop to about 2.5 which was sufficient to
stop the reaction.

The contents were then dialyzed, lyophi-

lized and chromatographed as discussed in Chapter II.

The

results of column chromatography of insulin after periods of
nitration of 120 and 1127 minutes in the absence of urea, are
shown (Figure 24).

In general, the figure seems to indicate

a tendency to shift to higher molecular weight species for
the 1127 minute nitration period as compared to nitration for
120 minutes.

A similar situation occurred for nitration in

the presence of urea (Figures 25,26).

In this case, however,

the shift to larger molecular weights was more evident since
shorter nitration periods were studied.
Finally, the nitration procedure was utilized on a
preparative basis for the production of nitrated insulin.
In this situation, insulin in

th~

presence and absence of urea,
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in the absence of urea.
.\: 280nrn; Eluant: o.os.~1 tris7M urea, pH 7.4; Sample: lml containing entire nitrated
product; Flow rate: 4.2ml per hour; Chart speed: lOmrn
per hour; Fractions: 3ml; Bed: 85crn Sephadex G-50 (superfine); ( • • • ·): after 120 minutes nitration; (--): after
1127 minutes nitration.
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FIGURE 25...
Column chromatography of insulin nitrated in
the pres1e·nce of urea. A.: 280nm; Eluant: O.OSM tris-7M
urea, pH 7.4; Sample: lml containing entire nitrated
prod~1ct; Flow rate: 4. 2rnl per hour; Chart speed: 1 Omm
per hour; Fractions: 3ml; Bed: 85cm Sephadex G-50 (superfine) ; (--) : 15 minutes ni tr at.ion; (---) : 30 minutes
nitration; (• • ••): 60 minutes nitration.
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was allowed to react with TW1 for a period of 2 hours.

The

pH changes at the beginning and end of the nitration procedure for both the insulin solutions and buffers without
insulin are shown below.
TABLE X.

Changes in pH during the nitration of insulin.

Time

T

TU

0

7.88

7.70

8.0

8.0

• 2hr

7.65

6.95

8.05

7.93

*

I
T

= insulin
= 0.05M tris, pH 8

TU=

0.05!.1 tris--7M urea, pH 8

It is most noteworthy that the change in pH for insulin nitrated
in the presence of urea was much greater than that which occurred in the absence of urea.

This observation supports the

view that insulin is nitrated to a greater extent in the presence
of urea.

The molecular weight distributions for both cases

along with the elution volumes for several markers are shown
(Figure 27).

Specific details concerning the markers and pro-

cedure were discussed in Chapter II.
were evident.

In both cases four peaks

Peak 4 eluted with a volume near that of insulin

(MW 5778) and most likely represents the nitrated insulin
monomer.

Consequently, tubes 26 to 32 were pooled and utilized

for the frontal gel studies presented later.

Peak 3 eluted

with a volume near that of ribonuclease (MW 13,600) while
peak 2 eluted between ribonuclease and myoglobin (MW 17,800).
Peak 1 eluted between rnyoglobin and chymotrypsinogen

(~IW

25, 000).
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FIGURE 27 •. Column chromatography of insulin nitrated
in the presence (--) and absence (----) of urea:
Molecular weight distribution defined by markers.
~=
280nm; Eluant: 0.0511 tris-7.M urea, pH 7.4; Sample: lml
containing entire nitrated product; Flow rate: 4.2ml
per hour; Chart speed: lOmm per hour; Fractions: 3ml;
Bed: 85cm Sephadex G-50 (superfin2); Nitration period:
120 minutes; B: blue dextran; C: chymotrypsinogen;
M: myoglobin; R: Ribonuclease; I: insulin.
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The implications for the latter three peaks are that they
may represent covalent dimers, trimers and tetramers of
insulin.

Another observation that deserves mention is the

difference in absorbance of peak 4 between insulin nitrated
in the presence and absence of urea.

The increased absorbance

(decreased % Transmittance) at 280nm is supportive for greater
nitration in the presence of urea since tyrosine absorbs at
this wavelength.

This observation must be interpreted with

caution since nitrotyrosine also absorbed at 280nm.

Overall,

however, the evidence seems to favor increased nitration in
the presence of urea.
Solubilization of Trivalent Chromium
Several buffers suitable for studies in the physiological pH range were selected.
adjusted to 7.4.

The pH in each case was

Trivalent chromium in the form of CrK(S04)2·

12H 2o was added to final concentrations of 5 x lo- 4 , 1 X 10-3
and 2 X lo-3M.

After 18 to 24 hours of agitation at room·tem-

perature (22.5°C), the solutions were observed for precipitation.
These observations as well as pH changes upon the addition of
chromium are shown below (Table XI).
cerning this procedure see Chapter II.

For further details conIt is clear from the

table that only the phosphate buffers (0.13M and 0.067M) allowed solubilization of trivalent chromium.

It was then

decided to add various nitrogen containing compounds to the
phosphate buffers with the idea in mind that they may act as
weak chelators of the metal.

In this case chromium was added

to a final concentration of 4 X 10-3M.

This concentration

132

TABLE XI.
Solubility of trivalent chromium in various
buffers in the physiological pH rarige.

Cr+J Co~centration

pH
Buff er
pH 7.42

l*

0.067M
Sorensen's
phosphate

7.35

0. l 3I'-1

7.40

2

3

7.31

No ppt.**
f

7.38

7.33

No ppt.

phosphate:

O.OSM

7.35

ppt.

tr is

O.lM

ppt.

barbital

O.OSH

7.30

ppt.

0.05M
MES

7.10

ppt.

O.OSM

7.21

ppt.

~ES

EEPES

O.OSM

ppt.

BICil-J"E

*pHl
pE2
pH
**ppt.

=
=
=

pH after addition of 5
pH after addition of l
pH after addition of 2

=
=

ppt.

precipitate
not recorded

x
x
x

l0- 4 M Cr +3
l0- 3 M cr+ 3
l0- 3 M Cr +3

No ppt.

ppt.
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was chosen since it was desirable for the planned spectral
studies.

Changes in pH and observations concerning prPcipi-

tation aftPr an 18 to 24 hour incubation period are shown
(Table XII) .

It is evident that three additions, namely

niacinamide, pyridine and imidazole, seemed to enhance
solubilization of trivalent chromium in 0.13M phosphate buffer
only~

Nicotinic acid, which has been implicated as a com-

ponent of the glucose tolerance factor

(58), did not seem to

enhance the solubilization of trivalent chromiur,1 according to
the criteria of this study.

Since niacinamide is both physic-

logically and structurally related to nicotinic acid, it was
chosen for further study in the solubilization of trivalent
chromium.
Chromiwn-Niacinamide Interactions
The first part of this study was concerned with the
ability of 0.067M phosphate buffer-0.lM niacinamide solutions
to solubilize trivalent chromium in the form of CrK(so ) ·12E o.
2
4 2
Chromium was added to the above solutions to a final concentration of l X 10

-3

, 2 X 10

-3

, 3 X 10

-3

, and 4 X 10

-3

M.

The

pH was recorded before the addition of chromium and after 0.5
and 16 hours incubation with chromium (Table XIII).

A de-

crease in pH was expected with increasing chromium concentration since 0.067M phosphate buffer is not quite strong
enough to counteract the acidity of the added chromium aliquots.
See Chapter II for more details concerning this matter.

It

is also important to note that less pH change occurred in the
presence of niacinamide for each chromium concentration over
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TASLE XII.
Solubility of trivalent chromium (4 X l0- 3 M)
in phosphate buffers containing various nitrogenous
compounds

0.067M PhosEhate

0.13M Phos:ehate

pHl

pH2

pHl

pH2

7.39

7.09

4+

7.40

7.26

4+

Niacinamide 7.42

7.18

4+

7.41

7.26

3+

Nicotinic .
Acid

7.20

4+

7.42

Addition
( 0. lH)
0

.

7.48

ppt. **

~

4+

Pyridine

7.46

7.30

2+

Urea

7.41

7.26

4+

Imidazole

7.44

7.36

l+

Formamide

7.46

7.24

4+

Ethylenedi amine

7.42

7.25

4+

Glycine

7.42

*pHl
pP.2

**ppt
4+
3+
2+
l+

=

pH before addition of 4 x l0- 3 M cr+3
pH after 18 to 24 hrs. incubation with
4 x l0- 3 M cr+3
not recorded

=
=
=
=
=

precipitate
heavy
medium
light
fine

=
=

4+
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TABLE XIII. Changes in pH during solubilization of
trivalent chromium in phosphate buff er - niacinamide
solutions.

Cr

0.067.M
Phosphate Buff er

+3

(M)

0.067.M Phosphate
Buffer-0.lM Niacinarnide

O*

0.5 hr

16 hr

0

0.5 hr

7.42

7.36

7.32

7.42

7.39

7.37

16 hr

l

x

10- 3

2

x

10- 3

7.42

7.31

7.28

7.42

7.33

7.31

3

x

10- 3

7.42

7.25

7.20

7.42

7.26

7.26

4

x

10- 3

7.42

7.18

7.16

7.42

7.20

7.17

* =

<

No chromium
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the 16 hour period that readings were taken.

Upon comple-

tion of the 18 hour incubation period, aliquots were removed
and the absorbance values recorded at 400nm (Figure 28).

It

is quite clear that the presence of niacinamide enhanced the
solubilization of trivalent chromium in 0.067M phosphate
buffer, pH 7.42.

This is

of the previous section.

con~rary

to the visual observations

The spectrophotometric measurements,

however, are much more reliable.
To further investigate a possible interaction between
chromium a~d niacinamide, a study was initiated concerning
the effect of trivalent chromium on the UV absorption spectrum
of niacinamide.

The UV absorption spectrum of 2 X 10-5M

niacinamide in 0 .13!,1 phosphate buffer, pH 7. 42 is shown
(Figure 29).

A characteristic spectrum was obtained with an

absorption maximum at 262nm and shoulders at 255 and 263nm.
Before completion of this study, however, it was necessary to
investigate the absorbance due to chromium over the same range.
Solutions of chromium (2 X lo-4 and 2

x

10-5M) in 0.13M phos-

phate buffer, pH 7.42, were scanned over the range of 240 to
340nrn (Figure 30).

It can be seen that trivalent chromium,

because of its electronic configuration, has a characteristic
UV spectrum.

Contributions of this metal to the total

absorbance, therefore, cannot be neglected.

Trivalent chromium

was added to solutions of 2 X lo-5M niacinamide in 0.13M phosphate buffer, pH 7.42, resulting in chromium concentrations
of 2

x

lo-4 and 2 X lo-5;1 and chromium-to-niacinarnide ratios

of 10:1 and 1:1, respectively.

Further details concerning the
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FIGURE 28~ A spectral study of the solubility of trivalent chromium in 0.067M phosphate buffer, pH 7.42,
in the presence (--) and absence (----) of O.lM
niacinamio.e.
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FIGURE 29: UV absorption spectrJm of 2 X io-Sr1 niacinamide
in 0.13M phosphate buffer, pH 7.42.
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composition of the various solutions of this UV study are
located in Chapter II.

After a 19.5 hour incubation period,

the absorption spectra of the respective solutions were taken
over the range of 250 to 350nm.

The resulting spectra, cor-

rected for absorbance due to chromium and buffer, are shown
(Figure 31).

The addition of chromium to a 1:1 ratio with

respect to niacinamide had no effect on the absorption spectrum
of niacinamide.

The addition of chromium to a 10:1 ratio with

respect to niacinamide resulted in an increase in absorbance
at 262nm and the appearance of a peak at 325nm.

The pH re-

mained constant after the addition of chromium and upon
completion of the incubation period.

To make an analogy, the

reduction of NAD+ (nicotinamide adenine dinucleotide) to NADH
is associated with an increase in absorbance at 340nm and a
decrease in absorbance at 260nrn (155).

Since the primary

component of NAD+ is the nicotinami~e moiety, identical to
niacinamide, a partial explanation may be related to reduction.
However, in this case an increase in absorbance at 262nm was
observed along with the appearance of a peak at 325nm.

Con-

sidering the stability of the trivalent state of chromium,
it seems unlikely that a change in its oxidation state to a
higher value could occur.

As a result, the peak at 325nm may

be related in some manner to complex formation (156).
It was previously shown (Table XII) that the presence
of O.lM niacinarnide enhanced the solubilization of trivalent
chromium after 18 to 24 hours in 0.13M phosphate buffer,
pH 7.4.

l

A pilot study was performed to determine how long

~
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chromium (III) in phosphate buffer and phosphate bufferniacinamide would remain solubilized.

The reader should

recall that chromium (III) undergoes elation and eventually
precipitates out of solution.

This process is slowed con-

siderably in the presence of stabilizing ligands such as
niacinamide.

Chromium (III) was added to solutions of 0.13M

phosphate buffer and 0.13M phosphate buffer- 2 X l0- 5 M
niaci~amide to a final concentration of 1 X lo-3M.

The pH

was recorded and the presence of precipitation observed over

.

a period.of 96 hours (Table XIV).

Results indicated that the

presence of niacinamide enhanced the solubilization of trivalent chromium.

This pilot procedure was followed by a long

term spectrophotometric study on the solubilization of chromium
(III) by 0.13M phosphate buffer-2 X l0- 5M niacinarnide solutions,
pH 7.43, at various chromium-to-niacinamide ratios (Figure 32).
The progressive increase in absorbance at T=O for the various
ratios was the result of chromiQm.
were clear at T=O.

In all cases solutions

It should be mentioned also that absorbance

readings were taken in a lOcm cell in this study.

Chromium

at a 1:1 and 10:1 ratio with respect to niacinamide remained
in solution for 118 hours.

At a 100:1 ratio, chromium gradually

precipitated following dissolution and was not studied beyond
10 hours.

At ratios of 25:1, 40:1 and 50:1, precipitation

occurred after 100, 50 and 40 hours, respectively.

Changes

in pH were recorded at 1 and 185 hours for the various ratios
studied.
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TABLE XIV.
Solubility of trivalent chromium (1 X 10-~M)
in phosphate buffer in the presence and absence of
niacinamide.

0.13M Phosphate Buff er
pH 7.43

Time·

0.13M Phosphate Buff erNiacinamide* pH 7.43

pH

ppt. **

_EB_

ppt.

24

7.38

0

7.30

0

48

7.38

+

7.38

0

72

7.38

+

7.38

+

96

7.38

+

7.38

+

(hrs)

*2 X 10

-5

M

**visual observance of precipitation
0 = absent
+ = present
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Solubilization of trivalent chromium at various
ratios. Niacinamide: 2 X lo-SM;
·
:Suffer: 0.13M: phosphate, pH 7.43; A: l to l; B: 10 to l;
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TABLE XV. Changes in pH during the solubilization of
trivalent chromium at various chromium-to-niacinamide
ratios in 0.13~ phosphate buffer.
pH at Various Chromium-to(2 X l0- 5 M) Niacinami<le Ratios

Time
(hrs)

0

1:1

10:1

25:1

40:1

50:1

1

7.43

7.43

7.41

7.40

7.39

7.37

·185

7.44

7.43

7.41

7.39

7.39

7.37

An expected drop occurred with increasing chromium (III)
concentration as discussed previously.

Within each ratio,

however, the pH remained rather constant over the entire
period.
Upon completion of this study, the individual tubes
were checked for bacterial growth.

Colonies were evenly

distributed over all plates and as a result bacterial

growt~

was not considered a factor in the observed absorbance changes.
Further details as to the procedure are outlined in Chapter II.
Four types of bacteria were identified; namely, Enterobacter
agglomerans, Pseudomonas maltophilia, Alcaligenes denitrificans
a11d

~·1oraxella

nonliquefaciens.

l\n interesting growth pattern

that deserves comment was obtained (Table XVI).

It seemed

that Enterobacter agglomerans and Moraxella nonliguef aciens
grew at all chromium concentrations whereas Alcaligenes
denitrificans and particularly Pseudomonas maltophilia seemed
to be limited in growth.

The pattern seems to suggest an

optimal requirement for chromium (III) above which the element
becomes inhibitory.

Further clarification is necessary,
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TABLE XVI.
Bacterial growth in 0.13M phosphate buffer,
7.37 to 7.44, at various chromium-to-niacinamide ratios.

pE

Growth at Various Chromium-to-(2
Niacinamide Ratios

x

lo-5M)

Bacteria
E.a. *

0

1:1

+

+

10:1

+

25:1
+

P.m.

+

A.d.

+

M.n.

+

+

+

+

*E.a.

=

Enterobacter a9srlomerans

P.m.

=

Pseudomonas malto12hilia

A.d.

=

Alcaligenes denitrificans

M.n.

=

Moraxella nonlig:uef aciens

40:1
+

50:1
+

100:1
+

+
+

+

+ = present
= absent

+
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however, before any definite conclusions can be drawn.
Hydrogen-Deuterium Exchange of Insulin
Infrared analysis of hydrogen-deuterium exchange is a
useful tool for the measurement of changes in protein conformation at the level of the peptide bond.

The technique

is limited to measurement of conformational changes involving
disruption of the a-helix or changes in secondary structure
involving hydrogen bonding.
for

measu~ing

This technique is not useful

subtle changes in protein conformation that

occur, for example, as a result of aggregation.

In this case

circular dichroism spectroscopy would be more appropriate.
One drawback of the infrared technique is that large concentrations of insulin (lOmg/ml) had to be utilized to achieve
a proper spectral response.

For comparative purposes, a study

of insulin by circular dichroism spectroscopy would require
approximately O.lmg/ml for a reasonable response in the near
UV region (250 to 320nm) and 0.004mg/ml for the far UV region
(190 to 250nm).

In this study, bovine crystalline zinc in-

sulin (10 mg/ml in

n2 o)

was examined by infrared spectroscopy

in the presence and absence of 10- 6 to 10-BM chromium (III)
potassium sulfate..

Insulin at this concentration and es-

pecially in the presence of zinc, is very difficult to
solubilize.

As a result, the solution had to be acidified

with deuterium chloride (DCl) to pD 2.5 (pH 2.1).

Such changes

in molecular environment undoubtedly contributed significantly
to alterations in macromolecular structure and as a result
data from this type of experiment must be interpreted with
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caution~

Dissolution of bovine zinc insulin in o 2 o (pD 2.5)

resulted in a decrease in the amide II response and an increase
in the deuterated amide II response with time (Figure 33).
In this case it is evident that a greater change occurred in
the deuterated amide II region.

As a result it was decided

to monitor the change in transmittijnce a~ 1~50cm-l with time
in the presence and absence of chromium, even though in most
cases the decrease in the amide II.region is measured.
Chapter II for

detail~.

See

In the absence of chromium a signi-

f icant exchange was obtained following a .period of absorbance
loss (Figure 34).

This loss was

attr~buted

to stabilization

of the insulin in equilibration to 37.5°C since sGlutions were
prepared at room temperature (22 to 24°C).

In the presence

of trivalent chromium the initial loss of absorbance as well
as the exchange, measured by the change in transmittance at
1450cm- 1 , were absent.
the period studied.

Also, the pD remained constant for

These results support the view that

trivalent chromium has a stabilizing effect on the conformation
of insulin (157).
Thermal Analysis of Insulin-Chromiwn III Solutions
A 1 X l0- 4M t0.578mg/ml) solution of porcine zinc-free
insulin was prepared in 0.13M phosphate buffer, pH 7.43.
Utilizing an extinction coefficient of 1. 04 ODU/cm (mg/ml)
at 276nm, the insulin concentration was determined to be
0.927 X l0- 4M (0.536mg/ml).

If the same solution of insulin

is placed in each of two matched cells (sample and reference)
and the rJv absorption spectrum taken over the range of 220 to
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FIGURE 33: Infrared spectra of bovine zinc insulin in
deuterium'oxide.
Sample: O.Olg in lml D20 1 pD 2.5;
Cell: CaF2 (0.065mm pathlength); Temperature: 37.5°C;
A : l hr ; B : 5 l1r s ; C : 8 hrs .
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320nm, a straight line would be expected.

If the solution in

the sample cell is subjected to some kind of treatment, a
difference spectrum is produced which is essentially the
difference in absorbance between the sample before and after
the treatment.

In this study insulin ( 1 o- 4 t1) in 0 .13M phos-

phate buffer in the presence and absence of lo-4M trivalent
chromium was incubated for 1 hour at room temperature.

It

was then placed in both sample and reference cells and the
UV absorption spectrum taken at 28°C over the range of 220 to
-<

320nm.

The sample compartment was then subjected to a gradual

change in temperature to 98°C by means of a Tm analyzer.
Chapter II for details as to this procedure.

See

After attainment

of 98°C, the UV absorption spectrum was again taken (Figure 35).
It can be seen that at 98°C absorption maxima occurred at 238,
281 and 29lnm and absorption minima occurred at 276 and 284nm.
There appeared to be very little difference at 284 and 29lnm
between insulin in the presence and absence of trivalent
chromium.

The greatest difference occurred at 238nm with less

of a difference at 276 and 28lnm.

Similarly, the UV absorption

spectrum of trivalent chromium (lo-4M) in 0.13M phosphate
buffer, pH 7.43 was taken at 28°C.

The sample cell was then

subjected to an increase in temperature to 98°C, after which
the UV spectrum between 220 and 320nm was taken (Figure 36).
The chromium solution exhibited a gradual increase in absorbance at shorter wavelengths at 98°C.

Since chromium undergoes

elation with an increase in temperature, it may be that the
olated product absorbed at lower wavelengths.

All solutions
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FIGURE 35·.
Temperature dependent difference
porcine zinc-free insulin in 0 .13l:''l phosphate
pH 7.43, in the presence (----) and absence
chromium (III).
Insulin: 1 x lo-4M; cr+3: 1
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were clear at room temperature and at 98°C, however, when
allowed to cool to room temperature, a precipitate formed.
This seemed to indicate that a soluble elation product with
a characteristic UV absorption spectrum was formed at elevated temperatures.
To determine whether the behavior of trivalent chroumium
at elevated

te~peratures

is unique, solutions of 0.13M phos-

phate buffer, pH 7.43, 10-4M chromium (III) in .13M phosphate
buffer, pH 7.43 and 0.5 X 10-4M zn+2 in 0.13M phosphate buffer,
pH 7.43 w~re subjected to thermal analysis after a 1 hour
incubation period.

In this case absorbance at 276nm was moni-

tored continuously over a temperature span of 20 to 100°C
(Figure 37).

It is evident that phosphate buffer underwent

little change while zinc in phosphate buffer exhibited a slight
decrease in absorbance above 60°C.

Chromi1m on the other hand,

exhibited a gradual increase in absorbance above 50°C.

In all

cases the pH remained at 7.43 after the addition of cr+3 and
zn+2 and upon completion of the study when the solutions cooled
to room temperature.
peratures.

The pH was not recorded at elevated tem-

It was decided to repeat the same procedure at 276

and 238nm for phosphate buffer, chromium in phosphate buffer,
insulin in phosphate buffer and
buffer.

i~sulin-chromium

in phosphate

The reader will recall that these wavelengths were

selected previously because they exhibited the greatest difference in absorbance between insulin and insulin-chromium at
98°C.

Absorbance at 238nm was recorded over the range of 25

to 98°C (Figure 38).

The absorbance due to chromium increased
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with change in temperature from 25 to 95°C.

Insulin-chromium

also exhibited an increase in absorbance, although considerably
greater.

If no change had occurred on interaction of chromium

(III) with insulin, it was reasoned that the subtraction curve
ICr-Cr would be identical to that for insulin (I).

It is

obvious from the figure that insulin in the presence of chromium
exhibits hypochromicity with increasing temperature.

Similar

reasoning can be applied to the ICr-I subtraction curve.

If,

as was discussed previously, the change in absorbance with
_,

increasing temperature for chromium (III) was due to olation,
it would be reasonable to assume from the nature of the curve
that less chromium underwent olation in the presence of
insulin.

One possible interpretation could be that chromium

(III) not bound to insulin undergoes olation to about 70°C.
After 88°C we may be looking at olation of bound chromium.
This seems unlikely, however, since the Cr/I molar ratio is
1:1.

A more likely explanation would attribute the absorbance

change solely to bound chromium.
Absorbance at 276nm was recorded over the temperature
range of 25 to 100°C (Figure 39).
pected increase in absorbance.

Chromium exhibited an ex-

Insulin-chromium exhibited

hypochromicity as before; the curve falling considerably below
t~at

for chromium.

Viewing the subtraction curve as before,

it can be seen that ICr-Cr is not identical to I.

Therefore,

it can be said that insulin in the presence of chromium exhibits hypochromicity at 276nm with elevated temperatures.
If the changes in absorbance are related to the olation of

158

....

..

0

\

\

'

\

\

-·'
I I
I
I

I

i..

.

01

--

\

'\

\

~

I

.a

\

\

\

\

/
I

O>

I

I

I

\

0

-1

GI

\\

FIGURE 39~ Absorbance at 27Gnm versus temperature for
solutions' of porcine zinc-free insulin (I), chromium
III (Cr) and insulin-chromium III (ICr) in 0.13M phosphate buffer, pH 7.43.
Insulin: 1 X 10-4M; cr+3; 1 X
lo-4M; (----) : represents subtraction curves ICr-I and
ICr-Cr.

\

ol
I I
I

2:

\

''\

T-

i..

i..

\

0

I

I

0

/

co

I

/
I

\
\

\

\
/

:or

i·,;

/

,,"

/

,,"

/

,,"

/

/

I

/

I

I

I

I

/

0

~

"""
Q)

,,"

0

co

0

~

0

M

q

C')

0

wu 9LC: ae a:>ueqJosqv

..

,.1

:J

""

Q)

0

U)

..""ns

a.
It)

co
q

""'
0

0

C\I

0

T-

o

E
Q)

I-

159
chromium, it can be said that less chromium elates in the
presence of insulin.

Also, elation began at a somewhat

higher temperature {70°C) in the presence of insulin than
in its absence {50°C).

In both experiments the pH remained

at 7.43 after the addition of chromium and upon completion of
the study when the solutions cooled to room temperature.
Thes~

observations seemed to suggest that chromium binds to

insulin and the product behaves characteristically at elevated
temperatures (158).
circular Dichroism Spectroscopy of Insulin-{Effect of Chromium
III)
This section introduces the topic of insulin conformation
and utilizes circular dichroism (CD) spectroscopy for studying
insulin-chromium (III) interactions.

Bovine zinc insulin

(1.71 X l0- 5 M) was prepared in 0.067M phosphate buffer, pH 7.42.
Trivalent chromium was added to a final concentration of 1.71 X
l0- 4 M.

The solutions were then incubated at room temperature

(22 to 24°C) for 1 hour after which the CD spectra were recorded over the range of 250 to 310nrn (Figure 40).

The CD

spectrum of bovine zinc insulin exhibited a negative extremum
at 276nm with a mean residue ellipticity of -192 deg cm 2 per
decimole.
284nm.

Also evident are shoulder regions at 262, 269 and

The addition of trivalent chromium resulted in a shift

of the negative extremum to 273nrn and a diminution of the negative circular dichroic band to -158 deg cm 2 per decimole.

The

trough was broadened and seemed to coincide with the shoulder
at 262nm.

Crossover occurred at 262 and 297nrn.

The pH
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FIGTJRE 40.

The effect of trivalent· chromium on the
near-UV circular dichroism spectrum of bovine zinc
insulin.
Sample: insulin (1. 71 X lo-SM) in 0. 067M
phosphate buffer, pH 7.42; (--):no ad.dition;
(----): 1.71 x 10-~M cr+3.
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remained at 7.42 after the addition of chromium and upon completion of the spectra.

To determine whether the same effect

would occur at higher ionic strength, the same experiment was
repeated in 0.067M phosphate buffer-0.15M NaCl, pH 7.42
(Figure 41).

In the absence of chromium a broad negative

extremum was observed at 274nm with an ellipticity of -185
deg cm 2 per decimole of residues.
264 and 284nm.

Shoulders were evident at

In the presence of chromium a negative extremum

was observed at 275nm with an ellipticity of -157 deg cm 2 per
decimole ;nd shoulders at 265 and 284nm.
at 256nm.

Crossover occurred

As before, the pH remained constant.

Another study was designed to compare the effect of
adding higher concentrations of trivalent chromium.

Trivalent

chromium was added to a final chromium-to-insulin ratio of 25
to 1 as compared to the previous experiment which was 10 to 1.
See Chapter II for more details.

The solutions were incubated

for 1 hour after which the CD spectra were recorded over the
range of 250 to 310nm (Figure 42) .

In the absence of chromium

a negative extremum was observed at 276nm with an ellipticity
of -205 deg crn 2 per decimole.
269 and 284nm.

Shoulders were evident at 263,

In the presence of chromium, a diminution of

the negative circular dichroic band occurreJ.

A negative

extrernum was observed at 273nm with an ellipticity of -157
deg cm 2 per decimole and shoulders at 263 and 284nm.
occ'.Irred at 254nrn only.
the study.

Crossover

The pH remained constant throughout

Utilizing a chromium-to-insulin ratio of 0.58 to 1

and incubation periods of 24 and 48 hours, compared to 1 hour
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above, resulted in no effect of chromium on the CD spectrum
of bovine zinc insulin.

The spectrum was identical to

Figure 42 with no effect of chromium occurring.

As before,

the pH remained at 7.42 for the entire study.
A study was undertaken whereby the CD spectrum of
bovine zinc insulin was repeatedly taken over a 33 minute
peri~d

after the addition of trivalent chromium to a chromium-

to-insulin ratio of 10 to 1.

See Chapter II for details.

The CD spectrum of bovine zinc insulin was performed at T=3,
13 and 23

~inutes

(Figure 43).

after the addition of trivalent chromium

In the absence of chromium a negative extremum

was observed at 276nm with an ellipticity of -193 deg cm2
per decimole.

Shoulders were located at 263, 269 and 284nm.

Upon the addition of trivalent chromium a progressive diminution of the negative circular dichroic band to an ellipticity
of -157 deg cm2 per decimole with a slight shift of the extremum
to approximately 274nm was observed.

if.

Shoulders were present

as above and crossover occurred in the 254 to 258nm region.
Bovine zinc insulin (6.66 X lo-7M) was prepared in
0.067M phosphate buffer, pH 7.42.

Trivalent chromium was added

to a final concentration of 1 X lo-4M.

The solutions were

then incubated at room temperature for a period of 24 hours
after which the far-UV circular dichroism spectra were recorded.
In the absence of chromium (III) a negative band was observed
(Figure 44).

The addition of trivalent chromiun resulted in

no change in this region of the CD spectrum.
A solution of porcine zinc-free insulin (1.71 X lo-5M)
was prepared in 0.067M phosphate buffer, pH 7.42.

cr+3 and
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FIGURE 43w Time dependence of the effect of trivalent
chromium on the near-UV circular dichroism spectrum o:'.:
bovine zinc insulin.
Sample: insulin (l.71 ~ 10-SM) in
0. 067M phosphate buffer z.. pH 7. 42; ( - ) : no addition;
(---): l. 71 X lo-4M cr+-1; A: 3 minutes; B: 13 minutes;
C: 23 minutes.
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FIGURE 44 .. The far-UV circular dichroism spectrum of
bovine zinc insulin. Sample: insulin (6.66 X lo-7M) in
0.067M phosphate buffer, pH 7.42; Identical spectra were
obtained in the presence and absence of 1 X lo-4M cr+3
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zn+2 were added to final concentrations of 1.71 X lo-4M and
0.85 X lo-5M, respectively.

The solutions were then incubated

at room temperature for 1.5 hours after which the CD spectra
were recorded over the range of 250 to 310nm (Figure 45) .
For porcine zinc-free insulin, a broad negative extremum was
observed at 274nm with an ellipticity of -143 deg cm 2 per
decimole and shoulders at 263, 268 and 285nm.

Addition of

zn+ 2 to the zinc-free insulin resulted in an increase of the
negative band to an ellipticity of -165 deg cm 2 per decirnole

.

and a shift of the extremur.i to 276nm.
at 262, 268 and 284nm.

Shoulders were visible

Addition of chromium to the zinc-free

insulin resulted in a diminution of the negative band at 274nm
to an ellipticity of -134 deg cm 2 per decimole at the extrernum.
Shoulders were visible as before.

Similarly, trivalent chro-

miurn was added to a solution of porcine zinc insulin and the
CD spectrum taken over the range of 250 to 310nm (Figure 46).
See Chapter II for further details.

For porcine zinc insulin

a negative extremum was observed at 276nm with an ellipticity
of -165 deg cm 2 per decimole and shoulders at 262, 268 and
284nm.

1\ddi tion of trivalent chromium resulted in a signif i-

cant diminution of the negative band to -144 deg cm 2 per
decimole; the same ellipticity observed for porcine zinc-free
insulin.

A shift of the extrernum to 274nrn and shoulders at

262, 268 and 280nm were also observed.

In both experiments

the pH remained at 7.42 throughout the study.
Insulin Aggregation as Evidenced by CD Spectroscopy
A stock lmg/rnl solution of porcine zinc-free insulin was

168
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FIGURE 4~. The near-UV circular dichroism spectrum of
porcine zinc-free insulin: Effect of cr+3and zn+2.
Sample: insulin (l.71 x io-SM) in 0.067!1 phosphate
buffer, pH 7.42; ( - ) : no addition; (• • • ·): 0.85 X
io-sM zn=i-2; (----): l. 71 x lo-4M cr+3.
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FIGURE 46.
The effect of trivalent chromium on the
near-UV circular dichroism spectrum of porcine zinc
insulin.
Sample: insulin (l.71 X io-5M) in 0.067M
phosphate buffer, pH 7.42; ( - ) : 0.85 x io-5M zn+2;
(----): 0.85 x io-5M zn+2 and 1.71 x io-4M cr+3.
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prepared in 0.067M phosphate buffer, pH 7.47.

The UV spectrum

between 240 and 320nm was recorded (Figure 47).

Insulin ex-

hibited a characteristic absorption spectrum with an absorption maximum at 276nm and shoulders at 258, 269 and 283nm.
Insulin

~olutions

A, B and C were then prepared from the stock

solution and aliquots of cr+3, zn+2 and dilute HCl were added
in pqirs as discussed in Chapter II.

The respective solutions

were incubated for a total of 3 hours, after which solution A
(0.5mg/ml), solution B (0.2mg/ml) and solution C (O.lmg/ml)
were placed in 2, 5 and lOcm cells, respectively.
were then recorded over the range of 250 to 310nm.

CD spectra
The CD

spectra of solutions A, B and C for the addition pair "10
microliters dilute HCl-50 microliters dilute HCl" are.shown
(Figure 48).

For solution A the negative extremum was observed

at 274nm with an ellipticity of -197 deg cm 2 per decimole.
For solution B the extremum was observed at 273nm with an ellipticity of -191 deg cm2 per decimole and for solution C it
was observed at 272nm with an ellipticity of -179 deg cm2
per decimole.

Note the shift in wavelength of the extremum

with progression from a more concentrated solution (A) to a
more dilute solution (C).

The CD spectra of solutions A, B

and C for the addition pair "10 microliters EDTA-50 microliters
dilute HCl" are shown (Figure 49).

For solution A the negative

extremum was observed at 274nm with an ellipticity of -198 deg
cm

per decimole.

For solution B the extremum was observed at

275nm with an ellipticity of -186 deg cm 2 per decimole and
for solution C it was observed at 273nm with an ellipticity

171
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FIGURE 47: Near UV spectrum of porcine zinc-free insulin.
Sample: insulin (lmg/ml) in 0.067M phosphate buffer,
pH 7.47.
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FIGURE 48.· Aggregation of porcine zinc-free insulin
as evidencied by circular dichroism spectroscopy.
Buffer: 0.067i·1 phosphate, pH 7.47; Addition pair: 10
microliters dilute HCl-50 microliters dilute HCl;
(--): solution A in 2cm cell; (---): solution B in
Scm cell; (••••): solution C in lOcm cell.
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FIGURE 491 Aggregation of porcine zinc-free insulin
as evidenced by circular dichroism spectroscopy:
Effect of EDTA.
Buffer: 0.067M phosphate, pH 7.47;
Addition pair: 10 microliters EDTA (l0- 1 M)-50 rnicroliters dilute HCl; (~-): solution A in 2cm cell;
(----): solution Bin Scro cell; (····): solution C in
lOcm cell.

- 70

QI

-

I

0

E

"C

-110

-150

-190

260

270

280

290

Wavelength (nm)

..

,.1

300

310

174
of -171 deg cw 2 per decirnolP.

This experiment was identical

to that above except for the addition of

It was
+?
presumed that the EDTA would chelate any traces of Zn that could cause insulin aggregation.

0.1~

EDTA.

As a result, it was

assumed that the CD changes were due solely to the aggregation
of zinc-free insulin.

The CD changes, on the other hand, must

2
be i~terpreted with caution since the Zn+ -EDTA complex may
still cause aggregation.

This seems unlikely, however, since

one method for the preparation of zinc-free insulin involved
the use

of EDTA (159).

The CD spectra of solutions A, Band

C for the addition pair "10 microliters dilute HCl-50 microliters Cr+ 3 " are shown (Figure 50).

For solution A the

negative extremum was observed at 273nm with an ellipticity
of -188 deg cm 2 per decimole.

For solution B, the extremum

was observed at 275nm with an ellipticity of -196 deg crn 2 per
decimole and for solution C it was observed at 273nm with an
ellipticity of -182 deg crn 2 per decimole.

Similar spectra

. d f or t h e a dd ition
. .
.
'' 5 0 micro
.
1 iters
.
were o b taine
pair
Cr + 3 - 10
microliters dilute HCl" and as a result it was not included
in this evaluation.

The CD spectra of solutions A, B and C

2
for the addition pair "10 microliters Zn+ -50 microliters
dilute HCl" are shown (Figure 51).

For solution A the nega-

tive extremum was observed at 276nm with an ellipticity of
-256 deg cm 2 per decimole.

For solution B the extremum was

observed at 277nm with an ellipticity of -222 deg cm 2 per
decimole and for solution C it was observed at 273nm with an
ellipticity of -186 deg cm 2 per decimole.

Similar spectra
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FIGURE 50~ Aggregation of porcine zinc-free insulin as
evidenced'by circular dichroism spectroscopy: Effect of
trivalent chromium. Buffer: 0.067M phosphate, pH 7.47;
Addition pair: 10 microliters dilute HCl-50 microliters
cr+3; (~-): solution A in 2cm cell; (----): solution B
in Scm cell; ( • • • ·) : solution C in 1 Ocm eel 1.
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FIGURE 51: Aggregation of porcine zinc-free insulin as
evidenced' by circular dichroism spectroscopy: Effect of
zn+2.
Buffer: 0.067M phosphate, pH 7.47; Addition pair:
10 microliters zn+2-so microliters dilute HCl; (--):
solution A in 2cm cell; (----): solution B in Scm cell;
(••••): solution C in lOcm cell.
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were obtained for the addition pair ''50 microliters dilute
IICl-10 microliters Zn+ 211 .

The CD spectra of solutions A, B

and C for the addition pair ''50 microliters Cr+ 3 -10 microliters zn+ 2 ,, are shown (Figure 52).

For solution A the nega-

tive extremum was observed at 275nm with an ellipticity of
-191 deg crn 2 per decimole.

For solution B the extremum was

observed at 274nm with an ellipticity of -189 deg crn 2 per
decirnole and for solution C it was observed at 273nm with an
ellipticity of -172 deg cm 2 per decimole.

Similar spectra

\·Jere obtained for the addition pair "10 rnicroli ters Zn + 2 50 microliters Cr+ 311 .

Up to this point the CD changes for

the 8 addition pairs have been briefly reviewed.

The entire

picture is clarified by a sumrnary of the CD changes at 2 7 4nm
for the various addition pairs (Table XVII).

It is evident

that the addition of EDTA to porcine zinc-free insulin resulted in little change in the CD band at 274nm for solutions
A, B and C although a slight diminution occurred for solutions B and C.

The addition of trivalent chromium on the

other hand, resulted in a dimunition of the CD band for solution A and a slight increase in the CD response for solutions
B and C when compared to zinc-free insulin.

The addition of

zinc resulted in a significant increase in the response at
274nm.

.
When both Zn +2 and Cr +3 were present, however, zinc

did not induce an increase in the CD band at 274nm.

In this

case the response for the individual solutions seemed to be
less than that of zinc-free insulin without any additions.
Implications will be presented in Chapter IV.

Upon completion
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FIGURE 52. Aggregation of porcine zinc-free insulin as
evidenced· b~ circular dichroism spectroscopy: Effect of
cr+3 and Zn 2. Buffer: 0.067M phosphate, pH 7.47; Addition pair: 50 microliters cr+3_10 microliters zn+2;
(--): solution A in 2cm cell; (----): solution B in
5cm cell; ( • • · ·): solution C in lOcm cell.
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TABLE XVII.
pairs.

Ellipticity at 274nm for various addition
I

Ellipticity (deg cm 2 dmole- 1 ) at 274nm
Solution
zn+ 2 -Hcl

Cr +3 - z n +2

-187

-246

-190

-186

-194

-219

-189

-171

-180

-186

-172

HCl-HCl *

EDTA-HCl

A

-197

-198

B

-191

c

-176

HC1-Cr+ 3

*Refers to zinc-free insulin with aliquots of dilute HCl
added to compensate for the other additions. For the
composition of solutions A, B and C and the concentrations
of zn+2 and cr+3, see Chapter II.

180
of the CD spectra, UV scans over the range of 250 to 320nm
were recorded for all solutions.

Since 8 addition pairs were

studied, the stock solution was prepared and dilutions made
at least 8 times.

Absorbance at 276nm for the stock solu-

tions and resulting dilutions along with their respective
concentrations are shown (Table XVIII).
rang~

The concentration

for the stock solutions was .860 to .904mg/ml.

The

concentration range for solution A was .443 to .465mg/ml
while that for solutions B and C were .168 to .178 and .085
to . 089, .respectively.

The fluctuations between the approxi-

mate concentrations (by weight) and the actual concentrations
[utilizing an extinction coefficient of 1.04 ODU/cm (mg/ml)]
are evident.

·Among the probable causes was the accumulation

of moisture with continued thawing and freezing of the freezedried insulin sample despite the precautions mentioned in
Chapter II.

Another cause involved the preparation of the

stock insulin solutions.
of insulin to 25ml.

They were prepared by diluting 25mg

Working with such small amounts can in-

troduce error among repetitive weighings.

Differences in

insulin concentration among the various experiments, however,
did not effect the CD data since
residue ellipticity.

e

was expressed as the mean

See Chapter II for further details.

Upon completion of the UV spectra, the pH of each solution
was recorded (Table XIX) .

In most cases the values were within

the range 7.42 to 7.48.
Finally, it was decided to study the time dependency of
the CD change at 274nm.

Solutions containing insulin at con-

-~~

.42

t

~

TABLE XVIII. Absorbance at 276nm and resulting concentrations for insulin
aggregation study by circular dichroism spectroscopy.

Absorbance at 276nrn and Concentration
Addition
Pair
Stock

Solution A

Solution B

Solution C

Actual Approx. A
Actual Approx.
Approx. A
Actual Approx. A Actual
A276 Cone.
Cone.
Cone.
276 Cone.
Cone.
27 6 Cone.
Cone.
27 6 Cone.
(mg/ml) (rng/ml)
(mg/ml) (rng/ml)
(mg/ml) (mg/ml)
(rrg/ml)
(mg/ml)

--

--

--

--

1

.903

.868

0.5

.443

.426

0.2

.178

.171

0.1

.089

.086

HC1-Zn+ 2

1

.940

.904

0.5

.458

.440

0.2

.185

.178

0.1

.091

.088

zn+ 2-oc1

1

.921

.886

0.5

.459

.441

0.2

.181

.174

0.1

.092

.088

Cr+ 3-HC1

1

.931

.895

0.5

.464

.446

0.2

.183

.176

0.1

.092

.088

HCl~r+ 3

1

.894

.860

0.5

.454

.437

0.2

.175

.168

0.1

.088

.085

LJn+2~ r +3

1

.913

.878

0.5

.449

.432

0,2

.183

.176

0.1

.091

.088

er+ 3-zn+ 2

1

.908

.873

0.5

.465

.447

0.2

.180

.173

0.1

.091

.088

EIJI'A-HCl

1

.926

.890

0.5

.455

.438

0.2

.182

.175

0.1

.093

.089

'7

*Refers to dilute HCl (pH 3. 5).

f-'

·co

HCl-OCl*

t-'

r

182
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TABLE XIX.
Final pH for selected addition pairs in
insulin aggregation study by circular dichroism
spectroscopy.

pH
Solution
I-ICl-HCl
Base A**

*

EDTA-I-!Cl

HCl-Cr

+3

Zn

+2

-HCl

Cr

+3

-Zn

7.47

7.48

7.44

7.47

7.42

A

7.44

7.45

7.41

7.44

7.39

Base E

7.45

7.47

7.45

7.46

7.43

B

7.45

7.46

7.44

7.45

7.42

7.46

7.46

7.45

7.47

7.44

7.45

7.46

7.45

7.46

7.44

Base

c

c

**Refers to the pH of the baseline solution detailed in
Chapter II.
The solution contains no protein.
*Refers to dilute HCl {pH 3.5).

+2

r

183
centrations equivalent to that of solutions A and B above
were prepared.

Zinc was added as before and the solutions

were incubated for 1.5 hours after which trivalent chromium
was added and the CD intensity monitored at 274nm with time
(Figure 53).

See Chapter II for details.

It can be seen

that the dimunition of the negative circular dichroic band
was complete in about 30 minutes with most of the change
occurring in the first 15 minutes.
CD change was determined.

In each case the total

Variations of percent of the total

CD change with time are shown (Table XX).

An attempt was also

made to monitor the effect of adding zinc to zinc-free insulin and recording the increase in CD intensity at 274nm.
CD increases were observed but the time dependency could not
be recorded because of the rapidity of the reaction.

In both

cases above, the pH remained constant throughout the study.
Frontal Gel Analysis of Insulin
For the frontal gel studies, a column was prepared, and
calibrated with specific markers as described in Chapter II.
The elution volumes (Ve) for the various markers were determined and the weight average sieve coefficients (ow) calculated
(Table XXI).

Note the reproducibility of the elution volumes

for the two determinations shown.

A standard curve was then

prepared by plotting the sieve coefficients versus the natural
log (ln) of the molecular weights (Figure 54).

Various solu-

tions of porcine zinc-free insulin were then prepared in
0.067M phosphate buffer, pH 7.42, according to Table V.

UV

scans over the range of 212 to 320nm were performed on each

184
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FIGURE 53~ The effect of trivalent chromium on the CD
spectrum of porcine zinc insulin: Time dependency at
274nrn. Buffer: 0.067M phosphate, oH 7.47. Addition
at T=O: 50µ1 of stock (1 X 10-lM) ~r+3 solution;
A: solution A; B: solution B.
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TABLE xx. The effect of trivalent chromiu~ on the CD
spectrum of porcine zinc-insulin: Variation of percent
of the total CD change with time.

Ellipticity in deg cm 2 dmole-l

(Min) 81
5

Solution B

Solution A

T

82-81 % Total

82

.

e1

82

82-81 % Total

-90 . -51

39

48

-90

-58

32

49

10

-90

-28

62

76

-90

-41

49

75

15

-90

-17'

73

89

-90

-33

57

88

20

-90

-12

78

95

-90

-28

62

95

25

-90

- 9

81

99

-90

-26

64

98

30

-90

-

82

100

-90

-25

65

100

8

TABLE XXI.
Column calibration for the self-association
of porcine zinc-free insulin as studied by frontal gel
chromatography.

MW

~1arker

Blue ·oextran **

Vel (ml)

Ve 2 (ml)

4.68

4.58

2,000,000

a

w + SD

*

Ovalb ..imin

45,000

4.85

4.81

.031 + .004

Chymotrypsinogen

25,000

5.48

5.47

.131 + .006

Myoglobin

17,700

6.00

5.93

.207 + .001

F.ibonuclease

12,600

6.43

6.38

.275 + .002

ACTG

4,500

7.81

7.73

.486 + .002

11.09

11. 08

1

K Cr0 ***
4
2

194

*Result of 2 determinations.
**Void volume (V

0

).

***Total volume (Vt).

r
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FIGURE 54~ Standard curve for the self-association of
porcine zinc-free insulin as studied by frontal gel
chromatography. Buffer: 0.067!·1 phosphate, pH 7.42;
Bed: Sephadex G-50 (superfine); Bedheight: 8.5cm; Flow
rate: 6ml per hour; 0: ovalburnin; C: chymotrypsinogen;
M: myoglobin; R: ribonuclease; A: ACTH.
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insulin solution to determine the actual concentrations and
to select the most appropriate wavelength at which to monitor the insulin solutions during frontal chromatography.

UV

scans for a 1.0 and O.lmg/ml solution of insulin in phosphate buff er are shown (Figure 55) .

A wavelength of 280nm

was selected at which to monitor the lmg/ml solution.

It

is obvious that the O.lmg/ml solution could not be monitored
at the same wavelength because of the poor absorbance response.
As a result, 230nm was selected for monitoring this solution.
Each insulin solution was then applied to the column and the
absorbance monitored at the selected wavelength.

Elution

profiles were obtained, two examples of which are shown
(Figure 56).

Hypersharp unimodal leading boundaries, a plateau

and diffuse unimodal trailing boundaries are evident.

It

was somewhat difficult to determine the elution volumes from
these profiles.

An estimate for the 4mg/ml solution would

be between 6 and 6.Sml and for the 0.05mg/ml solution between
7.5 and 8.5ml.

To obtain an accurate value for the elution

voluMes, the leading boundaries of the elution profiles were
differentiated (Figure 57).

Elution volumes of 6.2 and 8.0ml

for the 4 and 0.05mg/ml insulin solutions were recorded.

Sieve

coefficients were then calculated from the elution volumes as
discussed in Chapter II.

With the aid of the sieve coeffi-

cients, the weight average molecular weights

(~1w)

were

determined from the previously prepared standard curve.

All

insulin concentrations studied were treated similarly.

Actual

concentrations (as determined by extinction coefficient),
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FIGURE 55.
UV scans of porcine zinc-free insulin:
Selection of wavelengths for monitoring during frontal
gel chromatography.
Sample: lmg/ml insulin (~-) and
O.lmg/ml insulin (---) in 0.067M phosphate buffer,
pH 7.42.
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FIGURE 57: Differentiation of the elution profiles to
determine· elution volumes.
(--) : 4mg/ml insulin;
(----): O.OSmg/ml insulin.
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monitoring wavelengths, elution volumes, sieve coefficients
and molecular weights were recorded (Table XXII).

The pH

remained at 7.42 throughout the study.
In the remaining frontal gel studies, a nitrated insulin
was utilized for column calibration.

It was felt that a non-

associating marker with a molecular weight in the range of the
insulin monomer was most desirable since this is the limiting
molecular weight approached on continued dilution of the insulin solutions.

Because of the scarcity of a commercially

available marker in this molecular weight range, a nitrated
insulin was synthesized as discussed previously.

Before using

this compound as a marker, it was subjected to frontal gel
chromatography at pH 7.42 to study its associative properties.
As before, wavelengths had to be selected at which to monitor
the elution profiles.

Two solutions of the nitrated insulin

were prepared, namely 0.5 and 0.05mg/ml.

UV scans were per-

formed over the range of 210 to 370nm (Figure 58).

Wavelengths

of 305 and 220nm were selected at which to monitor the 0.5 and
0.05mg/ml solutions, respectively.

The nitrated insulin pre-

parations were then subjected to frontal gel chromatography
after which the elution profiles were differentiated and the
elution volumes determined (Figure 59).

Elution volumes of

8.71 and 8.75ml were obtained for the 0.5 and 0.05mg/ml
solutions, respectively.

In the previous study (Table XXII)

non-nitrated insulins had elution volumes of 7.23 and 8.00ml
for the same concentration range.

These results seemed to

indicate that the nitrated insulin did not aggregate at pH 7.42

193

Summary of results for the self-association
of porcine zinc-free insulin as studied by frontal gel
chromatography.

Tl\BLE XXI I.

Approx.
Cone.
(mg/ml)

Actual
Cone.
(mg/ml)

4

Monitoring
Wavelength

ve

aw

~

w

(HM)

(ml)

3.928

291

6.20

.1348

26,077

2

1. 957

288

6.43

.1704

21,829

1

.981

280

6.88

.2401

15,411

.9

.882

280

7.05

.2665

13,507

.7

.687

280

7.05

.2665

13,507

.5

.491

240

7.23

.2943

11,756

.3

.294

238

7.40

.3207

10,304

.1

. 09 8

230

7.85

.3904

7,274

. 05

.049

220

8.00

.4136

6,478

. 01

.0098

224

8.40

.4756

4,753

.005

.0049

212 *

8.47

.4864

4,503

*Scale expansion utilized.
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FIGURE 58~ UV scans of nitrated porcine insulins: Selection
of wavelengths for monitoring during frontal gel chromatography.
Buffer: 0.067M phosphate, pH 7.42; ( - ) : 0.5mg/ml;
(----).: O. 05mg/ml.
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over the concentration range studied.

The column was

calibrated utilizing the markers discussed in Table VII.
Elution .volumes were determined and sieve coefficients calculated (Table XXIII).

With the aid of the sieve coefficients,

a standard curve was drawn as before (Figure 60).

The slope

was determined to be approximately -2.33 while that for
Figuxe 54 was -2.00.

Finally, solutions A, B and C were

subjected to frontal gel chromatography in 0.067M phosphate
buffer, pH 7.42.

Details concerning the preparation and

composition of these solutions are located in Chapter II under
the CD aggregation study.

UV scans of the stock solutions

and dilutions (solutions A, B and C) were taken prior to the
addition of cr+ 3 and zn+ 2 (Figure 61).

Wavelengths of 239,

234 and 229nm were chosen at which to monitor solutions A, B
and C, respectively.

The absorbance at 276nm and resulting

insulin concentrations were determined for each solution
(Table XXIV).

Aliquots of cr+3 and zn+2 were added as addition

pairs and the solutions incubated at room temperature for a
total of 3 hours (Table XXV).

Upon completion of the in-

cubation period, the solutions were subjected to frontal gel
chromatography as discussed in Chapter II.

Elution profiles

representing solutions A, B and C for the "10µ1 dilute HCl50µ1 dilute HCl" addition pair are shown (Figure 62).

To

simplify matters, only that portion of the elution profile
corresponding to the leading boundary is presented.

Through

differentiation of the elution profiles, elution volumes of
7.50, 7.91 and 8.22rnl were obtained for solutions A, Band C,

TABLE XXIII.
Column calibration for the effect of Cr +
and zn+ 2 on the self-association of porcine zinc-free
insulin as studied by frontal gel chromatography.

:1arker
Blue·Dextran **

MW
2,000,000

Vel (ml) V8 2 (ml) Ve3

(ml)

4.58

4.67

4.54

3

*
ow + SD

Carbonic
Anhydrase

31,000

6.17

6.04

5.98

.194 + .011

Chymotrypsinogen

25,000

6.19

6.26

6.14

.212 +

Myoglobin

17,000

6.87

6.84

6.79

.297 + .006

Ribonuclease

12,600

7.44

7.42

7.30

.370 + .004

3.98

8.84

.573 + .001

12.19

12.04

Nitrated Insulin
K2 Cr04

5,891

***
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12.19

*Result of 3 determinations except nitrated insulin
(2 determinations).
**Void volume (V0

).

***Total volume (Vt).
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FIGURE 60~ Standard curve for the effect of cr+ 3 and
zn+2 on the self-association of porcine zinc-free
insulin as studied by frontal gel chromatography.
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50
(superfine); Bedheight: 9.0crn; Flow rate: 6ml per hour;
CA: carbonic anhydrase; C: chyrnotrypsinogen; M: rnyoglobin;
R: rihonuclease; In: nitra~ed insulin.
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FIGURE 61~ UV scans of solutions A, B and C: Selection
of wavelengths for monitoring during frontal gel chromatography of porcine zinc-free insulin.
Buffer: 0.067M
phosphate, pII 7.42; A: stock (lmg/ml) insulin solution;
B: solution A (O.Smg/ml); c. solutions B (0.25mg/ml);
D: solution C (O.lmg/ml).
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TAB~E XXIV.
Absorbance at 276nm and resultin2 insulin
·concentrations for the effect of cr+3 and zn+ on the
self-association of procine zinc-free insulin as studied
by frontal gel chromatography.

Addition
Pair'

Stock
A276

Solution A

Solution B

Solution C

Cone. *
Cone.
Cone.
Cone.
(mg/ml) A276 (mg/ml) A276 (mg/ml) A276 (mg/ml)

HCl-HCl** .957

.920

.478

.460

.182

.175

.096

.092

Zn+ 2 -EC1

.980

.942

.488

.469

.198

.190

.097

.093

HC1-Cr+ 3

.972

.935

.485

.466

.185

.178

.098

.094

2 " + 3 . 984
Zn + -..._r

.946

.488

.469

.187

.180

.097

.093

*Utilizing an extinction coefficient of 1.04 ODU/cm (mg/ml).
**10µ1 dilute HCl-50µ1 dilute HCl, synonymous with the term
"no addition".

r
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TABLE XXV.
Incubation periods and additions for the effect
of cr+J and zn+2 on the frontal gel chromatography of porcine zinc-free insulin.

Addition
Pair

0 to l . 5hrs

l. 5 to 3hrs

ECl-HCl

10µ1 dilute HCl

50µ1 dilute HCl

Zn+ 2 -HC1

10µ1 Zn+2

50µ1 dilute HCl

HC1-Cr+ 3

10µ1 dilute HCl

50µ1 Cr+ 3

Zn +2 - c r +3

10µ1 zn+ 2

50µ1 Cr+ 3

r

202

..

.....

.8

--- -----FIGURE 62~ Elution profiles for the frontal gel chromatography of porcine zinc-free insulin: No addition.
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50
(superfine); Bedheight: 9.0cm; Flow rate: 6.0ml per hour;
Addition pair: 10µ1 dilute I-ICl-50µ1 dilute HCl; (--):
solution A; (----): solution B; ( · · · ·): sol:1tion C.

I

.6
I

Q)

I

u

I.

•

I

Rt

..

I

I

c

.a

/

/

I

I

.4

I
I
I
I
I
I

0

(I)

.a

ca:

I
I

I
I
I

.2

I

I
I

_...

0 .__ _ _.--=;;__,... ............ .
6

7

I

,1

.

•

•
•

8

Volume (ml)

..

,-1

9

10

r

203
respectively.

Similarly, elution profiles representing

solutions A, B and C for the "10µ1 dilute HCl-50µ1 cr+3,,
addition pair are shown (Figure 63).

In this case elution

volumes of 7.51, 7.95 and 8.24ml were obtained for solutions
A, B and C, respectively.

It is quite clear that very little

difference exists between this and the previous addition pair.
The third addition pair studied was "10µ1 Zn+ 2 -50µl dilute
HCl".

The elution profiles representing solutions A, Band

C for this addition pair along with elution profiles for
solutions:A, B and C in the absence of zn+ 2 are shown (Figure 64).
For the Zn+ 2 addition pair, elution volumes of 6.93, 7.74 and
8.26ml were obtained for solutions A, B and C, respectively.
Finally, the addition pair "10µ1 Zn
(Figure 65).

+2

-50µ·1 Cr

+3

.
" was studied

Elution volumes of 7.41, 7.89 and 8.23ml were

obtained for solutions A, B and C, respectively.

It is ob-

vious that zn+ 2 does not have the same effect on elution volume
in the presence of cr+ 3 as in its absence.

To clarify the

matter, elution profiles for solutions A, B and C in the presence of Zn +2 and in the presence of Zn +2 and Cr +3 are shown
(Figure 66).

Sieve coefficients were then calculated and

molecular weights determined from the previously prepared
standard curve.

A summary including these values for all addi-

tion pairs to solutions A, B and C is presented (Table XXVI).
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FIGURE 63. Elution profiles for the frontal gel chromatography of porcine zinc-free insulin: Effect of cr+3.
Buffer: 0.067M phosphate, pH 7.42; Bed: Sephadex G-50
(superfine); Bedheight: 9.0cm; Flow rate: 6.0ml per hour;
Addition pair: 10µ1 dilute HCl-50µ1 cr+3; (~-): solution
A;(----): solutionB; (••••): solutionC.
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FIGURE 64.· Elution profiles for the frontal gel chromatography of porcine zinc-free insulin: Effect of zn+2
compared to no addition. Buffer: 0.067M phosphate,
pH 7.42; Bed: Sephadex G-50 (superfine); Bedheight:
9.0cm; Flow rate: 6ml per hour; Addition pairs: 10µ1
zn+2_50µ1 dilute llCl ( - ) and 10µ1 dilute HCl-50µ1
dilute HCl (-·-·-·); A: solution A; B: solution B;
C: solution C.
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FIGURE 66: Elution profiles for the frontal gel chromatography of porcine zinc-free insulin: Effect of zn+2
and cr+3 compared to effect of zn+2. Buffer: 0.067M
phosphate, pH 7.42; Bed: Sephadex G-50 (superfine);
Bedheight: 9.0crn; Flow rate: 6ml per hour; Addition pairs:
10µ1 zn+2-soµl cr+3 (---) and 10µ1 zn+2_50µ1 dilute HCl
(~-);A: solution A; B: solution B; C: solution C.
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TABLE XXVI.
Elution volumes, sieve coefficients and molecular weights of
solutions A, B and c for the effect of zn+2 and cr+3 on the frontal gel
chromatography of porcine zinc-free insulin.

zn+ 2 -Hcl

HCl-BCl *

Zn +2 - c r +3

HC1-Cr+3

Solution
Ve
(ml)
A

aw

M

w

Ve

M

Ve
aw
MW
w
(ml) ~~- -~~- (ml) _ _ _ __
aw

ve

aw

MW

(ml)

7.50 .3846 12,502 6.93 .3090 16,866 7.51 .3859 12,438 7.41 .3727 13,105
1\)

0

co
B

7.91 .4390 10,079 7.74 .4164 11,022 7.95 .4443

9,870 7.89 .4363 10,187

c

8.22 .4801

8,474 8.23 .4814

8,565 8.26 .4854

8,387 8.24 .4828

*Refers to addition pair (10µ1 dilute HCl-50µ1 dilute HCl).

8,521

CHAPTER IV
DISCUSSION AND CONCLUSION

It is the purpose of this dissertation to provide
evidence for an interaction between insulin and trivalent
chromium with particular emphasis on the associativedissociative process of insulin.

Although the techniques of

infrared analysis of hydrogen-deuterium exchange and thermal
denaturation of insulin-chromium (III) solutions provided
valuable evidence for an interaction between insulin and chromium they did not focus on the aggregation process.

Possible

conclusions concerning these two techniques were included in
Chapter III and will not be discussed further.

The remainder

of this discussion will be concerned with the techniques of
circular dichroism spectroscopy and frontal gel chromatography
which were specifically selected to provide evidence for the
effect of trivalent chromium on insulin aggregation.

Before

continuing, however, let us briefly discuss the topic of
chromium and insulin concentrations utilized in this dissertation and how they related to physiological levels.

Feldman

(18) reported an average plasma chromium concentration of 29ppb.
It has also been suggested (19) that plasma concentrations of
chromium may only represent 1/100 of the chromium concentrations
in most organs.

With these figures in mind and equating lppb

with lng/ml we can arrive at an approximation of plasma and
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tissue chromium levels.
TABLE XXVII.

Approximate physiological levels of insulin,
chromium and zinc.
Concentration
(M)

Plasma chromium

10- 7

Tissue chromium

10- 5

Plasma Insulin (116)

10- 9

Plasma Zinc (116)

10- 5

With regard to the chromium levels, the reader must be cautioned that a great deal of uncertainty exists in these values.
Low chromium levels do not necessarily indicate chromium def iciency since the metal is rapidly sequestered by certain
tissues.

Plasma levels are more appropriately a measure of

the most recent dietary intake.

It should also be pointed out

that plasma chromium concentrations increased considerably after
oral administration of glucose in both healthy subjects and
certain cases of impaired glucose tolerance (50).

No inform-

ation could be obtained regarding a similar behavior for zinc.
As a result plasma chromium concentrations may vary considerably
and it doesn't seem unreasonable to say that plasma chromium
levels may attain a level equal or greater than plasma zinc.
It can be seen from the data of Table XXVII that the chromium
to insulin ratio may be in the vicinity of 100 to 1.

Whether

the same ratio exists at the tissue receptor level is unknown
since insulin and chromium concentrations at these sites cannot
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be determined at present.

Information such as this would be

extremely valuable since it may implicate the concentration
dependent insulin aggregation process in the regulation of
insulin action.
With regard to the circular dichroism and frontal gel
chromatography studies of this dissertation, the following
concentrations were utilized.
TABLE XXVIII.

Experimental values for insulin, chromium and
zinc concentrations.
Approximate Concentration
(M)

Circular
Dichroism

Frontal
Gel

Chromium

10- 4

10- 4

Insulin

10- 5

10- 5

Zinc

10- 5

10- 5

Insulin concentrations as low as l0- 6M (.005mg/ml) were studied
by means of frontal gel chromatography (Table XXII).

In this

case an expanded scale had to be utilized on the UV monitor
in order to obtain an adequate response.

This resulted in error

in the elution profile due to noise amplification.

The lower

limit of insulin concentration for frontal gel chromatography
without scale expansion was of the order of l0- 5M (0.05mg/ml).
Also, the same concentration (l0- 5M) was the lower limit for
an adequate response in the near-UV circular dichroism spectrescopy studies (Figure 40).

Clearly, in both cases above, the
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most dilute working solutions resulting in reliable data were
selected.
As discussed in Chapter II, circular dichroism spectroscopy represented an excellent technique for studying the
association-dissociation process of insulin.

That trivalent

chromium (the primary component of the glucose tolerance factor)
caused a significant change in the near-UV circular dichroism
spectrum of bovine zinc insulin was shown in Figure 40.

It

is evident that the addition of chromium resulted in a significant diminution of the circular dichroism spectrum of insulin.
Several interpretations are available for this behavior.

The

most obvious is that the process represents dissociation of
a higher aggregated insulin species since dissociation is related to a decrease in the circular dichroism spectrum and
association is related to an increase in the spectrum (122).
Changes in the near-UV circular dichroism region (250 to 320nm)
result mainly from changes in the orientation of the tyrosyl
residues of insulin as a consequence of the state of aggregation
(124).

Clearly, as insulin associates or dissociates, these

essential residues will either become exposed or buried.

See

Chapter I for details concerning orientation of specific residues
of the insulin monomer on association.
Frank et al.

To draw an analogy,

(160), reported a molecular weight of 17,500 for

porcine zinc insulin at a concentration of O.lmg/ml and a
zinc-to-insulin ratio of 1/3 in 0.03M phosphate buffer, pH 7.02.
The conditions of Figure 40 were identical except for the use
of 0.067M phosphate buffer, pH 7.42 which probably makes a
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negligible contribution to the molecular weight in comparison.
Considering a MW of 5778 for the insulin monomer, it is clear
that the observed CD change could be the result of a dissociative process.

Just exactly how cr+ 3 accomplished this process

is not quite clear.

One explanation may be a direct inter-

action with zinc at the level of the BlO histidines which are
involved in the conversion of dimer to hexamer (Figure 12).
The rationale behind this statement stems from an equilibrium
dialysis binding study in 0.02M phosphate buffer, pH 7.4,
concerning the binding of trivalent chromium to various biological substances (161}.

Of all the amino acids studied,

histidine had the most outstanding coordinating ability with
respect to trivalent chromium.

Also, changes in the near-UV

circular dichroism spectrum of insulin in the presence of zinc
have been attributed to hexamer formation (Figure 14).

If the

observed CD changes are due to dimer-monomer conversion, then
Cr

+3

would have to affect dissociation at the level of the re-

sidues responsible for dimer formation, particularly the nonpolar
sidechains of the B21 to B30 residues (Figure 10).

This is a

rather interesting point since the hydrophobic residues such
as B24 Phe, B25 Phe, B26 Tyr, Bl2 Val and Bl6 Tyr may be invalved in receptor binding (121).

Another interpretation for

the observed CD changes resulting from chromium interaction may
involve reaction of the metal with a non-specific surface residue
leading to a conformational change which indirectly results in
the release of zinc and consequent dissociation of the hexamer.
At the dimer level, the conformational change would have to
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disturb the beta-pleated sheet structure formed between residues in the B21 to B30 region (Figure 11).
That cr+3 would induce the same effect on insulin
conformation in the presence of high ionic strength can be
seen by comparing Figures 40 and 41.

Although slight dif-

ferences in the CD spectrum are evident, the same basic change
(diminution of the CD response) occurred in the presence of
trivalent chromium.

It must be remembered that in these two

cases the insulin concentration was approximately O.lmg/ml and
the chromium-to-insulin ratio was 10/1.

A similar study uti-

lizing a ratio of 0.58/1 resulted in no change in the CD
spectrum of zinc insulin.

Ratios between 0.58/l and 10/1 were

not studied in this segment.

Thus far, the only conclusion

that could be drawn is that trivalent chromium at a chromiumto-insulin ratio between 0.58/1 and 10/1 induces a significant
change in the near-UV circular dichroism spectrum of insulin
at physiological pH.

Higher chromium concentrations produce

basically the same change (Figure 42), however solubilization
problems are encountered as discussed in Chapter II.
The time dependency for trivalent chromium to produce
the change in the CD spectrum of bovine zinc insulin was of
the order of 23 minutes (Figure 43).

If one compares curve

"C" of Figure 43 with the respective curve of Figure 40, it is
obvious that no further change occurred between 23 minutes and
1 hour.

Such a long period for trivalent chromium to achieve

its effect does not seem unreasonable since it is well documented (25) that this metal, in this state, has a strong
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tendency to form complexes whose ligand rates of exchange are
low (half-times of several hours).
Up to now we have been dealing with the effect of
trivalent chromium on the CD spectrum of bovine zinc insulin.
In Figures 45 and 46 the insulin was of porcine origin.

The

same effect of trivalent chromium was observed (162), however,
there were obvious differences in the absolute ellipticities
attained.

Porcine insulin differs from that of bovine origin

in that it contains threonine and isoleucine at positions 8
and 10 in the "A" chain while bovine insulin contains alanine
and valine at these positions.

One point that deserves men-

tion with regard to Figure 45 is that consistent decreases in
the CD spectrum were observed when trivalent chromium was
added to porcine "zinc-free" insulin.

The reader will recall

that up to this point the major topic of discussion concerned
"zinc insulin".

Since the insulin preparation was termed "zinc-

free" it was tempting to assume that displacement of zinc by
chromium could be eliminated as one of the mechanisms of action
of chromium.

This cannot be done, however, since a minimum

amount of zinc was supposedly present (less than 0.035 g-atom
of zinc per mole of insulin).

In comparison, the zinc insulin

contained 0.44 g-atom per mole of insulin.

The term "zinc-free"

is used commonly and usually represents a maximal effort to
remove most of the zinc.
The associative process can be viewed in another manner
as described in Chapter II.

The basic principle revolves about

the fact that differences exist between non-aggregating and
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aggregating protein systems with respect to their circular
dichroisrn spectra; pairing protein concentration and cell
size such that the product equals one.
and lcm),

For example:

(lmg/ml

(0.Smg/ml and 2cm) and (O.lmg/ml and lOcrn).

For

an interacting protein system sucllias insulin which undergoes
a concentration dependent association, CD spectra representing
each pair will differ.

The behavior of porcine zinc-free in-

sulin in this system was shown in Figure 48.
degrees of association are evident.

The different

In an attempt to elimi-

nate the effects due to the presence of trace amounts of zinc,
the same experiment was performed in the presence of EDTA
(Figure 49).

Basically, the same spectra were obtained.

interpretations can be made:

Two

(1) The amount of zinc present

was insufficient to induce association resulting in no CD
change in the presence of EDTA.

The degree of association

observed would be solely due to side chain interactions between monomers.

(2) Both zinc and the zinc-EDTA complex have the

same affinity for the essential histidines involved in the zinc
induced aggregation.

The situation would also lead to no

change in the CD spectrum in the presence of EDTA.

This seems

unlikely since EDTA has been used as a precaution against the
effects of metal ion contamination during a sedimentation
equilibrium study involving the self-association of porcine
insulin at pH 7.00 (126).

The available evidence seems to

favor the first interpretation.

In a similar manner, trivalent

chromium was added to porcine zinc-free insulin (Figure 50) .
At a first glance the CD changes seem to be somewhat decreased
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when compared to Figure 48 which can be referred to as a
"baseline" CD change to which all others are compared.

Taking

a closer look (Table XVII), it is obvious that the value representing solution A for the HC1-Cr+ 3 addition pair is somewhat decreased at 274nm in comparison to the values representing solutions B and C which seem to be much closer to the
respective values for the HCl-HCl addition pair.

The data

seemed to indicate that trivalent chromium resulted in a dis-·
sociative effect for solution A whereas solutions B and C
were unaffected (163).
insulin (Figure 51).

Once again zinc was added to zinc-free
An expected aggregation related increase

in the CD spectra was observed for all solutions with a more
pronounced effect for solution A and less of an effect for
solutions B and C when compared to "no addition"
Table XVII).

(Figure 48,

The addition of both Cr+ 3 and Zn+ 2 (Figure 52,

Table XVII) resulted in very little to no change in comparison
to "no addition"

(Figure 48, Table XVII).

It is obvious that

zinc did not cause an associative effect in the presence of
trivalent chromium.

Since the same results were obtained ir-

respective of the sequence of addition, the above statement can
be turned around to say that trivalent chromium resulted in a
dissociation of the zinc-induced aggregated species.

Also, in

the other cases, the reversal of the addition sequence produced the same CD change resulting in only one sequence being
discussed.
So far the data seem to indicate that trivalent chromium
has a dissociative effect on the zinc induced insulin aggregate.

/
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It was estimated (Figure 43) that the reaction was completed
in about 23 minutes.

To take a closer look, the ability of

trivalent chromium to produce a decrease in the CD spectrum
of zinc insulin was followed with time at 276nm (Figure 53).
If it is assumed that no further change occurred after 30
minutes, the total CD change can be calculated (Table XX).
It is obvious that the greatest effect was produced within
the first 10 minutes.
The remainder of this discussion will be centered about
defining molecular weight variations that occur upon the addition of trivalent chromium to zinc insulin.

The technique of

frontal gel chromatography was utilized in an attempt to aid
in the clarification of the previously discussed circular
dichroism changes.

The technique was adapted to study insulin

aggregation on a small scale utilizing a 1.2 x 9cm. column such
that a total of 65mg of insulin was all that was required for
the complete study.

That an aggregating protein system such

as insulin can be studied by frontal gel chromatography was
clearly established (164, Table XXII).

Insulin concentrations

over the range of 0.005 to 4mg/ml were studied and molecular
weights from 4,503 to 26,077, respectively, were determined.
This is in excellent agreement with ultracentrifugational data
concerning insulin association at neutral pH (115) .

Let us

now turn to the topic of "standard curves" which play a
critical role in the determination of molecular weight distribution by frontal gel chromatography.

It is obvious from

Table XXII that the molecular weight of the insulin monomer
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will be less than 4,503 when it is actually 5,778.

Such

variance is not unreasonable since there is a small amount
of deviation in the sieve coefficient for a single protein
as determined by repetitive chromatography.

For example,

for chymotrypsinogen (MW 25,000) the sieve coefficient was
reported as .131

~

.006 for two successive experiments.

On

the other hand, the sieve coefficient for myoglobin (MW 17,700)
was .207 + .001.

The larger proteins (MW greater than 25,000)

seemed to deviate somewhat more on repetitive chromatography
(Table XXI).

A closer look should be taken at the standard

curve for this frontal gel experiment (Figure 54).

It is ob-

vious that a curve with a greater slope would have resulted in
a larger molecular weight for the insulin monomer.

It was

reasoned that such a curve may have resulted if the two limiting
proteins, namely ovalbumin (MW 45,000) and ACTH (MW 4,500) were
eliminated.

The reader will recall from Table XXI that the

sieve coefficient for ACTH was determined to be in the range of
.484 to .488.

Insulin monomer, which has a molecular weight

greater than that of ACTH should have exhibited a sieve coefficient somewhat less than that of ACTH.

Keeping in mind

that the sieve coefficient for the insulin monomer is approached
upon dilution, it is obvious that its final value will be in the
range of that for ACTH (Table XXII).

The reader should also

be aware that the difference in molecular weight for insulin and
ACTH is only small and it is reasonable to assume that they
may not be separable under the conditions of this technique.
In any event it was decided to replace this protein by a
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nitrated insulin (MW 5891).

For ovalburnin, it was felt that

it eluted with a volume too near that of blue dextran which
was used in the determination of void volume and was completely excluded from the resin.

For the remaining experiments

ovalbumin was replaced by carbonic anhydrase (MW 31,000).
Before continuing, the use of nitrated insulin for a
marker protein should be discussed.

The procedure and results

concerning the synthesis of this insulin derivative were included in Chapters II and III.

Basically, any protein utilized

for column calibration should not possess aggregating properties.

That this derivative did not aggregate over the

concentration range of 0.05 to 0.5mg/ml was clearly shown
(Figure 59).

In comparison, insulin (non nitrated) exhibited

molecular weights of 6,478 and 11,756 at 0.05 and 0.5mg/ml,
respectively (Table XXII).

Finally the column was calibrated

with the new series of markers (Table XXIII) and a standard
curve drawn (Figure 60).

The slope of this curve was -2.33

in comparison to the previous curve which was -2.00.

In

any event, this curve was selected for the experimentation
involving the effect of trivalent chromium on insulin molecular weight distribution.
Solutions A, B and

c,

identical to those used in the

CD aggregation study, were prepared as described in Chapter
II.

A description of the various additions and insulin con-

centrations for solutions A, B and C in this study were located
in Table XXIV.

When the series representing "no addition" to

insulin (Table XXIV) was subjected to frontal gel chromatography,
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a clear separation of the leading boundaries representing each
solution was achieved

(Figure 62).

Utilizing the standard

curve, the molecular weights were determined to be 12,502,
10,079 and 8,565 for solutions A, B and C, respectively
(Table XXVI).

This provides excellent supportive evidence

that the changes observed for zinc-free insulin in the previous
CD study (Figure 48) most likely represented an aggregation
process.

When trivalent chromium was added to zinc free

insulin, very little change resulted in the molecular weight
distribution (Figure 63, Table XXVI) when compared to "no
addition".

The reader will recall, that in the CD aggregation

study (Figure 50, Table XVII), the addition of trivalent chromium resulted in a decreased CD spectrum for solution A whereas
solutions B and C were basically unaffected.

Now, it may be

that the aggregation process was affected, but it was too subtle to be picked up by frontal gel chromatography.

In any

event, the available CD evidence seems to indicate that trivalent chromium has a definite effect on zinc-free insulin
conformation at a concentration of 0.5mg/ml and it most likely
represents a direct interaction at the level of the residues
responsible for dimer formation.

When Zn

+2 as the "Zn +2 -

dilute HCl" addition pair was added to zinc-free insulin, an
aggregation related increase in weight-average molecular
weight (Mw) and consequent decrease in elution volume (Ve) was
obtained (Figure 64).

Weight average molecular weights of

16,866, 11,022 and 8,387 were obtained for solutions A, B and
C, respectively (Table XXVI).

The increase in

Mw

was probably
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due to a shift of the equilibrium toward hexamer formation
(Figure 12).

Finally, when zn+ 2 and cr+3 were present

together, irregardless of the sequence of addition, the zincinduced aggregation of insulin did not occur and the weightaverage molecular weights remained very similar to the values
corresponding to "no addition", namely "dilute HCl-dilute HCl".
The only exception was that the ~ for solution A in the presence of zn+ 2 was somewhat higher than that for "no addition"
(Table XXVI), indicating that the species did not dissociate
to the same extent in the presence of cr+3.

To place this

situation into perspective, the elution profiles representing
"no addition" and "zn+2_cr+3" were shown together (Figure 66).
These data are in excellent agreement with the circular dichroism spectroscopy data discussed above.

Clearly, insulin

did not associate to the same extent in the presence of zn+ 2
when cr+3 was present.
Previous investigators have labeled trivalent chromium
as a co-factor of insulin (161) and yet a direct relationship
on a molecular level between trivalent chromium and insulin has
never been established.

The results of this dissertation have

provided evidence for such a relationship and as a result have
contributed toward the understanding of the mechanism of action
of this trace metal.

As far as the site of such a reaction

is concerned, one can only speculate.

It may be that trivalent

chromium acts at the level of the pancreatic beta cell, facilitating the release of insulin through its dissociative effect.
On the other hand, the dissociative effect of trivalent chromium
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on insulin may be involved at the level of the insulin
receptor.

Whether the aggregation phenomenon of insulin

plays a role in insulin action remains a mystery.

Since the

discovery some time ago that chromium was a major component
of the glucose tolerance factor, a wide variety of data has
been published linking this element with impaired glucose
tolerance and indirectly with insulin action.

In view of the

fact that the identity of the glucose tolerance factor is as
yet unknown, and that crude extracts of glucose tolerance
factor and synthetic complexes resembling this factor have
significantly greater effects on glucose oxidation in the
presence of insulin than insulin alone, it seems reasonable
to predict that trivalent chromium, when part of the glucose
tolerance factor, is at an optimal sterochemical orientation
to permit maximum interaction with insulin.
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